
<html lang="en"     class="pb-page"  data-request-id="001948da-bc5a-40a7-9466-20b28080df70"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm1003232;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2010.53.issue-12"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Characterization of in Vitro and in Vivo Profiles of Hydroxybupropion Analogues: Aids to Smoking Cessation" /></meta><meta name="dc.Creator" content="Ronald J.  Lukas" /></meta><meta name="dc.Creator" content="Ana Z.  Muresan" /></meta><meta name="dc.Creator" content="M. Imad  Damaj" /></meta><meta name="dc.Creator" content="Bruce E.  Blough" /></meta><meta name="dc.Creator" content="Xiaodong  Huang" /></meta><meta name="dc.Creator" content="Hernán A.  Navarro" /></meta><meta name="dc.Creator" content="S. Wayne  Mascarella" /></meta><meta name="dc.Creator" content="J. Brek  Eaton" /></meta><meta name="dc.Creator" content="Syndia K.  Marxer-Miller" /></meta><meta name="dc.Creator" content="F. Ivy  Carroll" /></meta><meta name="dc.Description" content="To create potentially superior aids to smoking cessation and/or antidepressants and to elucidate bupropion’s possible mechanisms of action(s), 23 analogues based on its active hydroxymetabolite (2S..." /></meta><meta name="Description" content="To create potentially superior aids to smoking cessation and/or antidepressants and to elucidate bupropion’s possible mechanisms of action(s), 23 analogues based on its active hydroxymetabolite (2S..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 28, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm1003232" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm1003232" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm1003232" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm1003232" /></link>
        
    
    

<title>Synthesis and Characterization of in Vitro and in Vivo Profiles of Hydroxybupropion Analogues: Aids to Smoking Cessation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm1003232" /></meta><meta property="og:title" content="Synthesis and Characterization of in Vitro and in Vivo Profiles of Hydroxybupropion Analogues: Aids to Smoking Cessation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0003.jpeg" /></meta><meta property="og:description" content="To create potentially superior aids to smoking cessation and/or antidepressants and to elucidate bupropion’s possible mechanisms of action(s), 23 analogues based on its active hydroxymetabolite (2S,3S)-4a were synthesized and tested for their abilities to inhibit monoamine uptake and nAChR subtype activities in vitro and acute effects of nicotine in vivo. The 3′,4′-dichlorophenyl [(±)-4n], naphthyl (4r), and 3-chlorophenyl or 3-propyl analogues 4s and 4t, respectively, had higher inhibitory potency and/or absolute selectivity than (2S,3S)-4a for inhibition of DA, NE, or 5HT uptake. The 3′-fluorophenyl, 3′-bromophenyl, and 4-biphenyl analogues 4c, 4d, and 4l, respectively, had higher potency for antagonism of α4β2-nAChR than (2S,3S)-4a. Several analogues also had higher potency than (2S,3S)-4a as antagonists of nicotine-mediated antinociception in the tail-flick assay. The results suggest that compounds acting via some combination of DA, NE, or 5HT inhibition and/or antagonism of α4β2-nAChR can potentially be new pharmacotherapeutics for treatment of nicotine dependence." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm1003232"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm1003232">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm1003232&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm1003232&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm1003232&amp;href=/doi/10.1021/jm1003232" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 4731-4748</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100230k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm1003683" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Characterization of in Vitro and in Vivo Profiles of Hydroxybupropion Analogues: Aids to Smoking Cessation</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+J.++Lukas">Ronald J. Lukas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana+Z.++Muresan">Ana Z. Muresan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=M.+Imad++Damaj">M. Imad Damaj</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+E.++Blough">Bruce E. Blough</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaodong++Huang">Xiaodong Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hern%C3%A1n+A.++Navarro">Hernán A. Navarro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S.+Wayne++Mascarella">S. Wayne Mascarella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Brek++Eaton">J. Brek Eaton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Syndia+K.++Marxer-Miller">Syndia K. Marxer-Miller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+Ivy++Carroll">F. Ivy Carroll</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Center for Organic and Medicinal Chemistry, Research Triangle Institute, P.O. Box 12194, Research Triangle Park, North Carolina 27709</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 919-541-6679. Fax: 919-541-8868. E-mail: <a href="/cdn-cgi/l/email-protection#ef89868caf9d9b86c1809d88"><span class="__cf_email__" data-cfemail="086e616b487a7c6126677a6f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm1003232&amp;href=/doi/10.1021%2Fjm1003232" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 4731–4748</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 28, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 March 2010</li><li><span class="item_label"><b>Published</b> online</span>28 May 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 June 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm1003232" title="DOI URL">https://doi.org/10.1021/jm1003232</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4731%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRonald%2BJ.%2BLukas%252C%2BAna%2BZ.%2BMuresan%252C%2BM.%2BImad%2BDamaj%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D12%26contentID%3Djm1003232%26title%3DSynthesis%2Band%2BCharacterization%2Bof%2Bin%2BVitro%2Band%2Bin%2BVivo%2BProfiles%2Bof%2BHydroxybupropion%2BAnalogues%253A%2BAids%2Bto%2BSmoking%2BCessation%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4748%26publicationDate%3DJune%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm1003232"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2220</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm1003232" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Characterization of in Vitro and in Vivo Profiles of Hydroxybupropion Analogues: Aids to Smoking Cessation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;J. Lukas&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Z. Muresan&quot;},{&quot;first_name&quot;:&quot;M.&quot;,&quot;last_name&quot;:&quot;Imad Damaj&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;E. Blough&quot;},{&quot;first_name&quot;:&quot;Xiaodong&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Hernán&quot;,&quot;last_name&quot;:&quot;A. Navarro&quot;},{&quot;first_name&quot;:&quot;S.&quot;,&quot;last_name&quot;:&quot;Wayne Mascarella&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Brek Eaton&quot;},{&quot;first_name&quot;:&quot;Syndia&quot;,&quot;last_name&quot;:&quot;K. Marxer-Miller&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Ivy Carroll&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;4731-4748&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm1003232&quot;},&quot;abstract&quot;:&quot;To create potentially superior aids to smoking cessation and/or antidepressants and to elucidate bupropion’s possible mechanisms of action(s), 23 analogues based on its active hydroxymetabolite (2S,3S)-4a were synthesized and tested for their abilities to inhibit monoamine uptake and nAChR subtype activities in vitro and acute effects of nicotine in vivo. The 3′,4′-dichlorophenyl [(±)-4n], naphthyl (4r), and 3-chlorophenyl or 3-propyl analogues 4s and 4t, respectively, had higher inhibitory potency and/or absolute selectivity than (2S,3S)-4a for inhibition of DA, NE, or 5HT uptake. The 3′-fluorophenyl, 3′-bromophenyl, and 4-biphenyl analogues 4c, 4d, and 4l, respectively, had higher potency for antagonism of α4β2-nAChR than (2S,3S)-4a. Several analogues also had higher potency than (2S,3S)-4a as antagonists of nicotine-mediated antinociception in the tail-flick assay. The results suggest that compounds acting via some combination of DA, NE, or 5HT inhibition and/or antagonism of α4β2-nAChR can potentially be &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1003232&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1003232" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1003232&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1003232" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1003232&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1003232" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm1003232&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1003232&amp;href=/doi/10.1021/jm1003232" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm1003232" /></input><a href="/doi/pdf/10.1021/jm1003232" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm1003232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm1003232%26sid%3Dliteratum%253Aachs%26pmid%3D20509659%26genre%3Darticle%26aulast%3DLukas%26date%3D2010%26atitle%3DSynthesis%2Band%2BCharacterization%2Bof%2Bin%2BVitro%2Band%2Bin%2BVivo%2BProfiles%2Bof%2BHydroxybupropion%2BAnalogues%253A%2BAids%2Bto%2BSmoking%2BCessation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D12%26spage%3D4731%26epage%3D4748%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291184" title="Nicotine">Nicotine</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To create potentially superior aids to smoking cessation and/or antidepressants and to elucidate bupropion’s possible mechanisms of action(s), 23 analogues based on its active hydroxymetabolite (2<i>S</i>,3<i>S</i>)-<b>4a</b> were synthesized and tested for their abilities to inhibit monoamine uptake and nAChR subtype activities in vitro and acute effects of nicotine in vivo. The 3′,4′-dichlorophenyl [(±)-<b>4n</b>], naphthyl (<b>4r</b>), and 3-chlorophenyl or 3-propyl analogues <b>4s</b> and <b>4t</b>, respectively, had higher inhibitory potency and/or absolute selectivity than (2<i>S</i>,3<i>S</i>)-<b>4a</b> for inhibition of DA, NE, or 5HT uptake. The 3′-fluorophenyl, 3′-bromophenyl, and 4-biphenyl analogues <b>4c</b>, <b>4d</b>, and <b>4l</b>, respectively, had higher potency for antagonism of α4β2-nAChR than (2<i>S</i>,3<i>S</i>)-<b>4a</b>. Several analogues also had higher potency than (2<i>S</i>,3<i>S</i>)-<b>4a</b> as antagonists of nicotine-mediated antinociception in the tail-flick assay. The results suggest that compounds acting via some combination of DA, NE, or 5HT inhibition and/or antagonism of α4β2-nAChR can potentially be new pharmacotherapeutics for treatment of nicotine dependence.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tobacco use is the leading preventable cause of disease, disability, and death in the United States (U.S.). According to the Centers for Disease Control (CDC<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: CDC, Centers for Disease Control; DA, dopamine; 5HT, serotonin; NE, norepinephrine; SR, sustained release; HEK, human embryonic kidney; DAT, dopamine transporter; SERT, serotonin transporter; NET, norepinephrine transporter; nAChR, nicotine acetylcholine receptor; VTA, ventral tegmental area; NRT, nicotine replacement therapy; MPE, maximum possible effect.</p></div>) 2008 Smoking and Tobacco Use—Fact Sheet,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> cigarette smoking results in more than 400000 premature deaths in the U.S. each year, about 1 in every 5 deaths. On average, adults who smoke die 14 years earlier than nonsmokers.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Cigarette smoking accounts for about one-third of all cancers, including 90% of lung cancer cases. Smoking also causes lung diseases such as chronic bronchitis and emphysema and increases the risk of stroke, heart attack, vascular disease, and aneurysm.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In spite of these documented connections between tobacco use and disease, an unacceptable number of people continue to use tobacco products. In 2008, 28.6% of the US population 12 years of age and older (70.9 million people) used a tobacco product at least once in the prior month to being interviewed. This figure includes 3.1 million young people aged 12−17 (12.4% of this age group).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Nicotine (<b>1</b>) is considered to be the main psychoactive component in tobacco smoke that causes and maintains tobacco use.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Nicotine’s pharmacological and behavioral effects result from the activation of different nicotinic acetylcholine receptor (nAChR) subtypes. The subtypes are either homo- or heteropentameric ion channels, consisting of different combinations of genetically distinct subunits, (α1, α2−α10, β1−β4, γ, δ, ε).<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> The predominant nAChR subtypes found in the brain are thought to be heteromeric α4β2-nAChR or homomeric α7-nAChR.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, appreciable amounts of α3β4*- and α6β2*-nAChRs (where the * indicates that other subunits are known or possible assembly partners with those specified) also are in brain regions implicated in reward and drug dependence.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13">(8-13)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0005.gif" alt="" id="_i2" /></img><div class="NLM_p">Nicotine exposure can stimulate activity of somatodendritic nAChRs to alter neuronal electrical activity and neurotransmitter release as a consequence of neuronal activation. However, by acting at nAChRs positioned on nerve terminals, nicotine also can increase neurotransmitter release as a consequence of local depolarization of the nerve terminal membrane potential and/or calcium ion mobilization in terminals. The integration of these effects are likely to contribute to nicotine’s actions, including those that are presumably involved in its reinforcement of tobacco product use such as effects in monoaminergic reward pathways.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a></div><div class="NLM_p">Even though nicotine dependence has a huge impact on global health, pharmacotherapies for treating tobacco use are limited. They include nicotine-replacement therapies (NRTs), bupropion (<b>2</b>), and varenicline (<b>3</b>). Because only about one-fifth of smokers are able to maintain long-term (12 months) abstinence with any of the present pharmacotherapies,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> new and improved drugs are needed.</div><div class="NLM_p">Bupropion [(±)-2-<i>tert</i>-butylamino-3′-chloropropiophenone] is used clinically as a racemic mixture of its (<i>R</i>)- and (<i>S</i>)-isomers, (<i>R</i>)-bupropion [(<i>R</i>)-<b>2</b>] and (<i>S</i>)-bupropion [(<i>S</i>)-<b>2</b>], respectively. Bupropion is extensively metabolized, with less than 1% recovered intact in urine.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Major metabolites result from hydroxylation of the <i>N</i>-<i>tert</i>-butyl group by P450-(CYP)2B6 isoenzyme.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> The resulting hydroxylated metabolites cyclizes to give (2<i>R</i>,3<i>R</i>)- and (2<i>S</i>,3<i>S</i>)-hydroxybupropion [(2<i>R</i>,3<i>R</i>)-<b>4a</b> and (2<i>S</i>,3<i>S</i>)-<b>4a</b>, respectively]. Several studies suggest that (<i>2S</i>,3<i>S</i>)-hydroxybupropion [(2<i>S</i>,3<i>S</i>)-<b>4a</b>] contributes to the antidepressant and smoking cessation efficacy of <b>2</b>.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> Peak plasma and cerebrospinal fluid concentrations of (2<i>S</i>,3<i>S</i>)-<b>4a</b> exceed those of <b>2</b> by 4- to 7-fold, and (2<i>S</i>,3<i>S</i>)-<b>4a</b> has a longer elimination half-life than the parent drug.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a></div><div class="NLM_p">In a previous study, we reported that (2<i>S</i>,3<i>S</i>)-<b>4a</b> was an inhibitor of both dopamine (DA) and norepinephrine (NE) uptake.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Importantly, we found that (2<i>S</i>,3<i>S</i>)-<b>4a</b> was a noncompetitive functional antagonist at α4β2-nAChRs, with an IC<sub>50</sub> value of 3.3 μM, a concentration that is comparable to those needed to inhibit DA and NE uptake. In addition, (2<i>S</i>,3<i>S</i>)-<b>4a</b> was 3−10 times more potent than <b>2</b> after acute administration in mice in antagonizing nicotine-induced hypomobility and hypothermia and nicotine-induced analgesia in tail-flick and hot-plate tests. Compound (2<i>S</i>,3<i>S</i>)-<b>4a</b> also was equally potent with <b>2</b> in the mouse forced-swim test of depression. Because (2<i>S</i>,3<i>S</i>)-<b>4a</b> has higher potency at relevant targets compared to <b>2</b>, it may be a better drug candidate for smoking cessation pharmacotherapy. Moreover, (2<i>S</i>,3<i>S</i>)-<b>4a</b> can serve as a lead structure to design analogues with greater potency at the relevant targets and to possess better drug-like properties.</div><div class="NLM_p last">In this study, we report the synthesis and biological evaluation of 23 hydroxybupropion analogues <b>4b</b>−<b>4v</b>, <b>5</b>, and <b>6</b> (all with the (2<i>S</i>,3<i>S</i>)-stereochemistry except for <b>4n</b>, <b>4p</b>, <b>5</b>, and <b>6</b>, which are racemic). Some of the analogues have higher potencies than <b>2</b> for DA and NE uptake inhibition as well as for antagonism of the α4β2-nAChR. In addition, some of the compounds antagonize the antinociceptive, hypolocomotion, and hypothermic effects of acutely administered nicotine in mice with potencies greater than that of <b>2</b> or (2<i>S</i>,3<i>S</i>)-<b>4a</b>. 2-(3′-Bromophenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4d</b>), which was 19-fold more potent in inhibition of DA uptake and 6-fold more potent as an α4β2*-nAChR antagonist than (2<i>S</i>,3<i>S</i>)-<b>4a</b>, has one of the more interesting in vitro properties.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analogues <b>4a</b>−<b>g</b> and <b>4q</b>−<b>t</b> were synthesized in a fashion similar to that reported in the literature for optically active <b>4a</b> starting with an aryl ketone (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The commercially unavailable ketones (<b>8</b>) were synthesized by Grignard additions to commercially available aryl nitriles (<b>7</b>). (<i>Z</i>)-<i>tert</i>-Butyldimethylsilylenol ether formation from these propiophenones, <b>8a</b>−<b>k</b>, using <i>t</i>-butyldimethylsilyl triflate in methylene chloride, gave high yields of the (<i>Z</i>)-enol ethers <b>9a</b>−<b>k</b>. The key transformation in this sequence is a chiral Sharpless hydroxylation reaction of these enol ethers, which when using AD-mix-β, provided the (<i>R</i>)-α-hydroxy ketones <b>10a</b>−<b>k</b>. The products of these reactions were not checked for optical purity but were found to be optically active, so optical induction was successful at some level. Because of possible epimerization throughout the process, it was decided to aminate the ketone before establishing optical purity. Initial efforts to reproduce the literature preparation of (2<i>S</i>,3<i>S</i>)-<b>4a</b> by converting (<i>R</i>)-1-(3-chlorophenyl)-2-hydroxypropan-1-one (<b>10a</b>) to the desired product [(2<i>S</i>,3<i>S</i>)-<b>4a</b>] using the literature conditions with 2-amino-2-methyl-1-propanol and 2,6-lutidine failed or were low yielding. The presence of 2,6-lutidine overwhelmed silica gel chromatography, making purification difficult. A modified approach was developed using proton sponge and provided (2<i>S</i>,3<i>S</i>)-<b>4a</b> in good yields. This modified procedure was used to synthesize compounds <b>4a</b>−<b>g</b> and <b>4q</b>−<b>t</b>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) RCH<sub>2</sub>MgBr; (b) TBSOTf, CH<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N; (c) AD-mix-β, <i>t</i>-BuOH/H<sub>2</sub>O; (d) Tf<sub>2</sub>O, proton sponge, 2-amino-2-methyl-1-propanol, CH<sub>3</sub>CN.</p></p></figure><div class="NLM_p">Analogues <b>4n</b>, <b>4p</b>, <b>5</b>, and <b>6</b> were synthesized as racemic mixtures by following the standard synthesis of bupropion analogues<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> except substituting 2-amino-2-methyl-1-propanol for <i>t</i>-butylamine, shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. As illustrated in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, the appropriate ketones (<b>8l</b>−<b>o</b>) were first synthesized by the addition of ethylmagnesium bromide to the nitriles (<b>7</b>), or in the case of the 3-pyridyl analogue was synthesized by lithium halogen exchange starting with 3-bromopyridine (<b>11</b>) and adding proprionitrile. Simple bromination to form the α-bromo ketones (<b>12a</b>−<b>d</b>) followed by amination with 2-amino-2-methyl-1-propanol provided the desired analogues in good yield. It should be noted that the optically active syntheses of <b>5</b> and <b>6</b> were attempted using the approach in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, but the Sharpless reaction failed to provide the desired product.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) EtMgBr; (b) nBuLi, CH<sub>3</sub>CH<sub>2</sub>CN; (c) Br<sub>2</sub>; (d) 2-amino-2-methyl-1-propanol, CH<sub>3</sub>CN.</p></p></figure><div class="NLM_p">The synthesis of <b>4 h−m</b> and <b>4o</b> was accomplished by a novel convergent synthetic approach for the preparation of 2-substituted morpholinols as outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. This new approach utilized a nucleophilic addition of Grignard reagents to (<i>3S</i>)-3,5,5-trimethylmorpholin-2-one (<b>15</b>). Treatment of methyl (<i>R</i>)-(+)-lactate (<b>13</b>) with trifluoromethanesulfonic anhydride and 2,6-lutidine at 0 °C gave methyl (2<i>R</i>)-2-{[(trifluoromethyl)sulfonyl]oxy}propionate (<b>14</b>) in 77% yield. The alkylation of 2-amino-2-methyl-1-propanol with triflate <b>14</b> at −40 °C for 2 h and overnight at room temperature, and subsequent cyclization afforded <b>15</b> in 63% yield. To test the approach, reaction of lactone <b>15</b> with 3-chlorophenylmagnesium bromide resulted in the formation of (2<i>S</i>,3<i>S</i>)-trimethyl-2-(3′-chlorophenyl)morpholin-2-ol [(2<i>S</i>,3<i>S</i>)-<b>4a</b>] in 32% yield (98% ee), 16% overall from methyl-(<i>R</i>)-(+)-lactate (<b>13</b>). The addition of the appropriate arylmagnesium bromide to <b>15</b> provided <b>4 h−m</b> and <b>4o</b>.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Tf<sub>2</sub>O, 2,6-lutidine; (b) 2-amino-2-methyl-1-propanol, CH<sub>2</sub>Cl<sub>2</sub>, −40 °C to RT; (c) arylmagnesium bromide.</p></p></figure><div class="NLM_p">The C-3 stereocenter of these compounds was derived from the lactate, not created by a synthetic transformation such as the Sharpless hydroxylation used in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. This center was then leveraged to create the second C-2 stereocenter. The resulting stereochemistry at C-2 was a result of either facial selectivity during the Grignard addition anti to the C-3 methyl group and/or a thermodynamic equilibrium of the final product to the <i>S</i>,<i>S</i>-configuration because the resulting product can ring open and close. The ring opened form loses its C-2 stereochemistry, forming a ketone. This route was more convergent than the Sharpless hydroxylation route, and was more reliable, requiring far less analytical work. All of the compounds could have been synthesized by the new route, but this was deemed inefficient because those compounds were already available for pharmacological testing.</div><div class="NLM_p"><i>N</i>-Methylated compounds <b>4u</b> and <b>4v</b> were synthesized from their nonalkylated analogues (<b>4a</b> and <b>4i</b>, respectively) by reaction with methyl iodide in the presence of potassium carbonate (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>.</p></p></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> In Vitro Assays</h3><div class="NLM_p">The (2<i>S</i>,3<i>S</i>)-<b>4a</b> analogues <b>4b</b>−<b>4v</b> and <b>5</b> and <b>6</b> were evaluated for their ability to block reuptake of [<sup>3</sup>H]dopamine ([<sup>3</sup>H]DA), [<sup>3</sup>H]serotonin ([<sup>3</sup>H]5HT), and [<sup>3</sup>H]norepinephrine ([<sup>3</sup>H]NE), respectively, into HEK293 cells stably expressing human DA transporters [(h)DAT], 5HT transporters [(h)SERT], or NE transporters [h(NET)] using methods similar to those previously reported.<a onclick="showRef(event, 'ref21 ref26'); return false;" href="javascript:void(0);" class="ref ref21 ref26">(21, 26)</a> The results are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of Monoamine Uptake and nAChR Function for Hydroxybupropion Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0004.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center">monoamine uptake inhibition<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" colspan="4" align="center">nAChR inhibition<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]DA</th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]NE</th><th class="colsep0 rowsep0" align="center">[<sup>3</sup>H]5HT</th><th class="colsep0 rowsep0" align="center">α3β4*</th><th class="colsep0 rowsep0" align="center">α4β2</th><th class="colsep0 rowsep0" align="center">α4β4</th><th class="colsep0 rowsep0" align="center">α1*β1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">660 ± 178</td><td class="colsep0 rowsep0" align="left">1850 ± 300</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">1.8 (1.15)</td><td class="colsep0 rowsep0" align="left">12 (1.15)</td><td class="colsep0 rowsep0" align="left">12 (1.07)</td><td class="colsep0 rowsep0" align="left">7.9 (1.12)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(2<i>R</i>,3<i>R</i>)-<b>4a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">9900 ± 1400</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">6.5 (1.20)</td><td class="colsep0 rowsep0" align="left">31 (1.12)</td><td class="colsep0 rowsep0" align="left">41 (1.07)</td><td class="colsep0 rowsep0" align="left">7.6 (1.12)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(2<i>S</i>,3<i>S</i>)-<b>4a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">630 ± 50</td><td class="colsep0 rowsep0" align="left">241 ± 60</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">11 (1.48)</td><td class="colsep0 rowsep0" align="left">3.3 (1.07)</td><td class="colsep0 rowsep0" align="left">30 (1.10)</td><td class="colsep0 rowsep0" align="left">28 (1.45)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1065 ± 30</td><td class="colsep0 rowsep0" align="left">550 ± 90</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">8.9 (1.23)</td><td class="colsep0 rowsep0" align="left">6.4 (1.23)</td><td class="colsep0 rowsep0" align="left">92 (1.29)</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1380 ± 360</td><td class="colsep0 rowsep0" align="left">740 ± 150</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">15 (1.12)</td><td class="colsep0 rowsep0" align="left">1.3 (1.17)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3340 ± 680</td><td class="colsep0 rowsep0" align="left">920 ± 300</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">3.2 (1.12)</td><td class="colsep0 rowsep0" align="left">0.55 (1.23)</td><td class="colsep0 rowsep0" align="left">30 (1.07)</td><td class="colsep0 rowsep0" align="left">18 (1.07)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2600 ± 400</td><td class="colsep0 rowsep0" align="left">1130 ± 20</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">8.6 (1.12)</td><td class="colsep0 rowsep0" align="left">6.0 (1.20)</td><td class="colsep0 rowsep0" align="left">64 (1.20)</td><td class="colsep0 rowsep0" align="left">33 (1.07)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">16,000 ± 2000</td><td class="colsep0 rowsep0" align="left">3000 ± 900</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">11 (1.07)</td><td class="colsep0 rowsep0" align="left">10 (1.26)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">49 (1.07)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12,000 ± 4000</td><td class="colsep0 rowsep0" align="left">1210 ± 340</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">14 (1.10)</td><td class="colsep0 rowsep0" align="left">4.8 (1.26)</td><td class="colsep0 rowsep0" align="left">80 (1.10)</td><td class="colsep0 rowsep0" align="left">96 (1.10)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4200 ± 700</td><td class="colsep0 rowsep0" align="left">3800 ± 600</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">20 (1.15)</td><td class="colsep0 rowsep0" align="left">12 (1.10)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">69 (1.17)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4i</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">285 ± 70</td><td class="colsep0 rowsep0" align="left">830 ± 90</td><td class="colsep0 rowsep0" align="left">4600 ± 900</td><td class="colsep0 rowsep0" align="left">5.1 (1.07)</td><td class="colsep0 rowsep0" align="left">9.2 (1.17)</td><td class="colsep0 rowsep0" align="left">33 (0.05)</td><td class="colsep0 rowsep0" align="left">19 (1.15)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">832 ± 260</td><td class="colsep0 rowsep0" align="left">1680 ± 330</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">8.6 (1.07)</td><td class="colsep0 rowsep0" align="left">12 (1.12)</td><td class="colsep0 rowsep0" align="left">62 (1.10)</td><td class="colsep0 rowsep0" align="left">20 (1.15)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4k</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">11 (1.10)</td><td class="colsep0 rowsep0" align="left">27 (1.23)</td><td class="colsep0 rowsep0" align="left">72 (1.12)</td><td class="colsep0 rowsep0" align="left">25 (1.10)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4l</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">10,300 ± 1500</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">1.3 (1.12)</td><td class="colsep0 rowsep0" align="left">1.8 (1.12)</td><td class="colsep0 rowsep0" align="left">8.1 (1.07)</td><td class="colsep0 rowsep0" align="left">5.9 (1.15)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2140 ± 180</td><td class="colsep0 rowsep0" align="left">740 ± 110</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">11.9 (1.15)</td><td class="colsep0 rowsep0" align="left">12 (1.07)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">36 (1.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4n</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">70 ± 20</td><td class="colsep0 rowsep0" align="left">114 ± 30</td><td class="colsep0 rowsep0" align="left">360 ± 40</td><td class="colsep0 rowsep0" align="left">2.6 (1.10)</td><td class="colsep0 rowsep0" align="left">20 (1.07)</td><td class="colsep0 rowsep0" align="left">14 (1.17)</td><td class="colsep0 rowsep0" align="left">7.2 (1.12)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4o</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">1020 ± 190</td><td class="colsep0 rowsep0" align="left">151 ± 43</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">11 (1.15)</td><td class="colsep0 rowsep0" align="left">6.3 (1.51)</td><td class="colsep0 rowsep0" align="left">62 (1.07)</td><td class="colsep0 rowsep0" align="left">23 (1.12)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4p</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">8250 ± 720</td><td class="colsep0 rowsep0" align="left">2440 ± 730</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">3.9 (1.07)</td><td class="colsep0 rowsep0" align="left">11 (1.05)</td><td class="colsep0 rowsep0" align="left">18 (1.17)</td><td class="colsep0 rowsep0" align="left">7.2 (1.07)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4q</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1-napthyl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">—</td><td class="colsep0 rowsep0" align="left">10,000 ± 4000</td><td class="colsep0 rowsep0" align="left">411 ± 53</td><td class="colsep0 rowsep0" align="left">1565 ± 215</td><td class="colsep0 rowsep0" align="left">5.2 (1.15)</td><td class="colsep0 rowsep0" align="left">9.0 (1.07)</td><td class="colsep0 rowsep0" align="left">13 (1.10)</td><td class="colsep0 rowsep0" align="left">6.6 (1.10)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4r</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-napthyl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">453 ± 4</td><td class="colsep0 rowsep0" align="left">1570 ± 430</td><td class="colsep0 rowsep0" align="left">334 ± 42</td><td class="colsep0 rowsep0" align="left">2.0 (1.05)</td><td class="colsep0 rowsep0" align="left">6.5 (1.07)</td><td class="colsep0 rowsep0" align="left">11 (1.10)</td><td class="colsep0 rowsep0" align="left">11 (1.12)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4s</b></td><td class="colsep0 rowsep0" align="left">C<sub>2</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">204 ± 23</td><td class="colsep0 rowsep0" align="left">43.4 ± 72</td><td class="colsep0 rowsep0" align="left">2500 ± 540</td><td class="colsep0 rowsep0" align="left">4.3 (1.12)</td><td class="colsep0 rowsep0" align="left">2.9 (1.10)</td><td class="colsep0 rowsep0" align="left">16 (1.05)</td><td class="colsep0 rowsep0" align="left">14 (1.10)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4t</b></td><td class="colsep0 rowsep0" align="left">C<sub>3</sub>H<sub>7</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">30 ± 4</td><td class="colsep0 rowsep0" align="left">31 ± 10</td><td class="colsep0 rowsep0" align="left">4130 ± 770</td><td class="colsep0 rowsep0" align="left">4.8 (1.10)</td><td class="colsep0 rowsep0" align="left">7.5 (1.05)</td><td class="colsep0 rowsep0" align="left">18 (1.07)</td><td class="colsep0 rowsep0" align="left">10 (1.07)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4u</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3400 ± 600</td><td class="colsep0 rowsep0" align="left">415 ± 9</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">6.5 (1.05)</td><td class="colsep0 rowsep0" align="left">7.1 (1.07)</td><td class="colsep0 rowsep0" align="left">43 (1.20)</td><td class="colsep0 rowsep0" align="left">57 (1.05)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4v</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2870 ± 820</td><td class="colsep0 rowsep0" align="left">527 ± 104</td><td class="colsep0 rowsep0" align="left">6480 ± 1280</td><td class="colsep0 rowsep0" align="left">4.6 (1.15)</td><td class="colsep0 rowsep0" align="left">42 (1.17)</td><td class="colsep0 rowsep0" align="left">91 (1.12)</td><td class="colsep0 rowsep0" align="left">43 (1.05)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">7950 ± 1800</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values for mean ± standard error of three independent experiments, each conducted with triplicate determination.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Mean micromolar IC<sub>50</sub> values (to two significant digits) for bupropion and the indicated analogues from three independent experiments for inhibition of functional responses to an EC<sub>80</sub>−EC<sub>90</sub> concentration of carbamylcholine mediated by nAChR subtypes composed of the indicated subunits (where * indicates that additional subunits are or may be additional assembly partners with the subunits specified; see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Numbers in parentheses indicate SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> values shown [i.e., the value 1.8 (1.15) reflects a mean IC<sub>50</sub> value of 1.8 μM with an SEM range of 1.8 × 1.15 μM to 1.8/1.15 μM or 1.6−2.1 μM]. The value 11 (1.48) reflects a mean IC<sub>50</sub> value of 11 μM with an SEM range of 11 × 1.40 μM to 11/1.48 μM or 7.4−16 μM. IA: IC<sub>50</sub> > 100 μM.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Compounds <b>4b</b>−<b>4m</b>, and <b>4o</b>−<b>4v</b> are all (2<i>S</i>,3<i>S</i>)-isomers. Compounds <b>4n</b>, <b>4p</b>, <b>5</b>, and <b>6</b> are racemic materials.</p></div></div></div><div class="NLM_p">Compound (2<i>S</i>,3<i>S</i>)-<b>4a</b> and analogues <b>4b</b>−<b>4v</b> and <b>5</b> and <b>6</b> also were evaluated for their ability to antagonize functional responses of α3β4*-, α4β2-, α4β4-, and α1*-nAChR using previously reported methods<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> modified as described in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Results are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and in Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>−<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Specific <sup>86</sup>Rb<sup>+</sup> efflux (ordinate; percentage of control) was determined for functional, human muscle-type α1β1γδ-nAChR (●), ganglionic α3β4*-nAChR (○), α4β2-nAChR (▲), or α4β4-nAChR (▽) naturally or heterologously expressed in human cell lines in the presence of a receptor subtype-specific, EC<sub>80</sub>−EC<sub>90</sub> concentration of the full agonist, carbamylcholine, either alone or in the presence of the indicated concentrations (abscissa, log molar) of (2<i>S</i>,3<i>S)</i>-hydroxybupropion [(2<i>S</i>,3<i>S</i>)-<b>4a</b>] or its analogues (compounds <b>4d</b>, <b>4c</b>, and <b>4g</b>) as indicated. Mean micromolar IC<sub>50</sub> values and SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> value are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Specific <sup>86</sup>Rb<sup>+</sup> efflux (ordinate; percentage of control) was determined for functional, human muscle-type α1β1γδ-nAChR (●), ganglionic α3β4*-nAChR (○), α4β2-nAChR (▲), or α4β4-nAChR (▽) naturally or heterologously expressed in human cell lines in the presence of a receptor subtype-specific, EC<sub>80</sub>−EC<sub>90</sub> concentration of the full agonist, carbamylcholine, either alone or in the presence of the indicated concentrations (abscissa, log molar) of (2<i>R</i>,3<i>R</i>)-hydroxybupropion [(2<i>R</i>,3<i>R</i>)-<b>4a</b>] or analogues (compounds <b>4s</b>, <b>4w</b>, and <b>4t</b>) as indicated. Mean micromolar IC<sub>50</sub> values and SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> value are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vivo Assays</h3><div class="NLM_p">Compound (<i>2S,3S</i>)-<b>4a</b> analogues <b>4b</b>−<b>4v</b> and <b>5</b> and <b>6</b> also were evaluated for their ability to antagonize behavioral responses to acute nicotine administration as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Results are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacological Evaluation of Hydroxybupropion Analogues As Noncompetitive Nicotinic Antagonists<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center">AD<sub>50</sub> (mg/kg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">tail-flick<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hot-plate<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">locomotion<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hypothermia<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">1.2 (1−1.8)</td><td class="colsep0 rowsep0" align="left">15 (6−19)</td><td class="colsep0 rowsep0" align="left">4.9 (0.9−46)</td><td class="colsep0 rowsep0" align="left">9.2 (4−23)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(2<i>S</i>,3<i>S</i>)-<b>4a</b></td><td class="colsep0 rowsep0" align="left">0.2 (0.1−1.1)</td><td class="colsep0 rowsep0" align="left">1.0 (0.5−4.5)</td><td class="colsep0 rowsep0" align="left">0.9 (0.38−3.7)</td><td class="colsep0 rowsep0" align="left">1.5 (0.95−2.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(2<i>R</i>,3<i>R</i>)-<b>4a</b></td><td class="colsep0 rowsep0" align="left">2.5 (1.7−3.5)</td><td class="colsep0 rowsep0" align="left">10.3 (8.9−15)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">0.012 (0.002−0.16)</td><td class="colsep0 rowsep0" align="left">8.6 (0.7−10.5)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">4.4 (1.3−14.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">0.16 (0.05−0.6)</td><td class="colsep0 rowsep0" align="left">4.3 (1.8−9.8)</td><td class="colsep0 rowsep0" align="left">2.6 (0.7−10.1)</td><td class="colsep0 rowsep0" align="left">1.7 (0.5−6.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left">0.054 (0.04−0.066)</td><td class="colsep0 rowsep0" align="left">7.6 (2−29)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">2.3 (0.4−11)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left">5.85 (3.8−8.8)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">4.9 (1.6−15)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">4.7 (3.5−6.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">0.013 (0.005−0.03)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">5.67 (2.5−12.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4i</b></td><td class="colsep0 rowsep0" align="left">0.019 (0.063−0.1)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left">0.004 (0.002−0.012)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4k</b></td><td class="colsep0 rowsep0" align="left">0.019 (0.06−0.064)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4l</b></td><td class="colsep0 rowsep0" align="left">0.021 (0.005−0.1)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="left">0.006 (0.004−0.01)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4n</b></td><td class="colsep0 rowsep0" align="left">8.8 (4.3−18)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4o</b></td><td class="colsep0 rowsep0" align="left">0.0056 (0.004−0.009)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4p</b></td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4q</b></td><td class="colsep0 rowsep0" align="left">0.034 (0.001−0.1)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4r</b></td><td class="colsep0 rowsep0" align="left">0.04 (0.001−0.6)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4s</b></td><td class="colsep0 rowsep0" align="left">0.004 (0.001−0.03)</td><td class="colsep0 rowsep0" align="left">3.7 (0.8−17)</td><td class="colsep0 rowsep0" align="left">10.3 (1.4−75)</td><td class="colsep0 rowsep0" align="left">7 (4.5−10.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4t</b></td><td class="colsep0 rowsep0" align="left">0.004 (0.001−0.03)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4u</b></td><td class="colsep0 rowsep0" align="left">0.016 (0.004−0.06)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4v</b></td><td class="colsep0 rowsep0" align="left">0.32 (0.04−2.5)</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">n/a</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">n/a</td><td class="colsep0 rowsep0" align="left">n/a</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Results were expressed as AD<sub>50</sub> (mg/kg) ± confidence limits (CL) or % effect at the highest dose tested. Dose−response curves were determined using a minimum of four different doses of test compound, and at least eight mice were used per dose group.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Compounds <b>4b</b>−<b>4m</b>, and <b>4o</b>−<b>4v</b> are all (2<i>S</i>,3<i>S</i>)-isomers. Compounds <b>4n</b>, <b>4p</b>, <b>5</b>, and <b>6</b> are racemic materials <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">n/a: not assayed; IA: AD<sub>50</sub> > 15 mg/kg; NFT = no further testing.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Effects on Monoamine Uptake</h3><div class="NLM_p">Compound <b>2</b> inhibits DA reuptake (IC<sub>50</sub> = 660 nM), which would increase synaptic levels of DA and presumed reward. Compound (2<i>S</i>,3<i>S</i>)-<b>4a</b> (IC<sub>50</sub> = 630 nM), but not (2<i>R</i>,3<i>R</i>)-<b>4a</b> (IC<sub>50</sub> > 10 μM), is as effective as <b>2</b> in inhibiting DA uptake inhibition (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>2</b> also inhibits NE reuptake (IC<sub>50</sub> = 1850 nM), which increases synaptic levels of NE. Interestingly, (2<i>S</i>,3<i>S</i>)-<b>4a</b> (IC<sub>50</sub> = 241 nM), but not (2<i>R</i>,3<i>R</i>)-<b>4a</b> (IC<sub>50</sub> = 9900 nM), is 7.7 times more potent than <b>2</b> in inhibiting NE uptake (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Neither <b>2</b> nor its hydroxymetabolites are active (IC<sub>50</sub> > 10 μM; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) as inhibitors of 5HT uptake.</div><div class="NLM_p">Among the new hydroxybupropion analogues tested, the propyl extended chain form <b>4t</b> and the (±)-3′,4′-dichlorophenyl derivative (±)-<b>4n</b> of (2<i>S</i>,3<i>S</i>)-<b>4a</b> with IC<sub>50</sub> values of 30 and 70 nM, respectively, the ethyl extended chain form <b>4s</b> (IC<sub>50</sub> = 204 nM) and the 4-chlorophenyl analogue <b>4i</b> (IC<sub>50</sub> = 285 nM) have higher potency than (2<i>S</i>,3<i>S</i>)-<b>4a</b> (IC<sub>50</sub> = 630 nM) as inhibitors of DA uptake.</div><div class="NLM_p">In terms of activity for NE uptake inhibition, the ethyl and propyl extended chain forms, <b>4s</b> and <b>4t</b> (IC<sub>50</sub> values of 43 and 31 nM, respectively), and the (±)-3′-,4′-dichlorophenyl derivative (±)-<b>4n</b> (IC<sub>50</sub> = 114 nM), are more potent than (2<i>S</i>,3<i>S</i>)-<b>4a</b> (IC<sub>50</sub> = 241 nM).</div><div class="NLM_p">The only analogues that had submicromolar IC<sub>50</sub> values for inhibition of 5HT uptake were the (±)-3′,4′-dichlorophenyl analogue (±)-<b>4n</b> (IC<sub>50</sub> = 360 nM) and the 2-napthyl analogue <b>4r</b> (IC<sub>50</sub> = 334 nM). (2<i>S</i>,3<i>S</i>)-<b>4a</b>, (2<i>R</i>,3<i>R</i>)-<b>4a</b>, and 16 of the analogues were inactive at the SERT. The remaining analogues had IC<sub>50</sub> values greater than 1560 nM.</div><div class="NLM_p last">Compound <b>2</b> has ∼3-fold selectivity for inhibition at DA over NE uptake and is inactive at inhibition of 5HT uptake. Neither (2<i>R</i>,3<i>R</i>)-<b>4a</b> nor (2<i>S</i>,3<i>S</i>)-<b>4a</b> shows activity for 5HT uptake. Compound (2<i>R</i>,3<i>R</i>)-<b>4a</b>’s poor activity overall precludes comments about its transporter selectivity. On the other hand, (2<i>S</i>,3<i>S</i>)-<b>4a</b> has the opposite DA/NE inhibition of uptake selectivity relative to <b>2</b>, exhibiting ∼3-fold selectivity for inhibition of uptake of NE over DA. Analogues <b>4b</b>−<b>4g</b>, <b>4l</b>−<b>4m</b>, <b>4o</b>−<b>4q</b>, <b>4s</b>, and <b>4u</b>−<b>4v</b> share with (2<i>S</i>,3<i>S</i>)-<b>4a</b> selectivity for inhibition of NE over DA uptake inhibition. Relative to (2<i>S</i>,3<i>S</i>)-<b>4a</b>, <b>4s</b> and <b>4o</b> have the best combination of higher potency in NE uptake inhibition and selectivity for NE over DA uptake inhibition. The propyl-extended chain analogue, <b>4t</b>, has much higher potency than (2<i>S</i>,3<i>S</i>)- or (2<i>R</i>,3<i>R</i>)-<b>4a</b> at each of the monoamine transporter targets, but it is essentially equipotent for NE and DA uptake inhibition (IC<sub>50</sub> = 31 and 30 nM). The only analogues tested with selectivity for inhibition of DA over NE uptake [discounting the small preference for DA over NE and 5HT inhibition shown by (±)-3′,4′-dichlorophenyl analogue (±)-<b>4n</b>] are the 4′-chlorophenyl analogue <b>4i</b> or 4′-methylphenyl analogues <b>4j</b> and 2-napthyl analogue (<b>4r</b>) (3−5-fold). Only the 2-napthyl analogue <b>4r</b> shows slight selectivity for the SERT (IC<sub>50</sub> = 334 nM) over NET (IC<sub>50</sub> = 1570 nM). However, by contrast to <b>4r</b>, the structurally related 1-napthyl analogue (<b>4q</b>) has 24-fold selectivity for inhibition of NE over DA uptake. Thus, alkyl extension as well as phenyl substitution can impact inhibitory potency and selectivity of the hydroxybupropion analogues for monoamine transporters.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro Profiles for Drug Action at nAChR</h3><div class="NLM_p">Effects of hydroxybupropion analogues <b>4b</b>−<b>4v</b> and <b>5</b> and <b>6</b> on function of diverse, human nAChR subtypes naturally or heterologously expressed by human cell lines were assessed using <sup>86</sup>Rb<sup>+</sup> efflux assays that are specific only for nAChR function in the cells used. None of the analogues has activity as an agonist at α1*-, α3β4*-, α4β2-, or α4β4-nAChR because <sup>86</sup>Rb<sup>+</sup> efflux in the presence of these ligands alone at concentrations from ∼5 nM to 100 μM (data not shown here) was indistinguishable from responses in cells exposed only to efflux buffer.</div><div class="NLM_p"><sup>86</sup>Rb<sup>+</sup> efflux assays also were used to assess whether ligands had activity as antagonists at human nAChR. Representative concentration−response curves for selected ligands (2<i>S</i>,3<i>S</i>)-<b>4a</b>, <b>4d</b>, <b>4c</b>, and <b>4g</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and (2<i>R</i>,3<i>R</i>)-<b>4a</b>, <b>4s</b>, <b>4u</b>, and <b>4t</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) illustrate nAChR in vitro inhibitory profiles (see also Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). As we have shown previously,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (2<i>S</i>,3<i>S</i>)-<b>4a</b> is a full antagonist at all of the nAChR subtypes tested and is selective (<i>p</i> < 0.05) for α4β2- over α3β4*-, α4β4-, and α1*-nAChR (upper left panel, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Compounds <b>4c</b>, <b>4d</b>, and <b>4g</b> also block all nAChR function at an adequately high concentration, <b>4c</b> and <b>4d</b> have higher potency (<i>p</i> < 0.05) than (2<i>S</i>,3<i>S</i>)-<b>4a</b> at α4β2-nAChR, and all three compounds are more selective than (2<i>S</i>,3<i>S</i>)-<b>4a</b> for α4β2-nAChR over the other nAChR subtypes (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). By contrast, (2<i>R</i>,3<i>R</i>)-<b>4a</b>, which also is a full antagonist at all of the nAChR subtypes tested, is selective (<i>p</i> < 0.05) for α3β4*- and α1*-nAChR over α4β2- and α4β4-nAChR (upper left panel, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Compounds <b>4s</b> and <b>4u</b> have very similar potency as inhibitors of α4β2- and α3β4*-nAChR function and are selective for those over α1*- and α4β4-nAChR (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Compound <b>4t</b> is another full antagonist at all nAChR subtypes but with diminished selectivity for α3β4*-nAChR (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Note, more generally, that all of the ligands tested were full antagonists in that they blocked all nAChR function at the highest concentration tested or tended to do so if there still was submaximal block at 100 μM. Not shown here are other studies demonstrating that antagonism in all cases was mediated noncompetitively in that agonist concentration-ion flux response curves in the presence of ∼IC<sub>50</sub> concentrations of analogues showed diminished efficacy of agonist relative to response curves obtained in the absence of analogues and that agonist apparent EC<sub>50</sub> values were unaffected by the presence of analogues.</div><div class="NLM_p">As was previously noted,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (2<i>S</i>,3<i>S</i>)-<b>4a</b> has an altered nAChR functional inhibitory profile relative to <b>2</b>, showing higher potency at α4β2-nAChR (IC<sub>50</sub> = 3.3 μM compared to 12 μM for <b>2</b>) and higher selectivity for α4β2- over other nAChR (∼3-fold) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">Relative to (2<i>R</i>,3<i>R</i>)-<b>4a</b> and (2<i>S</i>,3<i>S</i>)-<b>4a</b> (IC<sub>50</sub> values of 6.5 and 11 μM, respectively), the 3′-deschlorophenyl-analogue <b>4b</b> and the 3′-methylphenyl and 4′-methylphenyl-analogues <b>4e</b> and <b>4j</b> have comparable inhibitory potencies at α3β4*-nAChR (IC<sub>50</sub> = 8.5−8.9 μM; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). By contrast, there is slightly higher potency at α3β4*-nAChR for the 3′-bromophenyl <b>4d</b>, 3′-chlorophenyl-4-(<i>N</i>-methyl) <b>4u</b>, ethyl and propyl chain extended analogues <b>4s</b> and <b>4t</b>, 4′-chlorophenyl <b>4i</b>, 3′,5′-dichlorophenyl <b>4p</b>, 1-naphthyl <b>4q</b>, and 4′-chlorophenyl-4-(<i>N</i>-methyl) <b>4v</b> analogues (IC<sub>50</sub> = 3.2−6.5 μM; <i>p</i> < 0.05 for IC<sub>50</sub> value differences between (2<i>R</i>,3<i>R</i>)-<b>4a</b> and <b>4d</b> or <b>4p</b>). Also having higher antagonist potencies (<i>p</i> < 0.05) than (<i>2R</i>,3<i>R</i>)-<b>4a</b> at α3β4*-nAChR are the (±)-3′,4′-dichlorophenyl analogue (±)-<b>4n</b> and the 2-naphthyl analogue <b>4r</b> (IC<sub>50</sub> values of 2.6 and 2.0 μM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>)). For these analogues, IC<sub>50</sub> values for inhibition of α1*-nAChR function are higher (>33 μM for <b>4b</b>, <b>4e</b>, <b>4u</b>, and <b>4v</b>) or are in the range (5.9−19 μM for <b>4d</b>, <b>4i</b>−<b>4j</b>, <b>4l</b>, (±)-<b>4n</b>, <b>4p</b>−<b>4t</b>) of IC<sub>50</sub> values for inhibition of α1*-nAChR by (2<i>S</i>,3<i>S</i>)-<b>4a</b> or (2<i>R</i>,3<i>R</i>)-<b>4a</b> (28 or 7.6 μM, respectively).</div><div class="NLM_p">In absolute terms, the 3′-bromophenyl- (<b>4d</b>), 3′-fluorophenyl- (<b>4c</b>), biphenyl <b>4l</b>, and ethyl extended chain analogue <b>4s</b> have higher inhibitory potency at α4β2-nAChR than (2<i>S</i>,3<i>S</i>)-<b>4a</b> [IC<sub>50</sub> values of 0.55, 1.3, 1.8 (all <i>p</i> < 0.05) and 2.9 relative to 3.3 μM, respectively].</div><div class="NLM_p last">Of the analogues tested, <b>4v</b> has the largest selectivity for α3β4*-nAChR over the other nAChR subtypes (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). (2<i>R</i>,3<i>R</i>)-<b>4a</b> is barely selective for α3β4*-nAChR over α1*-nAChR, but about 5-fold selective for α3β4*- over α4β2-nAChR (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Of all the analogues tested, <b>4b</b>−<b>4e</b>, <b>4 g−4h</b>, <b>4o</b>, and <b>4s</b> have reasonable selectivity for α4β2-nAChR over other nAChR subtypes. Compounds <b>4f</b>, <b>4m</b>, and <b>4u</b> are about equipotent at α4β2- and α3β4*-nAChR. From another perspective, only the racemic 3′,4′-dicholoro (±)-<b>4n</b> (∼8-fold) and 4′-chloro-4-(<i>N</i>-methyl) <b>4v</b> (∼9-fold) have higher selectivity for α3β4*- over α4β2-nAChR than (2<i>R</i>,3<i>R</i>)-<b>4a</b> (∼5-fold) or <b>2</b> (∼6.7-fold). The 3′-fluorophenyl <b>4c</b> (∼12-fold) and 3′-bromophenyl <b>4d</b> (∼6-fold) analogues have selectivity for α4β2-nAChR over other nAChR subtypes better than or comparable to that for (2<i>S</i>,3<i>S</i>)-<b>4a</b> (∼3-fold).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Multiple Target Actions of Hydroxybupropion Analogues</h3><div class="NLM_p last">We compared inhibitory potencies across transporters and nAChR relative to (2<i>S</i>,3<i>S</i>)-<b>4a</b>, which has ∼3-fold selectivity for inhibition of NE over DA uptake inhibition and ∼14-fold selectivity for inhibition of NE uptake inhibition over α4β2-nAChR function. Interestingly, there is a change to absolute selectivity for inhibition of α4β2-nAChR over DA uptake inhibition (∼6-fold) and over NE uptake inhibition (∼1.7-fold), and there is ∼3.6-fold selectivity for inhibition of NE over DA uptake for 3′-bromophenyl <b>4d</b>. There is an even more striking increase in selectivity for inhibition of α4β2-nAChR function over transporter inhibition for biphenyl analogue <b>4l</b> (>5-fold over DA uptake inhibition and 6-fold over NE uptake inhibition). Selectivity for inhibition of NE uptake inhibition over α4β2-nAChR function also is reduced relative to that for (2<i>S</i>,3<i>S</i>)-<b>4a</b> for analogues <b>4c</b> (∼1.7-fold), <b>4h</b> (∼3-fold), <b>4f</b> (∼3.3-fold), <b>4g</b> and <b>4r</b> (∼4-fold), <b>4e</b> (∼5.3-fold), and <b>4b</b> (∼12-fold), and for analogue <b>4p</b> (∼4.5-fold). Conversely, there is an increase in selectivity for inhibition of NE uptake over α4β2-nAChR function for <b>4t</b> (∼240-fold), (±)-<b>4n</b> (∼175-fold), <b>4v</b> (80-fold), <b>4s</b> (∼67-fold), and <b>4o</b> (42-fold), although selectivity for inhibition of NE uptake over inhibition of α3β4*- instead of α4β2-nAChR function is less for <b>4t</b>, (±)-<b>4n</b>, and <b>4v</b> (∼154-, 23-, and 9-fold, respectively; recall that <b>4t</b> has comparable activity for DA and NE uptake inhibition). Although its selectivity for inhibition of DA over NE uptake is marginal, (±)-<b>4n</b> has ∼37-fold selectivity for inhibition of DA uptake over α3β4*-nAChR and >285-fold selectivity for inhibition of DA uptake over α4β2-nAChR. The biphenyl analogue <b>4l</b> has 7.9-fold selectivity for inhibition of α3β4*-nAChR over inhibition of NE uptake, surpassing selectivity seen for (2<i>R</i>,3<i>R</i>)-<b>4a</b> (∼1.5-fold).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vivo Effects of Analogues</h3><div class="NLM_p">Compound <b>2</b> blocks nicotine-induced increases in locomotor activity with an AD<sub>50</sub> value of 4.9 mg/kg, while (2<i>S</i>,3<i>S</i>)-<b>4a</b> has a lower AD<sub>50</sub> value of 0.9 mg/kg in the same assay, but none of the analogues is better than (2<i>S</i>,3<i>S</i>)-<b>4a</b>, although <b>4d</b> and <b>4p</b> (2.6 and 1.9 mg/kg AD<sub>50</sub>, respectively) have slightly higher potency than <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">The ability of (2<i>S</i>,3<i>S</i>)-<b>4a</b> to block the nicotine-induced decrease in body temperature is better than that for <b>2</b> [AD<sub>50</sub> = 1.5 and 9.2 mg/kg, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>)]. Compound <b>4d</b> (AD<sub>50</sub> = 1.7 mg/kg) also rivals (2<i>S</i>,3<i>S</i>)-<b>4a</b> in this assay, and analogues <b>4c</b>, <b>4e</b>, <b>4g</b>, <b>4h</b>, and <b>4s</b> have intermediate potencies (2.3−7 mg/kg AD<sub>50</sub> values).</div><div class="NLM_p">In the hot-plate assay, <b>2</b> blocks nicotine-induced, supraspinally mediated analgesia with an AD<sub>50</sub> value of 15 mg/kg. Compound (2<i>S</i>,3<i>S</i>)-<b>4a</b> is 15-fold more potent (AD<sub>50</sub> value of 1 mg/kg), but blockade of nicotine-induced hot-plate analgesia is no better for any of the new analogues tested. However, <b>4c</b>, <b>4d</b>, <b>4e</b>, and <b>4s</b> (3.7−8.6 mg/kg AD<sub>50</sub> values) are more potent than <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">Nicotine-induced analgesia in the tail flick assay, which assesses spinal processes involved in nicotine antinociception,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> is blocked by <b>2</b> with an AD<sub>50</sub> of 1.2 mg/kg. Compound (2<i>S</i>,3<i>S</i>)-<b>4a</b> with an AD<sub>50</sub> = 0.2 mg/kg (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) has a 6-fold increase in effectiveness in this assay. Fifteen of the new analogues have even higher potency. AD<sub>50</sub> values (in mg/kg) are 0.004 for <b>4j</b>, <b>4s</b>, and <b>4t</b>, ∼0.006 for <b>4m</b> and <b>4o</b>, 0.012−0.013 for <b>4c</b> and <b>4h</b>, 0.016 for <b>4u</b>; 0.019 for <b>4i</b> and <b>4k</b>, 0.021 for <b>4l</b>, between 0.034 and 0.054 for <b>4q</b>, <b>4r</b>, and <b>4e</b>, and 0.16 for <b>4d</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">At the doses tested, none of the compounds showed sedative, convulsive, or other obvious toxic effects in mice.</div><div class="NLM_p last">Thus, in four assays of the ability of analogues to block acute actions of nicotine, 3′-bromophenyl analogue <b>4d</b> was more effective than <b>2</b> in each and rivaled effects of (2<i>S</i>,3<i>S</i>)-<b>4a</b> in tail-flick and hypothermia assessments. The 3′-fluorophenyl analogue <b>4c</b>, 3′-methylphenyl analogue <b>4e</b>, and ethyl extended chain analogue <b>4s</b> exceeded <b>2</b>’s potency in three assays and had higher potency than (2<i>S</i>,3<i>S</i>)-<b>4a</b> in the tail-flick assay. Compounds <b>4c</b>, <b>4d</b>, and <b>4s</b> also are remarkable for their higher inhibitory effectiveness at α4β2-nAChR than (2<i>S</i>,3<i>S</i>)-<b>4a</b>. Eleven of the other ligands had better effectiveness than <b>2</b> in one of the acute assays, with potency in the tail-flick assay correlating with IC<sub>50</sub> values <10 μM for inhibition of α4β2-nAChR function for <b>4c</b>−<b>4e</b>, <b>4l</b>, <b>4o</b>, and <b>4q</b>−<b>4u</b> but not for <b>4 h−4k</b>, <b>4m</b> and <b>4v</b>, which were potent in the tail-flick assay but not as α4β2-nAChR antagonists, or for <b>4b</b>, <b>4f</b>, and <b>4g</b>, which lacked effectiveness relative to (2<i>S</i>,3<i>S</i>)-<b>4a</b> in the tail-flick assay but have sub-10 μM IC<sub>50</sub> values at α4β2-nAChR. Lacking potency in tail-flick or inhibition of α4β2-nAChR function, but having activity as antagonists of α3β4*-nAChR, are <b>4n</b> and <b>4p</b>. Increased in vitro inhibition of DA and NE uptake did not necessarily correlate with increased in vivo inhibitory potency in nicotine-sensitive assays if there also was no increase in effectiveness at α4β2-nAChR or selectivity for that target (e.g., <b>4n</b>). On the other hand, the ligands with the highest inhibitory potency for NE uptake inhibition (and highest or higher effectiveness than (2<i>S</i>,3<i>S</i>)-<b>4a</b> at DA uptake inhibition) were among the most potent inhibitors of nicotine-induced analgesia in the tail-flick assay (<b>4s</b> and <b>4t</b>). Improvement over (2<i>S</i>,3<i>S</i>)-<b>4a</b> in the ability to block nicotine-induced analgesia in the tail-flick assay as seen for <b>4j</b>, <b>4m</b>, and <b>4o</b> has no obvious basis as judged from in vitro assays.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">New analogues of the hydroxybupropion isomer (2<i>S</i>,3<i>S</i>)-<b>4a</b> were generated and assessed for their ability to affect monoamine uptake, the function of four different nAChR subtypes, and the acute effects of nicotine on nociception, locomotor activity, and hypothermia.</div><div class="NLM_p">We succeeded in generating analogues with reasonably higher inhibitory potency than <b>2</b> or either of its hydroxymetabolite isomers (2<i>R</i>,3<i>R</i>)-<b>4a</b> and (2<i>S</i>,3<i>S</i>)-<b>4a</b> for DA uptake inhibition (<b>4i</b>, <b>4n</b>, <b>4s</b>, and <b>4t</b>), NE uptake inhibition [(±)-<b>4n</b>, <b>4s</b>, and <b>4t</b>], or 5HT uptake inhibition [(±)-<b>4n</b> and <b>4r</b>], or for functional inhibition of α3β4*-nAChR (<b>4l</b>) or α4β2-nAChR (<b>4c</b>, <b>4d</b>, <b>4l</b>, and <b>4s</b>). Selectivity for inhibition of DA uptake over nAChR or NE uptake inhibition better than that of <b>2</b> was achieved with retention of reasonable potency at DAT for <b>4i</b>. As predicted based on our previous studies of hydroxymetabolites, many of the compounds evaluated have some selectivity for inhibition of NE over DA uptake. This was improved relative to (2<i>S</i>,3<i>S</i>)-<b>4a</b> for <b>4f</b>−<b>4g</b>, <b>4s</b>, <b>4v</b>, <b>4o</b>, <b>4u</b>, and <b>4q</b>, but only <b>4s</b> and <b>4o</b> have improved potency at NE uptake inhibition. Compounds (±)-<b>4n</b>, <b>4t</b>, and <b>4s</b> are more selective than (2<i>S</i>,3<i>S</i>)-<b>4a</b> for inhibition of NE uptake inhibition over nAChR function. Only (±)-<b>4n</b> and <b>4v</b> have increased selectivity for α3β4*-nAChR over other nAChR subtypes relative to <b>2</b> or (2<i>R</i>,3<i>R</i>)-<b>4a</b>. Compounds <b>4l</b> and <b>4k</b> have improved selectivity for α3β4*-nAChR functional inhibition over DA and NE uptake inhibition relative to that of (2<i>R</i>,3<i>R</i>)-<b>4a</b>. Compound <b>4d</b> has absolute selectivity for inhibition of α4β2-nAChR over inhibition of α3β4*-nAChR as well as over NE, 5HT, or DA uptake inhibition, and <b>4l</b>’s similar potency at α4β2- and α3β4*-nAChR also means that it is selective for inhibition of α4β2-nAChR over monoamine transporters. Selectivity for α4β2-nAChR over α3β4*- and other nAChR subtypes was increased for <b>4c</b> and <b>4d</b> relative to that for <b>2</b> and (<i>2S,3S</i>)-<b>4a</b>. Selectivity for inhibition of α4β2-nAChR over NE uptake inhibition was increased relative to that of (2<i>S</i>,3<i>S</i>)-<b>4a</b> for <b>4b</b>, <b>4c</b>, <b>4e</b>, <b>4f</b>, <b>4g</b>, <b>4p</b>, and <b>4r</b>, with <b>4d</b> actually being absolutely selective for inhibition of α4β2-nAChR function over other nAChR subtypes and over inhibition of DA and NE uptake.</div><div class="NLM_p">From a chemical structure perspective, changes in the 3′-chlorophenyl group in (2<i>S</i>,3<i>S</i>)-<b>4a</b> to 3′-bromophenyl <b>4d</b> or 3′-fluorophenyl <b>4c</b> afforded ligands with improved affinity and selectivity for α4β2-nAChRs. Selectivity for monoamine transporter uptake over α4β2-nAChRs functional block was decreased while selectivity for α4β2-nAChRs over other nAChR subtypes was preserved by other changes in the phenyl substitution (nitro <b>4g</b>, methyl <b>4e</b>) or lack of chloro group (<b>4b</b>) but not for 3′-methoxyphenyl substitution (<b>4f</b>). The dichlorophenyl analogues (±)-<b>4n</b> and <b>4p</b> have increased selectivity for α3β4*-nAChR over other nAChR subtypes. In addition, the (±)-3′,4′-dichlorophenyl analogue [(±)-<b>4n</b>] also has a marked increase in affinity for inhibition of DA uptake. Replacement of the 3-methyl group on the morpholinol ring with an ethyl or propyl group (<b>4s</b> and <b>4t</b>) affords ligands with notable improvements in selectivity for inhibition of NE uptake over nAChR and increases in potencies for inhibition of DA and NE uptake. Changing the 3-chlorophenyl ring to a pyridine ring leads to ligands <b>5</b> and <b>6</b>, which are without activity. Naphthyl analogues <b>4q</b> and <b>4r</b> have modestly altered activities compared to (2<i>S</i>,3<i>S</i>)-<b>4a</b>. Interestingly, moving the 3-substituent of the phenyl group of (2<i>S</i>,3<i>S</i>)-<b>4a</b> and <b>4e</b> to the 4′ position affords ligands (<b>4i</b>−<b>4j</b>) that are selective for DA over NE uptake and nAChR functional inhibition and for inhibition of α3β4*- over α4β2-nAChR. However, the biphenyl analogue (<b>4l</b>) has almost no activity at monoamine transporters yet is very potent as an inhibitor of α4β2 and α3β4*-nAChR. Moving the 3′-substituent of the phenyl group of the <i>N</i>-methyl analogue <b>4u</b> to the 4′ position (<b>4v</b>) has little effect on inhibition or DA or NE uptake but increases selectivity for functional blockage of α3β4*- over α4β2-nAChRs from negligible to ∼9-fold.</div><div class="NLM_p">In silico predictions that all of the compounds synthesized would have drug-like character and activity in the central nervous system were consistent with the results of behavioral studies. We obtained several analogues with higher potency than (2<i>S</i>,3<i>S</i>)-<b>4a</b> or <b>2</b> as antagonists of nicotine-mediated antinociception in the tail-flick assay. The ethyl and propyl extended chain ligands <b>4s</b> and <b>4t</b> with high affinity for inhibition of DA and NE uptake, the 3′-fluoro and 3′-bromo phenyl substituted analogues <b>4c</b> and <b>4d</b> with high affinity and good selectivity for α4β2-nAChR, and to a lesser extent the 3′-methylphenyl analogue <b>4e</b> also with good activity at α4β2-nAChR, also had better potency in the tail-flick assay than <b>2</b> or (2<i>S</i>,3<i>S</i>)-<b>4a</b>. The naphthyl analogues <b>4q</b> and <b>4r</b> with selectivity for inhibition of NE over DA uptake and for inhibition of DA over NE uptake, respectively, but having comparable effects on nAChR function, both had ∼5-fold higher activity in the tail-flick assay than (2<i>S</i>,3<i>S</i>)-<b>4a</b>. However, the other in vivo assays mostly did not reveal striking inhibition by analogues of acute nicotine action. Moreover, the tail-flick assay could reflect CNS actions of ligands at a higher level than the presumed spinal level of nicotine-mediated antinociception in the test.</div><div class="NLM_p">The current studies dovetail with those based on modifications to the bupropion template<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> to provide insights into further target-directed drug development. The new analogues also illuminate roles of specific molecular targets in nicotine-mediated behavioral effects. Extensions of the R<sub>1</sub> methyl group in (2<i>S</i>,3<i>S</i>)-<b>4a</b> to an ethyl or propyl group (<b>4s</b> and <b>4t</b>) preferentially improve activities for inhibition of DA and NE uptake. The naphthyl analogues (<b>4q</b> and <b>4r</b>) afford ligands with better potency for 5HT uptake inhibition, and changing the 3′-chlorophenyl moiety of (<i>2S</i>,3<i>S</i>)-<b>4a</b> to a 3′-fluoro or 3′-bromophenyl group leads to ligands with better activity at α4β2-nAChRs (<b>4c</b> and <b>4d</b>).</div><div class="NLM_p last">Greater challenges come in correlating the in vivo effects to each other and to the in vitro fingerprints. Formation of metabolites, differences in pharmacokinetics, or difficulties in brain penetration following systemic administration could confound interpretations. However, even for assays that are done soon after delivery, the chemical modifications that selectively increase in vitro activity at transporters or at α4β2-nAChR afford ligands with potential as nicotine antagonists in vivo. That is, increased activity at either α4β2-nAChR or for inhibition of DA or NE uptake (or for one ligand, at 5HT uptake inhibition) correlates well with improvement in ligand antagonist potency in the tail-flick assay. Thus, the behavioral results suggest that effects of nicotine dependence and/or depression could be countered by ligands acting at DAT, NET, or α4β2-nAChR or any combination of the three.</div></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The current findings provide part of a preclinical foundation for development of compounds related to (2<i>S</i>,3<i>S</i>)-<b>4a</b>. Recently, Silverstone et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> reported that the racemic hydroxybupropion induced convulsions in mice after ip administration. However, the potency of (2<i>S</i>,3<i>S</i>)-<b>4a</b> in our mouse testing is close to 50-fold lower than the racemic hydroxy bupropion metabolite active doses reported by Silverstone et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Furthermore, we found no evidence for seizure or convulsive activities at any of the doses tested in our study. Thus, we will continue exploring use of hydroxybupropion analogues as potentially superior aids to smoking cessation.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nuclear magnetic resonance (<sup>1</sup>H NMR and <sup>13</sup>C NMR) spectra were recorded on a 300 MHz (Bruker AVANCE 300) unless otherwise noted. Chemical shift data for the proton resonances were reported in parts per million (δ) relative to internal (CH<sub>3</sub>)<sub>4</sub>Si (δ 0.0). Optical rotations were measured on an AutoPol III polarimeter, purchased from Rudolf Research. Elemental analyses were performed by Atlantic Microlab, Norcross, GA. Purity of compounds (>95%) was established by elemental analyses. Analytical thin-layer chromatography (TLC) was carried out on plates precoated with silica gel GHLF (250 μM thickness). TLC visualization was accomplished with a UV lamp or in an iodine chamber or ninhydrin staining. All moisture-sensitive reactions were performed under a positive pressure of nitrogen maintained by a direct line from a nitrogen source. Anhydrous solvents were purchased from Aldrich Chemical Co. 3-Methoxypropiophenone (<b>8f</b>), 3,4-dichloropropiophenone (<b>8l</b>), 3,5-dichloropropiophenone (<b>8m</b>), 1-(pyridin-2-yl)propan-1-one (<b>8n</b>), and 1-(pyridin-3-yl)propan-1-one (<b>8o</b>), were synthesized, but are now commercially available. 3-Chlorobutyrophenone (<b>8j</b>) and 3-chloropentaphenone (<b>8k</b>) were described in an earlier paper on bupropion analogues.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthesis of (2<i>S</i>,3<i>S</i>)-<b>4a</b> Using Optically Active Sharpless Hydroxylation Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Step 1: (<i>Z</i>)-<i>tert</i>-Butyl-[1-(3-chlorophenyl)prop-1-enyloxy]dimethylsilane (<b>9a</b>)</h4><div class="NLM_p last">In a 250 mL flask, 3′-chloropropiophenone (<b>8a</b>, 10 g, 0.059 mol) was dissolved in 100 mL in CH<sub>2</sub>Cl<sub>2</sub> and cooled with an ice water bath. Et<sub>3</sub>N (13 mL, 95 mmol) was added to the solution, followed by slow addition of TBDMSOTf (15 mL, 65 mmol). After stirring overnight at room temperature, the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub>. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The oily residue was purified by column chromatography on neutral alumina using hexanes (a few drops of Et<sub>3</sub>N were added) as the eluent to give 16.4 g (98%) of title product as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.46−7.44 (m, 1H), 7.35−7.32 (m, 1H), 7.21−7.20 (m, 2H), 5.23 (q, 1H, <i>J</i> = 6.9 Hz), 1.73 (d, 3H, <i>J</i> = 6.9 Hz), 0.99 (s, 9H), −0.03 (s, 6H). C<sub>15</sub>H<sub>23</sub>ClOSi.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Step 2: (<i>R</i>)-1-(3-Chlorophenyl)-2-hydroxypropan-1-one ((<i>R</i>)-<b>10a</b>)</h4><div class="NLM_p last">A mixture of AD-mix-β (50.6 g) and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (3.5 g, 0.037 mol) in <i>tert</i>-butyl alcohol−water (120 mL/120 mL) was cooled at 0 °C and treated with <b>9a</b> (10 g, 0.036 mol). The reaction mixture was stirred for 16 h at 0 °C. Sodium sulfite (36 g) was added, and the mixture was stirred for another hour. The mixture was filtered through a celite pad and washed with ether. The filtrate was transferred to a separation funnel and the lower dark-colored layer was discarded. The upper yellowish phase was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The crude product was purified by column chromatography on silica gel using hexanes−EtOAc (10:1 to 3:1) as the eluent to give 5.8 g (87%) of title product as light-greenish oil: [α]<sup>20</sup><sub>D</sub> +64.2° (c 1.2, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.91 (s, 1H), 7.80 (d, 1H, <i>J</i> = 7.8 Hz), 7.62−7.57 (m, 1H), 7.46 (t, 1H, <i>J</i> = 7.8 Hz), 5.15−5.08 (m, 1H), 3.68−3.65 (m, 1H), 1.45 (d, 3H, <i>J</i> = 7.1 Hz). C<sub>9</sub>H<sub>9</sub>ClO<sub>2</sub>. Characterization data is similar with that reported in the literature.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Step 3: (2<i>S</i>,3<i>S</i>)-2-(3-Chlorophenyl)-3,5,5-trimethylmorpholin-2-ol [(2<i>S</i>,3<i>S</i>)-<b>4a</b>] Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h4><div class="NLM_p">A sample of (<i>R</i>)-<b>10a</b> (2.47 g, 0.0134 mol) was added to a 250 mL flask and dissolved in CH<sub>2</sub>Cl<sub>2</sub> (40 mL). Proton sponge (3.5 g, 0.016 mol) was added to the reaction flask, and the reaction mixture was cooled to −50 °C. Triflic anhydride (2.47 mL, 14.7 mmol) was slowly added to the reaction flask, the temperature was allowed to rise to 0 °C, and the reaction mixture was stirred for an additional hour. The resulting orange slurry was transferred by syringe to another flask containing a solution of 2-amino-2-methyl-1-propanol (2.6 g, 0.029 mol) in CH<sub>3</sub>CN (40 mL) at −10 °C. After stirring for 4 h at 0 °C, the precipitate was removed by filtration and the filtrate was concentrated. The residue was extracted with ether and solid was removed by filtration and discarded. The filtrate was concentrated to an oil. Purification of the residue by chromatography on silica gel using EtOAc with 1% NH<sub>4</sub>OH as the eluent gave 1.39 g (41%) of (2<i>S</i>,3<i>S</i>)-<b>4a</b> as a white solid. Characterization data is similar with data reported in the literature.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p last">The product freebase (1.2 g, 0.0047 mol) was dissolved in 20 mL of MeOH and treated with a solution of <span class="smallcaps smallerCapital">d</span>-tartaric acid (350 mg, 2.30 mmol) in MeOH (3 mL). After stirring for 5 min at room temperature, the reaction mixture was concentrated, the sample dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and MeOH was added until the solution was clear. Next, ether was added slowly until it became cloudy or small crystals started to form. After keeping the mixture at 0 °C for 1 h, the white solid was collected by filtration and recrystallized to give 0.7 g of (2<i>S</i>,3<i>S</i>)-<b>4a</b>·hemi-<span class="smallcaps smallerCapital">d</span>-tartrate as a white solid (ee 98.4%): mp 128−131 °C; [α]<sup>23</sup><sub>D</sub> +13.7° (c 0.76, CH<sub>3</sub>OH). Anal. (C<sub>15</sub>H<sub>21</sub>ClNO<sub>5</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (2<i>R</i>,3<i>R</i>)-2-(3-Chlorophenyl)-3,5,5-trimethylmorpholin-2-ol ((2<i>R</i>,3<i>R</i>)-<b>4a</b>) Hemi-<span class="smallcaps smallerCapital">l</span>-tartrate</h3><div class="NLM_p last">Following the procedure described for (2<i>S</i>,3<i>S</i>)-<b>4a</b>, a sample of (<i>S</i>)-<b>10a</b> (4.5 g, 0.024 mol), was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (75 mL) and treated with Proton sponge (6.3 g) and cooled to −50 °C. Next, triflic anhydride (4.5 mL, 32 mmol) was added slowly, and the reaction mixture was stirred at 0 °C for an additional hour. The resulting orange slurry was transferred by syringe to another flask containing a solution of 2-amino-2-methyl-1-propanol, (4.7 g, 0.052 mol) in CH<sub>3</sub>CN. After purification, 3.3 g (78%) of the (2<i>R</i>,3<i>R</i>)-<b>4a</b> was isolated and converted to 2.7 g of the Hemi-<span class="smallcaps smallerCapital">l</span>-tartrate salt (>99%ee): mp 128−131 °C; [α]<sup>23</sup><sub>D</sub> −13.0° (c 0.79, CH<sub>3</sub>OH). Characterization data is similar with data reported in the literature.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (2<i>S</i>,3<i>S</i>)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol (<b>4b</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4b</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> using (<i>R</i>)-1-phenyl-2-hydroxypropan-1-one (<b>10b</b>, 3.49 g, 0.0233 mol), Proton sponge (5.9 g), triflic anhydride (4.2 mL, 26 mmol), and 2-amino-2-methyl-1-propanol (4.6 g, 0.052 mol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL). After purification by chromatography on silica gel, 3.52 g (68%) of the free base <b>4b</b> was isolated and converted to 1.19 g of the hemi-<span class="smallcaps smallerCapital">d</span>-tartrate salt, which had >99%ee: mp 112−113 °C; [α]<sup>20</sup><sub>D</sub> +15.8° (c 1.1, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.61−7.59 (m, 2H), 7.44−7.36 (m, 3H), 4.32 (s, 1H), 4.24 (d, 1H, <i>J</i> = 12.3 Hz), 3.58−3.48 (m, 2H), 1.64 (s, 3H), 1.39 (s, 3H), 1.09 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 179.1, 142.4, 130.3, 129.6 (2C), 127.9 (2C), 97.3, 75.4, 67.4, 55.47, 55.27, 24.1, 21.3, 14.3. LCMS (ESI) <i>m</i>/<i>z</i> 222.4 (M − tartrate)<sup>+</sup>. Anal. (C<sub>15</sub>H<sub>22</sub>NO<sub>5</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (2<i>S</i>,3<i>S</i>)-2-(3-Fluorophenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4c</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4c</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> using (<i>R</i>)-1-(3-fluorophenyl)-2-hydroxypropan-1-one (<b>10c</b>, 3.94 g, 0.024 mol), Proton sponge (6.0 g), triflic anhydride (4.6 mL, 25.8 mmol), and 2-amino-2-methyl-1-propanol (4.6 g, 0.052 mol) in acetonitrile (50 mL). After purification, 2.2 g (39%) of the free base <b>4c</b> was isolated and converted to the hemi-<span class="smallcaps smallerCapital">d</span>-tartrate salt, which had >99%ee: mp 131−132 °C; [α]<sup>20</sup><sub>D</sub> +20.4° (c 1.0, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.45−7.41 (m, 2H), 7.35−7.31 (m, 1H), 7.11−7.09 (m, 1H), 4.33 (s, 1H), 4.26 (d, 1H, <i>J</i> = 12.0 Hz), 3.56−3.45 (m, 2H), 1.59 (s, 3H), 1.34 (s, 3H), 1.06 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 178.1, 165.4, 162.1, 144.8, 130.8, 123.2, 116.3 (d), 114.3 (d), 96.2, 74.5, 67.0, 54.3, 23.6, 20.8, 13.7. LCMS (ESI) <i>m</i>/<i>z</i> 240.0 [(M − tartrate)<sup>+</sup>, M = C<sub>15</sub>H<sub>21</sub>FNO<sub>5</sub>]. Anal. (C<sub>15</sub>H<sub>21</sub>FNO<sub>5</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (2<i>S</i>,3<i>S</i>)-2-(3-Bromophenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4d</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4d</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> using (<i>R</i>)-1-(3-bromophenyl)-2-hydroxypropan-1-one (<b>10d</b>, 4.0 g, 0.018 mol), Proton sponge (4.5 g, 0.021 mol), triflic anhydride (3.2 mL, 192 mmol), and 2-amino-2-methyl-1-propanol (3.4 g, 0.038 mol) in acetonitrile (50 mL). After purification, 2.04 g (39%) of the free base <b>4d</b> was isolated and converted to 1.6 g of the hemi-<span class="smallcaps smallerCapital">d</span>-tartrate salt, which had >99%ee: mp 129−130 °C; [α]<sup>20</sup><sub>D</sub> +9.6° (c 1.0, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.77−7.76 (m, 1H), 7.63−7.53 (m, 2H), 7.38−7.32 (m, 1H), 4.37 (s, 1H), 4.14 (d, 1H, <i>J</i> = 12.0 Hz), 3.58−3.39 (m, 2H), 1.57 (s, 3H), 1.32 (s, 3H), 1.07−1.02 (m, 3H). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 178.8, 145.1, 133.3, 131.1, 126.9, 123.6, 96.7, 75.2, 67.7, 55.0, 24.4, 21.5, 14.4; LCMS (ESI) <i>m</i>/<i>z</i> 300.6 [(M − tartrate)<sup>+</sup>, M = C<sub>15</sub>H<sub>21</sub>BrNO<sub>5</sub>]. Anal. (C<sub>15</sub>H<sub>21</sub>BrNO<sub>5</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (2<i>S</i>,3<i>S</i>)-2-(<i>m</i>-Tolyl)-3,5,5-trimethylmorpholin-2-ol (<b>4e</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4e</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> using (<i>R</i>)-1-(3-methylphenyl)-2-hydroxypropan-1-one (<b>10e</b>, 4.2 g, 0.026 mol), Proton sponge (6.5 g, 0.030 mol), triflic anhydride (4.60 mL, 282 mmol), and 2-amino-2-methyl-1-propanol (5.0 g, 0.056 mol) in acetonitrile (55 mL). After purification, 4.0 g (66%) of the free base <b>4e</b> was isolated and converted to 3.6 g of the hemi-<span class="smallcaps smallerCapital">d</span>-tartrate salt, which had 94%ee: mp 104−105 °C; [α]<sup>20</sup><sub>D</sub> +11.9° (c 0.85, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.43−7.38 (m, 2H), 7.28 (t, 1H, <i>J</i> = 7.8 Hz), 7.21−7.18 (m, 1H), 4.33 (s, 1H), 4.20 (d, 1H, <i>J</i> = 12.0 Hz), 3.52−3.45 (m, 2H), 2.38 (s, 3H), 1.61 (s, 3H), 1.36 (s, 3H), 1.06 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 179.0, 142.3, 139.4, 130.9, 129.5, 128.4, 125.0, 97.2, 75.3, 67.4, 55.2, 24.2, 21.9, 21.4, 14.4. LCMS (ESI) <i>m</i>/<i>z</i> 236.2 [(M − tartrate)<sup>+</sup>, M = C<sub>16</sub>H<sub>24</sub>NO<sub>5</sub>]. Anal. (C<sub>16</sub>H<sub>24</sub>NO<sub>5</sub>·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (2<i>S</i>,3<i>S</i>)-2-(3-Methoxyphenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4f</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4f</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> using (<i>R</i>)-1-(3-methoxyphenyl)-2-hydroxypropan-1-one (<b>10f</b>, 4.2 g, 0.023 mol), Proton sponge (5.9 g, 0.028 mol), triflic anhydride (4.2 mL, 257 mmol), and 2-amino-2-methyl-1-propanol (4.5 g, 0.051 mol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL). After purification, 4.16 g (71%) of the free base <b>4f</b> was isolated and converted to 1.24 g the hemi-<span class="smallcaps smallerCapital">d</span>-tartrate salt, which had 91%ee: mp 99−100 °C; [α]<sup>20</sup><sub>D</sub> +7.9° (c 1.1, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.32 (t, 1H, <i>J</i> = 7.8 Hz), 7.19−7.14 (m, 2H), 6.96−6.92 (m, 1H), 4.33 (s, 1H), 4.18 (d, 1H, <i>J</i> = 12.3 Hz), 3.81 (s, 3H), 3.52 (d, 1H, <i>J</i> = 12.3 Hz), 3.48−3.45 (m, 1H), 1.59 (s, 3H), 1.34 (s, 3H), 1.06 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 178.8, 161.4, 144.1, 130.7, 120.1, 115.4, 113.8, 97.1, 75.2, 67.6, 56.1, 55.2, 24.4, 21.5, 14.5. LCMS (ESI) <i>mlz</i> 252.3 [(M − tartrate)<sup>+</sup>, M = C<sub>16</sub>H<sub>24</sub>NO<sub>6</sub>]. Anal. (C<sub>16</sub>H<sub>24</sub>NO<sub>6</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (2<i>S</i>,3<i>S</i>)-2-(3-Nitrophenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4g</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4g</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> using (<i>R</i>)-1-(3-nitrophenyl)-2-hydroxypropan-1-one (<b>10g</b>, 4.0 g, 0.021 mol), Proton sponge (5.2 g, 0.0246 mol), triflic anhydride (3.7 mL, 0.023 mol), and 2-amino-2-methyl-1-propanol (4.0 g, 0.045 mol) in acetonitrile (45 mL). After purification, 1.0 g (18%) of the free base <b>4g</b> was isolated and converted to the hemi-<span class="smallcaps smallerCapital">d</span>-tartrate salt, which had 94%ee: mp 192−193 °C; [α]<sup>20</sup><sub>D</sub> +6.5° (c 1.0, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.47−8.45 (m, 1H), 8.31−8.26 (m, 1H), 8.05−8.01 (m, 1H), 7.73−7.66 (m, 1H), 4.34 (s, 1H), 4.18 (d, 1H, <i>J</i> = 12.1 Hz), 3.59 (d, 1H, <i>J</i> = 6.6 Hz), 3.50 (q, 1H, <i>J</i> = 6.6 Hz), 1.60 (s, 3H), 1.35 (s, 3H), 1.07 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 178.3, 149.9, 145.3, 134.4, 131.0, 125.0, 123.0, 96.8, 75.0, 68.1, 54.8, 24.7, 21.7, 14.6. LCMS (ESI) <i>mlz</i> 267.3 [(M − tartrate)<sup>+</sup>, M = C<sub>15</sub>H<sub>21</sub>N<sub>2</sub>O<sub>7</sub>]. Anal. (C<sub>15</sub>H<sub>21</sub>N<sub>2</sub>O<sub>7</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (2<i>S</i>,3<i>S</i>)-2-(4-Fluorophenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4h</b>) Hemi-Fumarate</h3><div class="NLM_p">A solution of <b>15</b> (166 mg, 1.16 mmol) in dry THF (1.2 mL, 1M) under an N<sub>2</sub> atmosphere was cooled to −78 °C and treated with 4-fluorophenylmagnesium bromide (1.3 equiv, 1.5 mmol, 1.9 mL, 0.8 M solution in THF). The reaction mixture was stirred at −78 °C for 3 h. A saturated aqueous solution of NH<sub>4</sub>Cl was added to the reaction vessel, and the mixture was allowed to warm to room temperature. EtOAc (5 mL) was added to the reaction vessel, and the organic layer was separated. The aqueous phase was extracted with EtOAc (three times). The combined organic extracts were washed (water, brine), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by column chromatography on silica gel using CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>−MeOH (90:10) as the eluent to afford 80 mg of <b>4h</b> as a white solid: [α]<sup>22</sup><sub>D</sub> +31.2° (c 0.5, CHC1<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.60−7.55 (m, 2H), δ 7.08−7.00 (m, 2H), 3.83 (d, 1H, <i>J</i> = 11.3 Hz), 3.40 (d, 1H, <i>J</i> = 11.3 Hz), 3.17 (q, 1H, <i>J</i> = 6.4 Hz), 1.38 (s, 3H), 1.08 (s, 3H), 0.78 (d, 3H, <i>J</i> = 6.4 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 128.0, 127.9, 114.87, 114.58, 103.2, 98.4, 96.8, 69.5, 53.5, 27.3, 22.8, 16.4. LCMS (ESI) <i>m</i>/<i>z</i> 240.0 [(M + H)<sup>+</sup>, M = C<sub>13</sub>H<sub>18</sub>FNO<sub>2</sub>].</div><div class="NLM_p last">A sample of <b>4h</b> (56.0 mg, 0.234 mmol) in ether (2 mL) was treated with a solution of fumaric acid (30.0 mg, 0.258 mmol) in MeOH (0.6 mL). The mixture was stirred at room temperature overnight. Filtration and washing of the filter cake with ether, followed by recrystallization of the solid from MeOH−ether gave 45 mg (54%) of <b>4h</b>·0.5fumarate: mp 178−182 °C; [α]<sup>22</sup><sub>D</sub> +29° (c 0.6, MeOH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.65−7.59 (m, 2H), 7.15−7.08 (m, 2H), 6.66 (s, 1H), 4.15 (d, 1H, <i>J</i> = 12.2 Hz), 3.52 (d, 1H, <i>J</i> = 12.2 Hz), 3.41−3.33 (m, 1H), 1.56 (s, 3H), 1.32 (s, 3H), 1.03 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub><i>4</i></sub>) δ 136.7, 129.75, 129.64, 115.92, 115.63, 67.5, 54.8, 54.1, 24.3, 21.3, 14.3. LCMS (ESI) <i>m</i>/<i>z</i> 240.3 [(M − fumaric)<sup>+</sup>, M = C<sub>13</sub>H<sub>18</sub>FNO<sub>2</sub>·0.5C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>]. Anal. (C<sub>15</sub>H<sub>20</sub>FNO<sub>4</sub>·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (2<i>S</i>,3<i>S</i>)-2-(4-Chlorophenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4i</b>) Hemi-Fumarate</h3><div class="NLM_p">A solution of <b>15</b> (357 mg, 2.50 mmol) in dry THF (2.5 mL, 1M) under an N<sub>2</sub> atmosphere was cooled to −78 °C and treated with 4-chlorophenylmagnesium bromide (2 equiv, 5.00 mmol, 5.00 mL, 1 M solution in ether). The reaction mixture was stirred at −78 °C for 2 h. A saturated aqueous solution of NH<sub>4</sub>Cl was added to the reaction vessel, and the mixture was allowed to warm to room temperature. EtOAc was added, and the organic layer was separated and the aqueous phase was extracted with EtOAc (trice). The combined organic extracts were washed (water, brine), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by column chromatography on silica gel using CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>−MeOH (90:10) as the eluent to afford 180 mg (29%) of <b>4i</b> as a white solid: [α]<sup>23</sup><sub>D</sub> +33° (c 0.4, CHC1<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.54 (d, 2H, <i>J</i> = 8.5 Hz), 7.32 (d, 2H, <i>J</i> = 8.5 Hz), 3.83 (d, 1H, <i>J</i> = 11.3 Hz), 3.40 (d, 1H, <i>J</i> = 11.3 Hz), 3.18 (q, 1H, <i>J</i> = 6.5 Hz), 1.38 (s, 3H), 1.08 (s, 3H), 0.78 (d, 3H, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 128.5, 128.1, 127.6, 127.2, 101.6, 95.9, 69.5, 53.4, 49.7, 27.3, 22.8, 16.4. LCMS (ESI) <i>m</i>/<i>z</i> 256.3 [(M + H)<sup>+</sup>, M = C<sub>13</sub>H<sub>18</sub>ClNO<sub>2</sub>].</div><div class="NLM_p last">A sample of <b>4i</b> (161 mg, 0.629 mmol) in ether (3 mL) was treated with a solution of fumaric acid (73.0 mg, 0.629 mmol) in MeOH (1.2 mL). The mixture was stirred at room temperature overnight. Filtration and washing of the filter cake with ether, followed by recrystallization from MeOH−ether gave 123 mg (53%) of <b>4i</b>·0.5fumarate as a white solid; mp 187−190 °C; [α]<sup>22</sup><sub>D</sub> +22° (c 0.75, MeOH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.58 (d, 2H, <i>J</i> = 8.6 Hz), 7.41 (d, 1H, <i>J</i> = 8.6 Hz), 6.67 (s, 1H), 4.11 (d, 1H, <i>J</i> = 12.0 Hz), 3.51 (d, 1H, <i>J</i> = 12.0 Hz), 3.38−3.36 (m, 1H), 1.53 (s, 3H), 1.28 (s, 3H), 1.00 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 172.9, 141.1, 136.7, 135.8, 129.3, 96.6, 67.4, 54.68, 54.37, 24.1, 21.2, 14.1. LCMS (ESI) <i>m</i>/<i>z</i> 256.6 [(M − fumaric)<sup>+</sup>, M = C<sub>13</sub>H<sub>18</sub>ClNO<sub>2</sub>·0.5C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>]. Anal. (C<sub>15</sub>H<sub>20</sub>ClNO<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (2<i>S</i>,3<i>S</i>)-3,5,5-Trimethyl-2-(4-methylphenyl)morpholin-2-ol (<b>4j</b>) Hemi-Fumarate</h3><div class="NLM_p">A solution of morpholin-2-one <b>15</b> (270 mg, 1.88 mmol) in anhydrous THF (1.9 mL) was cooled to −78 °C and treated with <i>p</i>-tolylmagnesium bromide (1.2 equiv, 2.26 mmol, 2.26 mL, 1 M solution in THF) under an N<sub>2</sub> atmosphere. After stirring the reaction mixture at −78 °C for 1.5 h, saturated aqueous solution of NH<sub>4</sub>Cl (30 mL) was added to the reaction vessel, and the mixture was allowed to warm to room temperature. Ether (30 mL) was added to the reaction flask, and the organic layer was separated. The aqueous phase was extracted with ether (twice). The combined organic extracts were washed (water, brine), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by column chromatography on silica gel using CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>−MeOH (90:10) as the eluent to give 271 mg (41%) of <b>4j</b> as a yellow foam: [α]<sup>22</sup><sub>D</sub> +21.2° (c 0.9, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.47 (d, 2H, <i>J</i> = 8.2 Hz), 7.16 (d, 2H, <i>J</i> = 8.0 Hz), 3.85 (d, 1H, <i>J</i> = 11.3 Hz), 3.40 (d, 1H, <i>J</i> = 11.2 Hz), 3.20−3.07 (m, 1H), 2.35 (s, 3H), 1.39 (s, 3H), 1.08 (s, 3H), 0.81 (d, 3H, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 129.6, 128.60, 128.49, 125.9, 103.2, 96.2, 69.4, 53.9, 53.4, 49.6, 27.3, 22.8, 16.5. LCMS (ESI) <i>m</i>/<i>z</i> 236.3 [(M + H)<sup>+</sup>, M = C<sub>14</sub>H<sub>21</sub>NO<sub>2</sub>].</div><div class="NLM_p last">A sample of <b>4j</b> (240 mg, 0.683 mmol) in ether (3 mL) was treated with a solution of fumaric acid (87.0 mg, 0.751 mmol) in MeOH (2 mL) and stirred at room temperature overnight. Ether was added to the reaction mixture. The solid was recrystallized from MeOH−ether to give 140 mg (67%) of <b>4j</b>·0.5fumarate as a white solid: mp 178−182 °C; [α]<sup>22</sup><sub>D</sub> +19° (c 0.6, MeOH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.47 (d, 2H, <i>J</i> = 8.2 Hz), 7.21 (d, 2H, <i>J</i> = 8.0 Hz), 6.65 (s, 1H), 4.18 (d, 1H, <i>J</i> = 12.2 Hz), 3.51 (d, 1H, <i>J</i> = 12.2 Hz), 3.46 (q, 1H, <i>J</i> = 6.6 Hz), 2.35 (s, 3H), 1.58 (s, 3H), 1.34 (s, 3H), 1.04 (d, 1H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 139.9, 139.2, 136.9, 129.8, 127.4, 96.8, 67.2, 54.9, 54.6, 24.1, 21.1, 14.1. LCMS (ESI) <i>m</i>/<i>z</i> 236.2 [(M − fumaric)<sup>+</sup> C<sub>14</sub>H<sub>21</sub>NO<sub>2</sub>·0.5C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>]. Anal. (C<sub>16</sub>H<sub>23</sub>NO<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (2<i>S</i>,3<i>S</i>)-2-(4-Methoxyphenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4k</b>) Hydrochloride</h3><div class="NLM_p">A solution of <b>15</b> (434 mg, 3.03 mmol) in anhydrous THF (3 mL, 1M) was cooled to −78 °C and treated with 4-methoxyphenylmagnesium bromide (1.3 equiv, 3.93 mmol, 3.9 mL of 1 M solution in THF). The reaction mixture was stirred at −78 °C and under an N<sub>2</sub> atmosphere for 1.5 h. A saturated aqueous solution of NH<sub>4</sub>Cl (30 mL) was added to the reaction vessel, and the mixture was allowed to warm to room temperature. The mixture was extracted with ether (three times). The combined ether extracts were washed (water, brine), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by column chromatography on silica gel using CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>−MeOH−NH<sub>4</sub>OH (90:9:1) as the eluent to give 380 mg of a yellow solid.</div><div class="NLM_p last">The sample (379 mg, 0.783 mmol) in ether (5 mL) was treated with HCl (1.00 mmol, 0.250 mL, 4 M solution in dioxane). The mixture was stirred at room temperature overnight. Ether was added to the reaction mixture. The suspension was sonicated, centrifuged, and decanted three times to afford a solid pellet. The solid material was recrystallized from MeOH−ether to give 215 mg (95%) of <b>4k</b>·HCl as a pale-yellow solid: mp 170−172 °C; [α]<sup>20</sup><sub>D</sub> +19.6° (c 1.0, MeOH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.52 (d, 2H, <i>J</i> = 8.9 Hz), 6.95 (d, 2H, <i>J</i> = 8.9 Hz), 4.22 (d, 1H, <i>J</i> = 12.4 Hz), 3.81 (s, 3H), 3.58−3.45 (m, 2H), 1.62 (s, 3H), 1.39 (s, 3H), 1.10 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 161.8, 133.5, 132.8, 128.8, 114.6, 96.7, 66.6, 55.80, 55.7, 55.2, 23.4, 20.8, 13.7. LCMS (ESI) <i>m</i>/<i>z</i> 286.4 (M − H)<sup>+</sup>, M = C<sub>14</sub>H<sub>21</sub>NO<sub>3</sub>·HCl]. Anal. (C<sub>14</sub>H<sub>22</sub>ClNO<sub>3</sub>) C, H, N.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (2<i>S</i>,3<i>S</i>)-2-Biphenyl-4-yl-3,5,5-trimethylmorpholin-2-ol (<b>4l</b>) Hemi-Fumarate</h3><div class="NLM_p">A solution of <b>15</b> (394 mg, 2.75 mmol) in anhydrous THF (2.75 mL, 1M) was cooled to −78 °C and treated with 4-biphenylmagnesium bromide (1.2 equiv, 3.30 mmol, 6.60 mL, 0.5 M solution in THF) under an N<sub>2</sub> atmosphere. After stirring at −78 °C for 1.5 h, the reaction mixture was treated with saturated aqueous solution of NH<sub>4</sub>Cl (40 mL) and EtOAc was added (30 mL). The organic layer was separated. The aqueous phase was extracted with EtOAc trice. The combined organic extracts were washed (water, brine), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. Purification of the residue by column chromatography on silica gel using CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>−MeOH (90:10) as the eluent afforded 300 mg (37%) of <b>4l</b> as a white solid: [α]<sup>23</sup><sub>D</sub> +15.2° (c 0.3, CHC1<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.70−7.33 (m, 9H), 3.88 (d, 1H, <i>J</i> = 11.3 Hz), 3.44 (d, 1H, <i>J</i> = 11.3 Hz), 3.29−3.25 (m, 1H), 1.42 (s, 3H), 1.10 (s, 3H), 0.86 (d, 3H, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 140.9, 129.0, 128.97, 128.74, 128.4, 127.54, 127.30, 127.13, 126.7, 126.5, 96.2, 69.5, 53.4, 51.4, 49.6, 27.4, 22.8, 16.6. LCMS (ESI) <i>m</i>/<i>z</i> 298.4, 280.3 [(M + H)<sup>+</sup>, M = C<sub>19</sub>H<sub>23</sub>NO<sub>2</sub>].</div><div class="NLM_p last">A sample of <b>4l</b> (379 mg, 1.27 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was treated with a solution of fumaric acid (148 mg, 1.27 mmol) in MeOH (4 mL). The mixture was stirred at room temperature overnight. Filtration and washing of the filter cake with ether, followed by recrystallization from MeOH−ether gave 130 mg (25%) of <b>4l</b>·0.5fumarate as a white solid: mp 197−202 °C; [α]<sup>22</sup><sub>D</sub> +18° (c 1.6, MeOH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.70−7.63 (m, 6H), 7.49−7.35 (m, 3H), 6.69 (s, 1H), 4.20 (d, 1H, <i>J</i> = 12.1 Hz), 3.55 (d, 1H, <i>J</i> = 12.1 Hz), 3.47 (q, 1H, <i>J</i> = 6.7 Hz), 1.60 (s, 3H), 1.34 (s, 3H), 1.08 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 142.9, 141.8, 141.4, 136.7, 129.9, 128.6, 128.04, 128.02, 127.7, 96.9, 67.5, 54.8, 54.1, 30.7, 24.4, 21.3, 14.4. LCMS (ESI) <i>m</i>/<i>z</i> 298.6, 280.3 [(M − fumaric)<sup>+</sup>, M = C<sub>19</sub>H<sub>23</sub>NO<sub>2</sub>·0.5C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>]. Anal. (C<sub>21</sub>H<sub>25</sub>NO<sub>4</sub>·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (2<i>S</i>,3<i>S</i>)-2-(3,4-Difluorophenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4m</b>) Hemi-Fumarate</h3><div class="NLM_p">A solution of morpholin-2-one <b>15</b> (410 mg, 2.86 mmol) in anhydrous THF (2.9 mL, 1M) was cooled to −78 °C and treated with 3,4-difluorophenylmagnesium bromide (1.2 equiv, 3.43 mmol, 6.90 mL, 0.5 M solution in THF) under an N<sub>2</sub> atmosphere. After stirring the reaction mixture at −78 °C under an inert atmosphere for 1.5 h, saturated aqueous solution of NH<sub>4</sub>Cl was added to the reaction vessel. The reaction mixture was allowed to warm to room temperature and extracted with ether (three times). The combined organic extracts were washed (water, brine), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. Purification of the residue by column chromatography on silica gel using CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>−MeOH−NH<sub>4</sub>OH (90:9:1) as the eluent gave 190 mg (25%) of <b>4m</b> as a yellow solid: [α]<sup>22</sup><sub>D</sub> +18.2° (c 1.0, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.45−7.39 (m, 1H), 7.34−7.32 (m, 1H), 7.18−7.10 (m, 1H), 3.82 (d, 1H, <i>J</i> = 11.3 Hz), 3.40 (d, 1H, <i>J</i> = 11.3 Hz), 3.18 (q, 1H, <i>J</i> = 6.5 Hz), 1.38 (s, 3H), 1.08 (s, 3H), 0.78 (d, 3H, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 122.40, 122.31 116.74, 116.51, 115.8, 115.6, 96.5, 69.6, 53.4, 49.8, 27.3, 22.8, 16.5. LCMS (ESI) <i>m</i>/<i>z</i> 258.6 [(M + H)<sup>+</sup>, M = C<sub>13</sub>H<sub>17</sub>F<sub>2</sub>NO<sub>2</sub>].</div><div class="NLM_p last">A sample of <b>4m</b> (180 mg, 0.699 mmol) in ether (3 mL) was treated with a solution of fumaric acid (80.0 mg, 0.689 mmol) in MeOH (2.5 mL). The mixture was stirred at room temperature overnight. Ether was added to the reaction mixture. The suspension was sonicated, centrifuged, and decanted to afford a solid pellet that was recrystallization from MeOH−ether. The suspension was sonicated, centrifuged, and decanted three times to afford 119 mg (53%) of <b>4m</b>·0.5fumarate as a white solid: mp 187−189 °C; [α]<sup>22</sup><sub>D</sub> +29.6° (c 0.5, MeOH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.52−7.41 (m, 2H), 7.38−7.22 (m, 1H), 6.65 (s, 1H), 4.34 (s, 1H), 4.15 (d, 1H, <i>J</i> = 12.2 Hz), 3.54 (d, 1H, <i>J</i> = 12.2 Hz), 3.46 (q, 1H, <i>J</i> = 6.6 Hz), 1.57 (s, 3H), 1.33 (s, 3H), 1.06 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 136.7, 124.4, 118.1, 117.8, 117.1, 116.9, 98.2, 67.5, 54.58, 54.36, 24.1, 21.2, 14.1. LCMS (ESI) <i>m</i>/<i>z</i> 258.6, [(M − fumaric)<sup>+</sup> M = C<sub>13</sub>H<sub>17</sub>F<sub>2</sub>NO<sub>2</sub>·0.5C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>]. Anal. (C<sub>15</sub>H<sub>19</sub>F<sub>2</sub>NO<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-(3,4-Dichlorophenyl)-3,5,5-trimethylmorpholin-2-ol [(±)-<b>4n</b>] Hemi-Fumarate</h3><div class="NLM_p">To a solution of 3′,4′-dichloropropiophenone (<b>8l</b>, 5.02 g, 0.247 mol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) was added 10 drops of bromine. After stirring at room temperature under nitrogen for several min, the characteristic red color of bromine disappeared, indicating initiation of the reaction. The remainder of the bromine (1.27 mL, 24.7 mmol) was added dropwise, and the reaction solution was allowed to stir at room temperature under nitrogen atmosphere for 1.75 h. Analysis by TLC (silica, 2:1 hexane:CH<sub>2</sub>Cl<sub>2</sub>) indicated consumption of starting material. The reaction solution was quenched and brought to a pH of 9 with a saturated aqueous solution of NaHCO<sub>3</sub> and concentrated NH<sub>4</sub>OH. The solution was extracted with CH<sub>2</sub>Cl<sub>2</sub>, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated, and dried under vacuum to give 7.14 g (100%) of 2-bromo-(3′,4′-dichlorophenyl)propan-1-one as a white solid. Characterization data is similar with data reported in the literature.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">2-Bromo-(3′,4′-dichlorophenyl)propan-1-one (6.97 g, 0.025 mol) in a minimal amount of CH<sub>2</sub>Cl<sub>2</sub> was transferred to a sealable reaction tube. Most of the CH<sub>2</sub>Cl<sub>2</sub> was removed via positive nitrogen flow. 2-Amino-2-methyl-1-propanol (23.6 mL, 247 mmol) was added in one portion, and the tube was sealed and placed in an oil bath heated to 75 °C. After stirring at 75 °C overnight, analysis by TLC (silica, 9:1:20 ether−Et<sub>3</sub>N−hexane) showed only a trace amount of starting material remaining and the reaction was allowed to cool to room temperature. The reaction mixture was quenched and brought to a pH of 10 with a saturated aqueous solution of NaHCO<sub>3</sub>, and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated, and dried under vacuum to give 11.29 g of a yellow oil. The residue was purified by column chromatography on silica gel using ether−Et<sub>3</sub>N−hexane (9:1:50) as eluent to give 3.50 g (49%) of <b>4n</b> as a white solid. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.70−7.67 (m, 1H), 7.47−7.39 (m, 2H), 3.81 (d, 1H), 3.40 (d, 1H), 3.22−3.14 (m, 1H), 1.38 (s, 3H), 1.08 (s, 3H), 0.78 (d, 3H).</div><div class="NLM_p last">A solution of (±)-<b>4n</b> (3.34 g, 0.012 mol) in methanol was treated with fumaric acid (1.34 g, 0.012 mol). The mixture was allowed to stir for 15 min and a white solid precipitated out of solution, which was collected by vacuum filtration to afford 2.23 g (53%) of <b>4n</b>·0.5fumarate as a white solid: mp 188−189 °C. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.68−7.62 (m, 2H), 7.52−7.48 (m, 1H), 3.77 (d, 1H), 3.36 (d, 1H), 3.13−3.07 (q, 1H), 1.33 (s, 3H), 1.07 (s, 3H), 0.76 (d, 3H). Anal. (C<sub>15</sub>H<sub>19</sub>Cl<sub>2</sub>NO<sub>4</sub>) C, H, N.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (2<i>S</i>,3<i>S</i>)-2-(3,5-Difluorophenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4o</b>) Hydrochloride</h3><div class="NLM_p">A solution of <b>15</b> (448 mg, 3.13 mmol) in anhydrous THF (3 mL, 1M) was cooled to −78 °C and treated with 3,5-dipfluorophenylmagnesium bromide (1.2 equiv, 3.75 mmol, 7.5 mL, 0.5 M solution in THF). The reaction mixture was stirred at −78 °C and under an N<sub>2</sub> atmosphere for 1.5 h. Saturated aqueous solution of NH<sub>4</sub>Cl was added to the reaction vessel, and the mixture was allowed to warm to room temperature. The reaction mixture was extracted with ether (three times). The combined ether extracts were washed (water, brine), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. Purification of the residue by column chromatography on silica gel using CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>−MeOH−NH<sub>4</sub>OH (90:9:1) as the eluent gave 105 mg (13%) of <b>4o</b> as a yellow solid: [α]<sup>22</sup><sub>D</sub> +19.5° (c 0.8, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.16−7.10 (m, 2H), 6.82−6.67 (m, 1H), 3.81 (d, 1H, <i>J</i> = 12.0 Hz), 3.40 (d, 1H, <i>J</i> = 12.0 Hz), 3.18 (q, 1H, <i>J</i> = 6.0 Hz), 1.39 (s, 3H), 1.12 (s, 3H), 0.83 (d, 3H, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 109.63, 109.40, 103.9, 103.5, 103.2, 95.8, 69.2, 53.3, 50.1, 49.6, 26.9, 22.5, 15.2. LCMS (ESI) <i>m</i>/<i>z</i> 258.8 [(M + H)<sup>+</sup>, M = C<sub>13</sub>H<sub>17</sub>F<sub>2</sub>NO<sub>2</sub>].</div><div class="NLM_p last">A sample of <b>4o</b> (71.0 mg, 0.275 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) was treated with HCl (0.386 mmol, 0.100 mL solution 4 M in dioxane). The mixture was stirred at room temperature overnight, and ether was added to the reaction mixture. The suspension was sonicated, centrifuged, and decanted to afford a solid pellet; this procedure was repeated three times. The solid material was recrystallized from methanol−ether. The suspension was sonicated, centrifuged, decanted, and dried to give 60 mg (74%) of <b>4o</b>·HCl as a pale-yellow solid: mp 199−204 °C; [α]<sup>22</sup><sub>D</sub> +21.5° (c 1.0, MeOH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.23−7.18 (m, 2H), 7.03−6.92 (m, 1H), 4.19 (d, 1H, <i>J</i> = 12.0 Hz), 3.65−3.54 (m, 2H), 1.62 (s, 3H), 1.39 (s, 3H), 1.12 (d, 3H, <i>J</i> = 6.0 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 166.1, 162.8, 111.1, 110.9, 105.6, 105,2, 104.9, 66.9, 55.6, 54.5, 23.5, 20.9, 13.7. LCMS (ESI) <i>m</i>/<i>z</i> 258.5 [(M − HCl)<sup>+</sup>, M = C<sub>13</sub>H<sub>17</sub>F<sub>2</sub>NO<sub>2</sub>·HCl]. Anal. (C<sub>13</sub>H<sub>18</sub>ClF<sub>2</sub>NO<sub>2</sub>) C, H, N.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-(3,5-Dichlorophenyl)-3,5,5-trimethylmorpholin-2-ol [(±)-<b>4p</b>] Hemi-Fumarate</h3><div class="NLM_p last">To a stirred solution of 3,5-dichloropropiophenone (<b>8m</b>, 3.81 g, 0.0188 mol) in CH<sub>2</sub>Cl<sub>2</sub> (28 mL) was added bromine (0.986 mL, 19.1 mmol) dropwise. The bromine was immediately consumed upon addition of each drop until the end of addition when it had a consistent brownish color, indicative of excess bromine. The reaction was immediately quenched with saturated aqueous NaHCO<sub>3</sub>, extracted three times with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, combined, and concentrated under reduced pressure without drying to afford a yellow oil. The oil was dissolved in anhydrous diethyl ether (50 mL) and 2-amino-2-methyl-1-propanol (6.7 g, 0.075 mol) was added. The reaction mixture was stirred overnight and quenched with saturated aqueous NaHCO<sub>3</sub>. The aqueous layer was extracted three times with CH<sub>2</sub>Cl<sub>2</sub>, and the organic layers were separated, dried, and concentrated to afford another yellow oil. Purification by column chromatography on silica gel afforded 2.51 g (46%) of the title compound. The hemifumarate salt was prepared by dissolving the free base in methanol and adding 1.0 g of fumaric acid to form the title compound: mp 188−190 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.58−7.57 (m, 1H), 7.47−7.46 (m, 2H), 6.67 (s, 0.5H), 4.09 (d, 1H, <i>J</i> = 11.9 Hz), 3.53 (d, 1H, <i>J</i> = 12.0 Hz), 3.41−3.37 (m, 1H), 1.53 (s, 3H), 1.28 (s, 3H), 1.02 (d, 3H, 6.6 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 134.9, 133.6, 127.7, 125.2, 94.7, 67.2, 52.5, 50.1, 25.0, 21.6, 14.6. Anal. (C<sub>15</sub>H<sub>19</sub>Cl<sub>2</sub>NO<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (2<i>S</i>,3<i>S</i>)-2-(Naphthalen-1-yl)-3,5,5-trimethylmorpholin-2-ol (<b>4q</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4q</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> employing (<i>R</i>)-2-hydroxy-1-(naphthalen-1-yl)propan-1-one (<b>10h</b>, 1.15 g, 0.058 mol), Proton sponge (1.5 g, 0.070 mol), triflic anhydride (1.1 mL, 64 mmol), and 2-amino-2-methyl-1-propanol (1.1 g, 0.012 mol) in CH<sub>3</sub>CN (45 mL). After purification, 1.35 g (86%) of the free base <b>4q</b> was isolated and converted to the <span class="smallcaps smallerCapital">d</span>-tartrate salt, which was recrystallized from H<sub>2</sub>O−MeOH−Et<sub>2</sub>O solvent system: mp 115−116 °C; [α]<sup>20</sup><sub>D</sub> −9.5° (c 0.74, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.89 (d, 1H, <i>J</i> = 8.4 Hz), 7.97−7.89 (m, 3H), 7.54−7.50 (m, 3H), 4.33 (s, 1H), 3.70 (d, 1H, <i>J</i> = 12.2 Hz), 3.48 (q, 1H, <i>J</i> = 7.0 Hz), 1.77 (s, 3H), 1.41 (s, 3H), 0.96 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 136.5, 132.3, 131.9, 130.5, 130.2, 128.1, 127.4, 127.0, 126.1, 99.0, 75.1, 68.1, 67.3, 53.9, 24.8, 22.9, 15.8, 15.2. LCMS (ESI) <i>m</i>/<i>z</i> 272.3 [(M − tartrate)<sup>+</sup>, M = C<sub>19</sub>H<sub>24</sub>NO<sub>5</sub>]. Anal. (C<sub>19</sub>H<sub>24</sub>NO<sub>5</sub>·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (2<i>S</i>,3<i>S</i>)-2-(Naphthalen-2-yl)-3,5,5-trimethylmorpholin-2-ol (<b>4r</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4r</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> using (<i>R</i>)-2-hydroxy-1-(naphthalen-2-yl)propan-1-one (<b>10i</b>, 2.5 g, 0.013 mol), Proton sponge (3.24 g, 0.0151 mol), triflic anhydride (2.4 mL, 137 mmol), and 2-amino-2-methyl-1-propanol (2.4 g, 0.027 mol) in acetonitrile (40 mL). After purification, 2.2 g (65%) of the free base <b>4r</b> was isolated and converted to the hemi-<span class="smallcaps smallerCapital">d</span>-tartrate salt: mp 179−180 °C; [α]<sup>20</sup><sub>D</sub> −1.5° (c 0.55, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.13−8.12 (m, 1H), 7.95−7.88 (m, 3H), 7.75−7.71 (m, 1H), 7.57−7.50 (m, 2H), 4.33 (s, 1H), 4.25 (d, 1H, <i>J</i> = 11.9 Hz), 3.66−3.57 (m, 2H), 1.65 (s, 3H), 1.37 (s, 3H), 1.09 (d, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 178.7, 139.9, 135.3, 134.6, 129.8, 129.33, 129.00, 128.0, 127.8, 127.4, 125.4, 97.4, 75.2, 67.7, 55.1, 24.5, 21.6, 14.6. LCMS (ESI) <i>m</i>/<i>z</i> 272.5 [(M − tartrate)<sup>+</sup>, M = C<sub>19</sub>H<sub>24</sub>NO<sub>5</sub>]. Anal. (C<sub>19</sub>H<sub>24</sub>NO<sub>5</sub>) C, H, N.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (2<i>S</i>,3<i>S</i>)-2-(3-Chlorophenyl)-3-ethyl-5,5-dimethylmorpholin-2-ol (<b>4s</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4s</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> using (<i>R</i>)-1-(3-chlorophenyl)-2-hydroxybutan-1-one (<b>10j</b>, 1.13 g, 0.0568 mol), Proton sponge (1.43 g, 0.0667 mol), triflic anhydride (1.0 g, 0.063 mol), and 2-amino-2-methyl-1-propanol (1.09 g, 0.0122 mol) in CH<sub>2</sub>Cl<sub>2</sub> (13 mL). After purification, the free base <b>4r</b> was converted to 0.230 g of its <span class="smallcaps smallerCapital">d</span>-tartrate salt: mp 160−161 °C; [α]<sup>20</sup><sub>D</sub> +5.6° (c 0.8, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.49−7.46 (m, 1H), 7.41−7.35 (m, 3H), 4.37−4.34 (m, 1H), 4.30−4.24 (m, 1H), 3.81−3.62 (m, 2H), 1.57 (s, 3H), 1.47−1.36 (m, 2H), 1.33 (s, 3H), 0.81−0.71 (m, 3H). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 178.5, 145.2, 135.6, 131.2, 130.3, 128.2, 126.5, 97.1, 75.0, 67.8, 61.1, 55.0, 24.3, 23.1, 21.6, 11.2. LCMS (ESI) <i>m</i>/<i>z</i> 270.4 [(M − tartrate)<sup>+</sup>, M = C<sub>16</sub>H<sub>23</sub>ClNO<sub>5</sub>). Anal. (C<sub>16</sub>H<sub>23</sub>ClNO<sub>5</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (2<i>S</i>,3<i>S</i>)-2-(3-Chlorophenyl)-5,5-dimethyl-3-propyl-morpholin-2-ol (<b>4t</b>) Hemi-<span class="smallcaps smallerCapital">d</span>-tartrate</h3><div class="NLM_p last">Compound <b>4t</b> was synthesized by a procedure similar to that described for (2<i>S</i>,3<i>S</i>)-<b>4a</b> using (<i>R</i>)-1-(3-chlorophenyl)-2-hydroxypent-1-one (<b>10k</b>, 1.5 g, 0.0704 mol), Proton sponge (1.8 g, 0.0840 mol), triflic anhydride (1.29 g, 0.081 mol), and 2-amino-2-methyl-1-propanol (1.42 g, 0.0159 mol) in CH<sub>2</sub>Cl<sub>2</sub> (7 mL). After purification, 790 mg (40%) of the free base <b>4t</b> was isolated and converted to the hemi-<span class="smallcaps smallerCapital">d</span>-tartrate salt, which had 99%ee: mp 151−152 °C, [α]<sup>20</sup><sub>D</sub> −10.1° (c 0.77, CH<sub>3</sub>OH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.50−7.47 (m, 1H), 7.43−7.36 (m, 3H), 4.38 (s, 1H), 4.32 (d, 1H, <i>J</i> = 10.0 Hz), 3.81−3.66 (m, 1H), 1.58 (s, 3H), 1.49−1.38 (m, 2H), 1.35 (s, 3H), 1.34−1.27 (m, 1H), 1.02−0.92 (m, 1H), 0.77 (t, 3H, <i>J</i> = 7.0 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 176.1, 142.9, 133.3, 128.9, 128.0, 125.9, 124.2, 94.8, 72.7, 65.4, 57.0, 52.7, 29.9, 22.0, 19.3, 18.2, 12.1. Anal. (C<sub>17</sub>H<sub>25</sub>ClNO<sub>5</sub>) C, H, N.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2<i>S</i>,3<i>S</i>)-2-(3-Chlorophenyl)-3,4,5,5-tetramethylmorpholin-2-ol (<b>4u</b>) Di-<i>p</i>-tolyl-<span class="smallcaps smallerCapital">l</span>-tartrate</h3><div class="NLM_p last">A sample of (2<i>S</i>,3<i>S</i>)-2-(3-Chlorophenyl)-3,5,5-trimethylmorpholin-2-ol (<b>4i</b>, 107 mg, 0.42 mmol) in DMF (2.0 mL) was treated with K<sub>2</sub>CO<sub>3</sub> (174 mg, 1.26 mmol). After stirring the reaction mixture at room temperature under an inert atmosphere for 1.5 h, CH<sub>3</sub>I (19 μL, 0.30 mmol) was added to the reaction flask and the reaction mixture was stirred at 70 °C for 24 h. The reaction mixture was cooled to 0 °C water added, followed by extraction with ether (thee times). The combined organic extracts were washed (water, brine), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to a pale-yellow oil. Purification of the residue by column chromatography gave a 72 mg (63%) of <b>4u</b> as a white solid. The compound <b>4u</b> was converted to the corresponding di-<i>p</i>-tolyl-<span class="smallcaps smallerCapital">l</span>-tartrate salt: mp 128−129 °C; [α]<sup>20</sup><sub>D</sub> −50.0° (c 0.83, CH<sub>3</sub>OH). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.85 (d, 4H, <i>J</i> = 7.8 Hz), 7.50−7.40 (m, 4H), 7.32 (d, 4H, <i>J</i> = 7.8 Hz), 5.6 (s, 2H), 4.07 (d, 1H, <i>J</i> = 12.4 Hz), 3.50−3.40 (m, 1H), 2.56 (s, 3H), 2.36 (s, 6H), 1.40 (s, 3H), 1.21 (s, 3H), 0.90 (d, 3H, <i>J</i> = 6.2 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 168.2, 164.9, 143.9, 132.7, 129.9, 129.3 (d), 128.6, 126.67, 126.31, 125.3, 96.4, 72.2, 66.2, 60.4, 59.2, 33.3, 21.1, 15.9, 11.5. Anal. (C<sub>34</sub>H<sub>38</sub>ClNO<sub>10</sub>·2H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (2<i>S</i>,3<i>S</i>)-2-(4-Chlorophenyl)-3,4,5,5-tetramethylmorpholin-2-ol (<b>4v</b>) Fumarate</h3><div class="NLM_p">A sample of (<b>4i</b>) (144 mg, 0.563 mmol) in anhydrous THF (1.9 mL) was treated with K<sub>2</sub>CO<sub>3</sub> (4 folds, 311 mg, 2.25 mmol). After stirring the reaction mixture at room temperature under inert atmosphere for 1 h, CH<sub>3</sub>I (1.3 equiv, 46.0 μL, 0.731 mmol) was added to the reaction flask. The reaction mixture was stirred at room temperature for 24 h, cooled to 0 °C, and water added, followed by extraction with ether (thee times). The combined organic extracts were washed (water, brine), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to a pale-yellow oil. Purification of the residue by column chromatography on silica gel and CH<sub>2</sub>Cl<sub>2</sub>−MeOH−NH<sub>4</sub>OH (90:9:1) as the eluent gave 93.0 mg (61%) of a white solid: mp = 75−78 °C; [α]<sup>22</sup><sub>D</sub> +28.0° (c 1.0, CHCl<sub>3</sub>). <sup>1</sup>H NMR δ 7.58−7.53 (m, 2H), 7.34−7.31 (m, 2H), 4.52−4.49 (br, 1H), 3.90 (d, 1H, <i>J</i> = 11.6 Hz), 3.32 (d, 1H, <i>J</i> = 11.6 Hz), 2.85 (q, 1H, <i>J</i> = 6.5 Hz), 2.20 (s, 3H), 1.19 (s, 3H), 1.07 (s, 3H), 0.76 (d, 3H, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR δ 133.9, 128.59, 128.36, 128.05, 127.7, 97.5, 70.4, 59.3, 53.8, 32.3, 25.5, 14.4, 13.1. MS (ESI) <i>m</i>/<i>z</i> 270.4 [(M + H)<sup>+</sup> M = C<sub>14</sub>H<sub>20</sub>ClNO<sub>2</sub>].</div><div class="NLM_p last">A sample of <b>4v</b> (90 mg, 0.33 mmol) in ether (1.5 mL) was treated with a solution of fumaric acid (38 mg, 0.33 mmol) in MeOH (1 mL). The mixture was stirred at room temperature overnight. Ether was added to the reaction mixture. The suspension was sonicated, centrifuged, and decanted to afford a solid pellet; this procedure was repeated three times. Recrystallization from MeOH−ether afforded the title product as white solid 101 mg (77%): mp =167−169 °C; [α]<sup>22</sup><sub>D</sub> +44.3° (c 1.0, MeOH). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.60 (d, 2H, <i>J</i> = 8.6 Hz), 7.43 (d, 2H, <i>J</i> = 8.6 Hz), 6.68 (s, 2H), 4.35 (d, 1H, <i>J</i> = 12.8 Hz), 3.64−3.54 (m, 2H), 2.79 (s, 3H), 1.60 (s, 3H), 1.41 (s, 3H), 1.14 (d, 3H, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>) δ 171.4, 140.9, 136.3, 129.4, 98.1, 67.6, 63.4, 62.5, 34.3, 21.8, 20.8, 16.9, 12.3. MS (ESI) <i>m</i>/<i>z</i> 270.4 [(M − fumaric)<sup>+</sup>, M = C<sub>14</sub>H<sub>20</sub>ClNO<sub>2</sub>·C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>]. Anal. (C<sub>18</sub>H<sub>24</sub>ClNO<sub>6</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3,5,5-Trimethyl-2-(pyridin-3-yl)morpholin-2-ol (<b>5</b>) <span class="smallcaps smallerCapital">d</span>-Tartrate</h3><div class="NLM_p last">A sample of 1-(pyridin-3-yl)propan-1-one (<b>8o</b>, 685 mg, 5.00 mmol) was dissolved in CCl<sub>4</sub> (20 mL). Bromine (0.26 mL, 5 mmol) was added to the reaction flask, and the reaction mixture was gently refluxed for 1 h. The solvent was decanted. The deep-red solid at the bottom of flask was washed with ether, dried, suspended in CH<sub>3</sub>CN (40 mL), and treated with 2-amino-2-methyl-1-propanol (0.89 g, 0.01 mol). The reaction mixture was stirred for 8 h. The precipitate was removed by filtration, and the filtrate was extracted with EtOAc. The organic layer was washed with aqueous NaHCO<sub>3</sub>, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to a deep-red oil residue. The oily residue was purified by column chromatography on silica gel and CH<sub>2</sub>Cl<sub>2</sub>−MeOH (20:1 to 5:1) with 1% NH<sub>4</sub>OH) to give 56 mg free base that was converted to <b>5</b>·tartrate as a yellow solid: mp 115−116 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.85−8.83 (m, 1H), 8.54 (dd, 1H, <i>J</i> = 4.7, 1.7 Hz), 7.91 (tt, 1H, <i>J</i> = 8.0, 2.0 Hz), 7.31−7.25 (m, 1H), 3.85−3.82 (m, 1H), 3.42 (d, 1H, <i>J</i> = 11.2 Hz), 3.21 (q, 1H, <i>J</i> = 6.5 Hz), 1.40 (s, 3H), 1.10 (s, 3H), 0.81 (d, 3H, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 149.4, 148.1, 137.2, 134.1, 122.8, 95.4, 69.4, 53.55, 49.8, 27.4, 22.8, 16.4. LCMS (ESI) <i>m</i>/<i>z</i> 223.3 [(M − tartrate)<sup>+</sup>, M = C<sub>16</sub>H<sub>24</sub>N<sub>2</sub>O<sub>8</sub>]. Anal. (C<sub>16</sub>H<sub>24</sub>N<sub>2</sub>O<sub>8</sub>·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3,5,5-Trimethyl-2-(pyridin-2-yl)morpholin-2-ol (<b>6</b>) <span class="smallcaps smallerCapital">d</span>-Tartrate</h3><div class="NLM_p last">1-(Pyridin-2-yl)propan-1-one (<b>8n</b>, 1.71 g, 0.013 mol) was dissolved in CCl<sub>4</sub> (50 mL). Bromine (0.66 mL, 12.7 mmol) was added and gently refluxed for 1 h. The solvent was decanted. The orange solid at the bottom of flask was washed with ether, vacuum-dried, and then suspend in CH<sub>3</sub>CN (40 mL), followed by the addition of 2-amino-2-methyl-1-propanol (2.30 g, 0.0254 mol). The reaction mixture was stirred for 24 h. The precipitate was separated by filtration and was extracted with EtOAc. The organic layer was washed with aqueous NaHCO<sub>3</sub> and dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to give a orange oil. The residue was purified by column chromatography on silica gel using, CH<sub>2</sub>Cl<sub>2</sub>−MeOH (50:1 to 20:1) with 1% NH<sub>4</sub>OH) to give 0.94 g (33%) of free base that was converted to the corresponding tartrate salt. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.55−8.51 (m, 1H), 7.84−7.59 (m, 1H), 7.63−7.57 (m, 1H), 7.34−7.26 (m, 1H), 6.00 (s, 1H), 3.97−3.91 (m, 1H), 3.47−3.37 (m, 2H), 1.42 (s, 3H), 1.10 (s, 3H), 0.74 (d, 3H, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 158.6, 147.2, 137.5, 123.6, 120.5, 94.2, 70.0, 52.1, 48.9, 27.1, 22.9, 16.2. LCMS (ESI) <i>m</i>/<i>z</i> 223.4 [(M − tartrate)<sup>+</sup>, M = C<sub>16</sub>H<sub>24</sub>N<sub>2</sub>O<sub>8</sub>]. Anal. (C<sub>16</sub>H<sub>24</sub>N<sub>2</sub>O<sub>8</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-Naphthalen-1-ylpropan-1-one (<b>8q</b>)</h3><div class="NLM_p last">A sample of 1-cyanonaphthylene (<b>7a</b>, 5.0 g, 0.0327 mol) in dry diethyl ether (200 mL) was treated with ethyl magnesium bromide (49.2 mol, 16.4 mL 3 M solution in ether) under nitrogen atmosphere at room temperature. The solution was stirred overnight at 25 °C and then cooled to 0 °C. The reaction was quenched slowly with 1 N aqueous HCl and allowed to warm to room temperature over 1 h with stirring. The aqueous layer was extracted with ether. The combined organic layers were washed with aqueous NaHCO<sub>3</sub>, water, and brine, and dried (Na<sub>2</sub>SO<sub>4</sub>). The organic layers were concentrated, and the resulting yellow oil was purified by column chromatography on silica gel using hexane−EtOAc (20:1) to (10:1) as the eluent afforded 3.55 g (60%) of the title product. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.59−8.52 (m, 1H), 8.00−7.94 (m, 1H), 7.90−7.81 (m, 2H), 7.62−7.45 (m, 3H), 3.08 (q, 2H, <i>J</i> = 7.3 Hz), 1.29 (t, 3H, <i>J</i> = 7.3 Hz). C<sub>13</sub>H<sub>12</sub>O.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-Naphthalen-2-ylpropan-1-one (<b>8r</b>)</h3><div class="NLM_p last">Compound <b>8r</b> was synthesized by a procedure similar to that described for a procedure similar to <b>8q</b> using identical amounts, except commercially available 2-cyanonaphthylene (<b>7b</b>) was used in place of 1-cyanonaphthylene. Purification by column chromatography on silica gel using hexane−EtOAc (20:1) to (10:1) afforded 4 g (66%) of the title product as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.48 (s, 1H), 8.05 (d, 1H, <i>J</i> = 7.5 Hz), 8.00−7.94 (m, 1H), 7.93−7.85 (m, 2H), 7.64−7.51 (m, 2H). 3.15 (q, 2H, <i>J</i> = 7.2 Hz), 1.29 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 129.9, 128.8 (d), 128.2, 127.1, 124.3, 32.3, 8.8. C<sub>13</sub>H<sub>12</sub>O.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>Z</i>)-<i>tert</i>-Butyl(1-phenylprop-1-enyloxy)dimethylsilane (<b>9b</b>)</h3><div class="NLM_p last">Compound <b>9b</b> was synthesized by a procedure similar to <b>9a</b> using commercially available propiophenone (<b>8b</b>, 5.0 g, 0.037 mol), TBDMSOTf (9.4 mL, 41.0 mmol), and of Et<sub>3</sub>N (8.3 mL) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL). After purification, 7.32 g (79%) of <b>9b</b> was isolated as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.50−7.40 (m, 2H), 7.35−7.22 (m, 3H), 5.23 (q, 1H, <i>J</i> = 6.9 Hz), 1.77 (d, 3H, <i>J</i> = 6.9 Hz), 1.03 (s, 9H), −0.04 (s, 6H). <sup>13</sup>C NMR (CDCI<sub>3</sub>) δ 150.4, 140.0, 128.0, 127.4, 125.9, 105.9, 25.9, 18.5, 11.9, −3.9. C<sub>15</sub>H<sub>24</sub>OSi.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>Z</i>)-<i>tert</i>-Butyl(1-(3-fluorophenyl)prop-1-enyloxy)dimethylsilane (<b>9c</b>)</h3><div class="NLM_p last">Compound <b>9c</b> was synthesized by a procedure similar to that described for <b>9a</b> using commercially available 3-fluoropropiophenone (<b>8c</b>, 5.0 g, 0.033 mol), TBDMSOTf (8.3 mL, 36.1 mmol), and Et<sub>3</sub>N (7.3 mL) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL). After purification, 8.1 g (93%) of <b>9c</b> was isolated as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.38−7.10 (m, 2H), 7.00−6.87 (m, 1H), 5.26 (q, 1H, <i>J</i> = 6.9 Hz), 1.75 (d, 3H, <i>J</i> = 6.9 Hz), 1.00 (s, 9H), −0.02 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 164.5, 161.2, 149.2, 142.4, 129.4, 121.4, 114.3, 114.0, 112.8, 112.5, 107.1, 105.9, 26.0, 18.5, 11.9, −3.9. C<sub>15</sub>H<sub>23</sub>FOSi.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>Z</i>)-<i>tert</i>-Butyl(1-(3-bromophenyl)prop-1-enyloxy)dimethylsilane (<b>9d</b>)</h3><div class="NLM_p last">Compound <b>9d</b> was synthesized by a procedure similar to that described for <b>9a</b> using commercially available 3-bromopropiophenone (<b>8d</b>, 1.0 g, 0.0047 mol), TBDMSOTf (1.4 mL, 5.1 mmol), and Et<sub>3</sub>N (1.1 mL) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL). After workup, 1.15 g (75%) of crude <b>9d</b> was isolated as colorless oil with a <i>Z</i>−<i>E</i> ratio of 94:6. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.64−7.58 (m, 1H), 7.41−7.34 (m, 2H), 7.17 (t, 1H, <i>J</i> = 8.04 Hz), 5.25 (q, 1H, <i>J</i> = 6.9 Hz), 1.75 (d, 3H, <i>J</i> = 6.9 Hz), 1.02 (s, 9H), −0.03 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.8, 141.9, 130.2, 129.5, 128.7, 124.1, 122.1, 25.8, 18.3, 11.8, −4.0. C<sub>15</sub>H<sub>23</sub>BrOSi.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>Z</i>)-<i>tert</i>-Butyl(1-(<i>m</i>-tolyl)prop-1-enyloxy)dimethylsilane (<b>9e</b>)</h3><div class="NLM_p last">Compound <b>9e</b> was synthesized by a procedure similar to that described for <b>9a</b> using commercially available 3-methylpropiophenone (<b>8e</b>, 5.0 g, 0.033 mol), TBDMSOTf (8.5 mL, 36.1 mmol), and Et<sub>3</sub>N (7.5 mL) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL). After purification by column chromatography on silica gel, 7.45 g (84%) of <b>9e</b> was isolated as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.31−7.24 (m, 2H), 7.23−7.17 (m, 1H), 7.10−7.05 (m, 1H), 5.22 (q, 1H, <i>J</i> = 6.9 Hz), 2.37 (s, 3H), 1.76 (d, 3H, <i>J</i> = 6.9 Hz), 1.03 (s, 9H), −0.03 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 150.7, 140.1, 137.7, 128.4, 127.9, 126.8, 123.2, 105.9, 26.3, 21.8, 18.7, 12.1, −3.6. C<sub>16</sub>H<sub>26</sub>OSi.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>Z</i>)-<i>tert</i>-Butyl-(1-(3-methoxyphenyl)prop-1-enyloxy)dimethylsilane (<b>9f</b>)</h3><div class="NLM_p last">Compound <b>9f</b> was synthesized by a procedure similar to that described for <b>9a</b> using 3-methoxypropiophenone (<b>8f</b>, 6.00 g, 0.0366 mol), TBDMSOTf (9.2 mL, 40.2 mmol), and Et<sub>3</sub>N (8.1 mL) in CH<sub>2</sub>Cl<sub>2</sub> (60 mL). After purification on alumina, 8.14 g (80%) of <b>9f</b> was isolated as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.24−7.16 (m, 1H), 7.07−6.98 (m, 2H), 6.84−6.76 (m, 1H), 5.23 (q, 1H, <i>J</i> = 6.9 Hz), 3.81 (s, 3H), 1.75 (d, 3H, <i>J</i> = 6.9 Hz), 1.01 (s, 9H), −0.01 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 159.4, 150.1, 141.5, 129.0, 118.4, 113.3, 111.2, 106.1, 55.3, 26.0, 18.5, 11.9, −3.9. C<sub>16</sub>H<sub>26</sub>O<sub>2</sub>Si.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>Z</i>)-<i>tert</i>-Butyl-(1-(3-nitrophenyl)prop-1-enyloxy)dimethylsilane (<b>9g</b>)</h3><div class="NLM_p last">Compound <b>9g</b> was synthesized by a procedure similar to that described for <b>9a</b> using commercially available 3-nitropropiophenone (<b>8g</b>, 5.0 g, 0.028 mol), TBDMSOTf (7.1 mL, 30.7 mmol), and Et<sub>3</sub>N (6.2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL). After purification on alumina, 8.0 g (98%) of <b>9g</b> was isolated as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.34−8.30 (m, 1H), 8.12−8.06 (m, 1H), 7.80−7.75 (m, 1H), 7.52−7.42 (m, 1H), 5.40 (q, 1H, <i>J</i> = 6.9 Hz), 1.78 (d, 3H, <i>J</i> = 6.9 Hz), 1.02 (s, 9H), −0.02 (s, 6H). <sup>13</sup>C NMR (CDCI<sub>3</sub>) δ 148.8, 141.6, 131.3, 129.0, 122.1, 120.5, 108.6, 106.8, 25.9, 18.4, 12.0, −3.8. C<sub>15</sub>H<sub>23</sub>NO<sub>3</sub>Si.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>Z</i>)-<i>tert</i>-Butyldimethyl-(1-(naphthalen-1-yl)prop-1-enyloxy)silane (<b>9q</b>)</h3><div class="NLM_p last">Compound <b>9q</b> was synthesized by a procedure similar to that described for <b>9a</b> using 1-naphthalen-1-yl-propan-1-one (<b>8h</b>, 3.5 g, 0.019 mol), TBDMSOTf (4.8 mL, 0.021 mol), and Et<sub>3</sub>N (4.3 mL) in CH<sub>2</sub>Cl<sub>2</sub> (26 mL). After purification, 4.58 g (81%) of title product was isolated as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.27−8.24 (m, 1H), 7.83−7.75 (m, 2H), 7.48−7.38 (m, 4H), 5.04 (q, 1H, <i>J</i> = 6.0 Hz), 1.83 (d, 3H, <i>J</i> = 6.0 Hz), 0.87 (s, 9H), −0.29 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 150.0, 138.3, 133.6, 131.6, 128.1, 128.0, 126.8, 126.2, 125.7, 125.1, 108.4, 26.3, 25.7, 18.2, −4.6. C<sub>19</sub>H<sub>26</sub>OSi.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>Z</i>)-<i>tert</i>-Butyldimethyl-(1-(naphthalen-2-yl)prop-1-enyloxy)silane (<b>9r</b>)</h3><div class="NLM_p last">Compound <b>9r</b> was synthesized by a procedure similar to that described for <b>9a</b> using 1-naphthalen-2-ylpropan-1-one (<b>8i</b>, 4.0 g, 0.0217 mol, TBDMSOTf (5.5 mL, 23.9 mmol), and Et<sub>3</sub>N (4.9 mL) in CH<sub>2</sub>Cl<sub>2</sub> (26 mL). After purification, 4.7 g (73%) of the title product was isolated as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.86−7.74 (m, 1H), 7.86−7.74 (m, 3H), 7.59 (dd, 1H, <i>J</i> = 8.6, 1.7 Hz), 7.51−7.41 (m, 2H), 5.38 (q, 1H, <i>J</i> = 6.9 Hz), 1.81 (d, 3H, <i>J</i> = 6.9 Hz), 1.04 (s, 9H), 0.02 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 150.5, 137.5, 133.5, 133.2, 128.5, 127.9, 127.8, 126.4, 126.0, 107.0, 105.9, 26.3, 26.1, 18.8, −3.6. C<sub>19</sub>H<sub>26</sub>OSi.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>Z</i>)-<i>tert</i>-Butyl(1-(3-chlorophenyl)but-1-enyloxy)dimethylsilane (<b>9s</b>)</h3><div class="NLM_p last">Compound <b>9s</b> was synthesized by a procedure similar to that described for <b>9a</b> using 3-chlorobutyrophenone (<b>8j</b>, 3.10 g, 0.0169 mol), TBDMSOTf (4.3 mL, 18.6 mmol), and Et<sub>3</sub>N (3.8 mL) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL). After purification, 3.7 g (74%) of the title product was isolated as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.48−7.44 (m, 1H), 7.38−7.32 (m, 1H), 7.31−7.29 (m, 2H), 5.16 (t, 1H, <i>J</i> = 7.1 Hz), 2.30−2.19 (m, 2H), 1.09− 1.03 (m, 3H), 1.01 (s, 9H), −0.04 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 147.5, 141.7, 133.9, 129.2, 127.3, 125.9, 123.8, 114.9, 25.8, 19.5, 14.1, 0.0, −4.1. C<sub>16</sub>H<sub>25</sub>ClOSi.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>Z</i>)-<i>tert</i>-Butyl(1-(3-chlorophenyl)pent-1-enyloxy)dimethylsilane (<b>9t</b>)</h3><div class="NLM_p last">Compound <b>9t</b> was synthesized by a procedure similar to that described for <b>9a</b> using 3-chloropentaphenone (<b>8k</b>, 2.7 g, 0.014 mol), TBDMSOTf (3.5 mL, 15 mmol), and Et<sub>3</sub>N (3.1 mL) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL). After purification, 4.18 g (96%) of the title product was isolated as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.47−7.44 (m, 1H), 7.38−7.32 (m, 1H), 7.30−7.28 (m, 1H), 7.25−7.22 (m, 1H), 5.18 (t, 1H, <i>J</i> = 7.2 Hz), 2.20 (q, 2H, <i>J</i> = 7.5 Hz), 1.54−1.38 (m, 2H), 1.02 (s, 9H), 1.00−0.90 (m, 3H), −0.05 (s, 6H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 148.0, 141.8, 133.9, 129.2, 127.6, 125.9, 123.9, 113.0, 28.3, 25.8, 22.8, 14.0, 0.0, −4.01. C<sub>17</sub>H<sub>27</sub>ClOSi.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>S</i>)-1-(3-Chlorophenyl)-2-hydroxypropan-1-one [(<i>S</i>)-<b>10a</b>]</h3><div class="NLM_p last">Compound (<i>S</i>)-<b>10a</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-(3-chlorophenyl)prop-1-enyloxy)dimethylsilane (<b>9a</b>, 8.8 g, 0.031 mol), AD-mix-α (43.5 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (<b>3a</b>, 3.0 g, 0.032 mol) in <i>tert</i>-butyl alcohol−water (120 mL:120 mL). The reaction mixture was quenched with sodium sulfite (31.1 g). After purification, 4.51 g (78%) of the (<i>S</i>)-<b>10a</b> was isolated. Characterization data is similar with data reported in the literature.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>R</i>)-1-Phenyl-2-hydroxypropan-1-one (<b>10b</b>)</h3><div class="NLM_p last">Compound <b>10b</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-phenylprop-1-enyloxy)dimethylsilane (<b>9b</b>, 7.2 g, 0.029 mol), AD-mix-β (40.7 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (2.8 g, 0.0294 mol) in <i>tert</i>-butyl alcohol−water (110 mL:110 mL). The reaction was quenched with sodium sulfite (29.1 g). After purification, 2.49 g (80%) of the title product was isolated: [α]<sup>20</sup><sub>D</sub> +84.9° (c 1.6, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCI<sub>3</sub>) δ 7.96−7.90 (m, 2H), 7.66−7.58 (m, 1H), 7.54−7.47 (m, 2H), 5.23−5.12 (m, 1H), 3.84 (d, 1H, <i>J</i> = 6.3 Hz), 1.45 (d, 3H, <i>J</i> = 7.05 Hz). <sup>13</sup>C NMR (CDCI<sub>3</sub>) δ 202.4, 134.0, 133.4, 128.9, 128.7, 69.3, 22.3. C<sub>9</sub>H<sub>10</sub>O<sub>2</sub>.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>R</i>)-1-(3-Fluorophenyl)-2-hydroxypropan-1-one (<b>10c</b>)</h3><div class="NLM_p last">Compound <b>10c</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-(3-fluorophenyl)prop-1-enyloxy)dimethylsilane, (<b>9c</b>, 8.0 g, 0.030 mol), AD-mix-β (42.1 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (2.90 g, 0.0301 mol) in <i>tert</i>-butyl alcohol−water (120 mL:120 mL). The reaction was quenched with sodium sulfite (30.1 g). After purification, 4.4 g (87%) of the desired product <b>10c</b> was isolated: [α]<sup>20</sup><sub>D</sub> +58.1° (c 3.2, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.74−7.59 (m, 2H), 7.54−7.45 (m, 1H), 7.37−7.28 (m, 1H), 5.19− 5.07 (m, 1H), 1.76 (d, 1H, <i>J</i> = 6.3 Hz), 1.46 (d, 3H, <i>J</i> = 6.9 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 201.6, 164.9, 131.0, (d), 124.7, 121.3 (d), 115.8 (d), 69.9, 22.4. C<sub>9</sub>H<sub>9</sub>FO<sub>2</sub>.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>R</i>)-1-(3-Bromophenyl)-2-hydroxypropan-1-one (<b>10d</b>)</h3><div class="NLM_p last">Compound <b>10d</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-(3-bromophenyl)prop-1-enyloxy)dimethylsilane, (<b>9d</b>, 1.15 g, 0.0035 mol), AD-mix-β (4.9 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (334 mg, 3.5 mmol) in <i>tert</i>-butyl alcohol−water (17.5 mL:17.5 mL). The reaction was quenched with sodium sulfite (3.5 g). After purification by column chromatography on silica gel, 0.700 g (88%) of the desired product was isolated: [α]<sup>20</sup><sub>D</sub> +61.1° (c 1.3, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.09−8.04 (m, 1H), 7.87−7.81 (m, 1H), 7.78−7.72 (m, 1H), 7.39 (t, 1H, <i>J</i> = 8.0 Hz), 5.18−5.05 (m, 1H), 3.66 (d, 1H, <i>J</i> = 6.4 Hz), 1.45 (d, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 201.2, 136.8, 135.2, 131.6, 130.4, 127.1, 123.3, 69.5, 22.1. C<sub>9</sub>H<sub>9</sub>BrO<sub>2</sub>.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>R</i>)-1-(<i>m</i>-Tolyl)-2-hydroxypropan-1-one (<b>10e</b>)</h3><div class="NLM_p last">Compound <b>10e</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-(3-methylphenyl)prop-1-enyloxy)dimethylsilane, (<b>9e</b>, 7.4 g, 0.028 mol), AD-mix-β (39.5 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (2.73 g, 0.029 mol) in <i>tert</i>-butyl alcohol−water (110 mL:110 mL). The reaction was quenched with sodium sulfite (28.3 g). After purification, 4.2 g (85%) of the desired <b>10e</b> was isolated: [α]<sup>20</sup><sub>D</sub> +83.9° (c 2.0, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.78−7.67 (m, 2H), 7.46−7.33 (m, 2H), 5.20−5.09 (m, 1H), 3.86 (d, 1H, <i>J</i> = 6.3 Hz), 2.42 (s, 3H), 1.44 (d, 3H, <i>J</i> = 7.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 202.6, 138.8, 134.8, 133.5, 129.1, 128.7, 125.9, 69.4, 22.3, 21.4. C<sub>10</sub>H<sub>12</sub>O<sub>2</sub>.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>R</i>)-1-(3-Methoxyphenyl)-2-hydroxypropan-1-one (<b>10f</b>)</h3><div class="NLM_p last">Compound <b>10f</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-(3-methoxyphenyl)prop-1-enyloxy)dimethylsilane, (<b>9f</b>, 8.1 g, 0.029 mol), AD-mix-β (40.7 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (2.8 g, 0.0294 mol) in <i>tert</i>-butyl alcohol−water (110 mL:110 mL). The reaction was quenched with sodium sulfite (29.1 g). After purification, 4.2 g (80%) of the desired <b>10f</b> was isolated: [α]<sup>20</sup><sub>D</sub> +71.1° (c 1.1, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.51−7.45 (m, 2H), 7.44−7.37 (m, 1H), 7.19−7.13 (m, 1H), 5.19−5.09 (m, 1H), 3.87 (s, 3H), 3.76 (d, 1H, <i>J</i> = 6.5 Hz), 1.45 (d, 3H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 202.3, 160.0, 134.7, 129.9, 121.1, 120.3, 113.1, 69.4, 55.5, 22.4. C<sub>10</sub>H<sub>12</sub>O<sub>3</sub>.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>R</i>)-1-(3-Nitrophenyl)-2-hydroxypropan-1-one (<b>10g</b>)</h3><div class="NLM_p last">Compound <b>10g</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-(3-nitrophenyl)prop-1-enyloxy)dimethylsilane, (<b>9g</b>, 8.0 g, 0.027 mol), of AD-mix-β (38 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (2.64 g, 0.0277 mol) in <i>tert</i>-butyl alcohol−water (110 mL:110 mL). The reaction was quenched with sodium sulfite (27.4 g). After purification by column chromatography on silica gel, 4.0 g (75%) of the desired product was isolated: [α]<sup>20</sup><sub>D</sub> +63.8° (c 1.3, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCI<sub>3</sub>) δ 8.80−8.74 (m, 1H), 8.52−8.44 (m, 1H), 8.31−8.24 (m, 1H), 7.83−7.68 (m, 1H), 5.27−5.13 (m, 1H), 3.59 (d, 1H, <i>J</i> = 6.5 Hz), 1.49 (d, 3H, <i>J</i> = 7.08 Hz). <sup>13</sup>C NMR (CDCI<sub>3</sub>) δ 200.4, 148.6, 134.9, 134.1, 130.2, 128.1, 121.6, 69.8, 21.9. C<sub>9</sub>H<sub>9</sub>NO<sub>4</sub>.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>R</i>)-2-Hydroxy-1-(naphthalen-1-yl)propan-1-one (<b>10h</b>)</h3><div class="NLM_p last">Compound <b>10h</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl-(1-(naphthalen-1-yl)prop-1-enyloxy)dimethylsilane, (<b>9h</b>, 4.58 g, 0.015 mol), AD-mix-β (21.4 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (1.5 g, 0.0158 mol) in <i>tert</i>-butyl alcohol−water (60 mL:60 mL). The reaction was quenched with sodium sulfite (15.3 g). After purification by column chromatography on silica gel, 1.15 g (38%) of the title product was isolated plus 2.1 g of starting olefin was recovered, raising the effective yield to 70%: [α]<sup>20</sup><sub>D</sub> +140.2° (c 3.2, CHCl<sub>3</sub>), <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.51−8.46 (m, 1H), 8.04 (d, 1H, <i>J</i> = 8.3 Hz), 7.93−7.87 (m, 1H), 7.80−7.75 (m, 1H), 7.66−7.48 (m, 3H), 5.30−5.17 (m, 1H), 3.96 (d, 1H, <i>J</i> = 5.8 Hz), 1.36 (d, 3H, <i>J</i> = 7.1 Hz), <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 205.7, 134.1, 133.5, 132.5, 130.7, 128.7, 128.4, 127.7, 126.9, 125.5, 124.4, 71.2, 21.3. LCMS (ESI) <i>m</i>/<i>z</i> 201.2 [(M + H)<sup>+</sup>, M = C<sub>13</sub>H<sub>12</sub>O<sub>2</sub>].</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>R</i>)-2-Hydroxy-1-(naphthalen-2-yl)propan-1-one (<b>10i</b>)</h3><div class="NLM_p last">Compound <b>10i</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-(naphthalen-2-yl)prop-1-enyloxy)dimethylsilane, (<b>9i</b>, 4.7 g, 0.016 mol), AD-mix-β (22.0 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (1.55 g, 0.016 mol) in <i>tert</i>-butyl alcohol−water (60 mL:60 mL). The reaction was quenched with sodium sulfite (15.7 g). After purification by column chromatography on silica gel, 2.5 g (80%) of the desired product was isolated: [α]<sup>20</sup><sub>D</sub> +115° (c 0.7, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.44 (s, 1H), 8.01−7.86 (m, 4H), 7.69−7.54 (m, 2H), 5.37−5.27 (m, 1H), 3.86 (d, 1H, <i>J</i> = 6.5 Hz), 1.52 (d, 3H, <i>J</i> = 7.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 202.3, 136.0, 132.4, 130.7, 130.5, 129.7, 129.0, 128.8, 127.9, 127.1, 124.0, 69.4, 22.5. C<sub>13</sub>H<sub>12</sub>O<sub>2</sub>.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>R</i>)-1-(3-Chlorophenyl)-2-hydroxybutan-1-one (<b>10j</b>)</h3><div class="NLM_p last">Compound <b>10j</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-(3-chlorophenyl)but-1-enyloxy)dimethylsilane (<b>9j</b>, 3.7 g, 0.013 mol), AD-mix-β (17.5 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (1.2 g, 0.0126 mol) in <i>tert</i>-butyl alcohol−water (45 mL:45 mL). The reaction was quenched with sodium sulfite (12.5 g). After purification by column chromatography on silica gel, 2.2 g (79%) of the title product was isolated: [α]<sup>20</sup><sub>D</sub> +31.4° (c 1.0, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.91−7.88 (m, 1H), 7.81−7.75 (m, 1H), 7.62−7.56 (m, 1H), 7.45 (t, 1H, <i>J</i> = 7.8 Hz), 5.06−4.98 (m, 1H), 3.60 (d, 1H, <i>J</i> = 6.5 Hz), 2.04−1.87 (m, 1H), 1.70−1.51 (m, 1H), 0.94 (t, 3H, <i>J</i> = 7.4 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 201.4, 135.8, 135.7, 134.2, 130.6, 128.9, 126.9, 74.5, 29.1, 9.2. C<sub>10</sub>H<sub>11</sub>ClO<sub>2</sub>.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>R</i>)-1-(3-Chlorophenyl)-2-hydroxypentan-1-one (<b>10k</b>)</h3><div class="NLM_p last">Compound <b>10k</b> was synthesized by a procedure similar to that described for (<i>R</i>)-<b>10a</b> using (<i>Z</i>)-<i>tert</i>-butyl(1-(3-chlorophenyl)pent-1-enyloxy)dimethylsilane (<b>9k</b>, 4.1 g, 0.013 mol), AD-mix-β (18.5 g), and CH<sub>3</sub>SO<sub>2</sub>NH<sub>2</sub> (1.3 g, 0.014 mol) in <i>tert</i>-butyl alcohol−water (50 mL:50 mL). The reaction was quenched with sodium sulfite (13.2 g). After purification, 2.4 g (77%) of the desired product was isolated: [α]<sup>20</sup><sub>D</sub> +33.3° (c 1.1, CHCl<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.91−7.87 (m, 1H), 7.80−7.75 (m, 1H), 7.63−7.17 (m, 1H), 7.45 (t, 1H, <i>J</i> = 7.6 Hz), 5.08−5.00 (m, 1H), 3.58 (d, 1H, <i>J</i> = 6.5 Hz), 1.89−1.75 (m, 1H), 1.61−1.35 (m, 3H), 0.93 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 201.1, 135.4, 133.8, 130.2, 128.6, 126.5, 73.2, 37.8, 18.2, 13.8. C<sub>11</sub>H<sub>13</sub>ClO<sub>2</sub>.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Methyl (2<i>R</i>)-2-[(trifluoromethyl)sulfonyl]oxypropionate) (<b>14</b>)</h3><div class="NLM_p last">Following a reported procedure<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> with modification, a solution of methyl-(<i>R</i>)-(+)-lactate (<b>13</b>) (5.20 g, 0.05 mol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (200 mL, 0.25 M) was cooled to 0 °C and was treated with trifluoromethane sulfonic anhydride (8.8 mL, 52.5 mmol) and 2,6-lutidine (6.10 mL, 52.5 mmol) under an N<sub>2</sub> atmosphere. After stirring for 20 min at 0 °C, the reaction mixture was concentrated to a pink oil residue. Column chromatography on silica gel using CH<sub>2</sub>Cl<sub>2</sub> as the eluent afforded 9.15 g (77%) of <b>14</b> as a light-pink oil with characterization data as previously reported:<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> [α]<sup>25</sup><sub>D</sub> +40.5° (c 1.0, CHC1<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 5.27 (q, 1H, <i>J</i> = 6.9 Hz), 3.85 (s, 3H), 1.71 (d, 3H, <i>J</i> = 6.9 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 167.8, 79.9, 53.3, 18.0. LCMS (ESI) <i>m</i>/<i>z</i> 240.1 [(M + 4H)<sup>+</sup>, M = C<sub>5</sub>H<sub>7</sub>F<sub>3</sub>O<sub>5</sub>S].</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>3S</i>)-3,5,5-Trimethylmorpholin-2-one (<b>15</b>)</h3><div class="NLM_p">A solution of triflate <b>14</b> (5.00 g, 0.021 mol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (80 mL) under an N<sub>2</sub> atmosphere, was cooled to −40 °C and was treated with a solution of 2-amino-2-methyl-1-propanol (2.5 folds, 4.68 g, 0.0525 mol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL). After stirring for 2 h at −40 °C, the reaction mixture was warmed slowly to 0 °C then to room temperature and stirred overnight. The reaction mixture was treated with saturated aqueous NaHCO<sub>3</sub> solution (100 mL). The organic phase was washed (water, brine), separated, and dried (Na<sub>2</sub>SO<sub>4</sub>). The aqueous layer was extracted with EtOAc (twice). The organic layer was separated, washed (water, brine), and dried (Na<sub>2</sub>SO<sub>4</sub>). The organic extracts were combined and concentrated to give a yellow oil. Column chromatography on silica gel using hexanes−EtOAc (1:2) to EtOAc gave 1.88 g (63%) of <b>15</b> as a light-yellow oil: [α]<sup>23</sup><sub>D</sub> −75° (c 1.0, CHC1<sub>3</sub>). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 4.11 (s, 2H), 3.71 (q, 1H, <i>J</i> = 6.8), 1.39 (d, 3H, <i>J</i> = 6.8 Hz), 1.26 (s, 3H), 1.18 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 229.2, 77.6, 49.5, 49.3, 27.2, 24.2, 18.4. LCMS (APCI) <i>m</i>/<i>z</i> 144.3 [(M + H)<sup>+</sup>, M = C<sub>7</sub>H<sub>13</sub>NO<sub>2</sub>].</div><div class="NLM_p last">Note: <sup>1</sup>H NMR data is similar with the data reported in the literature for the racemic compound.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec5_50_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Cell Lines and Culture</h3><div class="NLM_p">Human embryonic kidney (HEK-293) cells stably expressing human DAT, NET or SERT were maintained as previously described.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p last">Use was made of several human cell lines that naturally or heterologously express specific, functional, human nAChR subtypes.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Cells of the TE671/RD line naturally expresses muscle-type nAChR (α1β1γδ- or α1*-nAChR), and SH-SY5Y neuroblastoma cells naturally express autonomic α3β4*-nAChRs (containing α3, β4, probably α5, and sometimes β2 subunits). Different clones of SH-EP1 epithelial cell lines have been engineered to heterologously express either α4β2-nAChR, which are thought to be the most abundant, high affinity nicotine-binding nAChR in mammalian brain, or α4β4-nAChR, another possible brain nAChR subtype (SH-EP1-hα4β2 or α4β4 cells, respectively).<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> These cells were maintained as low passage number (1−26 from our frozen stocks) cultures to ensure stable expression of native or heterologously expressed nAChR as previously described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Cells were passaged once weekly by splitting just-confluent cultures 1/300 (TE671/RD), 1/5 (SH-SY5Y), or 1/20 (transfected SH-EP1) in serum-supplemented medium to maintain log-phase growth.</div></div><div id="sec5_50_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Transporter Assays</h3><div class="NLM_p last">The abilities of <b>2</b> and its analogues to inhibit uptake of [<sup>3</sup>H]dopamine ([<sup>3</sup>H]DA), [<sup>3</sup>H]serotonin ([<sup>3</sup>H]5-HT), or [<sup>3</sup>H]norepinephrine ([<sup>3</sup>H]NE) by the respective, human transporters were evaluated using the appropriate HEK-293 cell line as previously reported.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec5_50_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> nAChR Functional Assays</h3><div class="NLM_p">Cells were harvested at confluence from 100 mm plates by mild trypsinization (Irvine Scientific, Santa Ana, CA) and trituration or (for SH-SY5Y cells) by trituration alone before being suspended in complete medium and evenly seeded at a density of 1.25−2 confluent 100 mm plates per 24-well plate (Falcon; ∼100−125 μg of total cell protein per well in a 500 μL volume). After cells had adhered (generally overnight, but no sooner than 4 h later), the medium was removed and replaced with 250 μL per well of complete medium supplemented with ∼350000 cpm of <sup>86</sup>Rb<sup>+</sup> (PerkinElmer Life and Analytical Sciences, Boston, MA) and counted at 40% efficiency using Cerenkov counting (TriCarb 1900 liquid scintillation analyzer, 59% efficiency; PerkinElmer Life Sciences). After at least 4 h and typically overnight, <sup>86</sup>Rb<sup>+</sup> efflux was measured using the “flip-plate” technique.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Briefly, after aspiration of the bulk of <sup>86</sup>Rb<sup>+</sup> loading medium from each well of the “cell plate,” each well containing cells was rinsed 3× with 2 mL of fresh <sup>86</sup>Rb<sup>+</sup> efflux buffer (130 mM NaCl, 5.4 mM KCl, 2 mM CaCl<sub>2</sub>, 5 mM glucose, 50 mM HEPES, pH 7.4) to remove extracellular <sup>86</sup>Rb<sup>+</sup>. Following removal of residual rinse buffer by aspiration, the flip-plate technique was used again to simultaneously introduce 1.5 mL of fresh efflux buffer containing drugs of choice at indicated final concentrations from a 24-well “efflux/drug plate” into the wells of the cell plate. After a 5 min incubation, the solution was “flipped” back into the efflux/drug plate and any remaining buffer in the cell plate was removed by aspiration. Cells remaining in the cell plate were lysed and suspended by addition of 1.5 mL of 0.1 M NaOH, 0.1% sodium dodecyl sulfate to each well. Suspensions in each well were then subjected to Cerenkov counting (Wallac Micobeta Trilux 1450; 25% efficiency) after placement of inserts (Wallac 1450−109) into each well to minimize cross-talk between wells.</div><div class="NLM_p">For quality control and normalization purposes, the sum of <sup>86</sup>Rb<sup>+</sup> in cell plates and efflux/drug plates was defined to confirm material balance (i.e., that the sum of <sup>86</sup>Rb<sup>+</sup> released into the efflux/drug plates and <sup>86</sup>Rb<sup>+</sup> remaining in the cell plate were the same for each well). This assured that <sup>86</sup>Rb<sup>+</sup> efflux was the same whether measured in absolute terms or as a percentage of loaded <sup>86</sup>Rb<sup>+</sup>. Similarly, the sum of <sup>86</sup>Rb<sup>+</sup> in cell plates and efflux/drug plates also determined the efficiency of <sup>86</sup>Rb<sup>+</sup> loading (the percentage of applied <sup>86</sup>Rb<sup>+</sup> actually loaded into cells).</div><div class="NLM_p">Control, total <sup>86</sup>Rb<sup>+</sup> efflux was assessed in the presence of only a fully efficacious concentration of carbamylcholine (1 mM for SH-EP1-hα4β2, SH-EP1-hα4β4 cells or TE671/RD cells; 3 mM for SH-SY5Y cells). Control, nonspecific <sup>86</sup>Rb<sup>+</sup> efflux was measured either in the presence of the fully efficacious concentration of carbamylcholine plus 100 μM mecamylamine, which gave full block of agonist-induced and spontaneous nAChR-mediated ion flux, or in the presence of efflux buffer alone. Either determination of nonspecific efflux was equivalent. Specific efflux was then taken as the difference in control samples between total and nonspecific <sup>86</sup>Rb<sup>+</sup> efflux. Any intrinsic agonist activity of test drugs was ascertained using samples containing test drug only at different concentrations and was normalized, after subtraction of nonspecific efflux, to specific efflux in test drug-free, control samples. Antagonism of carbamylcholine-evoked <sup>86</sup>Rb<sup>+</sup> efflux was assessed in samples containing the full agonist at a concentration where it stimulates 80−90% of maximal function (i.e., its EC<sub>80</sub>−EC<sub>90</sub> value) when exposed alone to a given nAChR subtype (i.e, 460 μM for TE671/RD cells, 2 mM for SH-SY5Y cells; 200 μM for SH-EP1-hα4β2 or -α4β4 cells) and test drugs at the concentrations shown. After subtraction of nonspecific efflux, results were normalized to specific ion flux in control samples. For studies of mechanism of antagonism, concentration−response curves were obtained using samples containing the full agonist, carbamylcholine, at the indicated concentrations alone or in the presence of a concentration of the test ligand close to its IC<sub>50</sub> value for inhibition of nAChR function.</div><div class="NLM_p last">Ion flux assay results were fit using Prism (GraphPad) to the Hill equation, <i>F</i> = <i>F</i><sub>max</sub>/(1 + (<i>X</i>/<i>Z</i>)<sup><i>n</i></sup>), where <i>F</i> is the test sample specific ion flux as a percentage of control, <i>F</i><sub>max</sub> is specific ion flux in the absence of test drug (i.e., for control samples), <i>X</i> is the test ligand concentration, <i>Z</i> is the EC<sub>50</sub> (<i>n</i> > 0 for agonists) or IC<sub>50</sub> (<i>n</i> < 0 for antagonists), and <i>n</i> is the Hill coefficient. All concentration-ion flux response curves were simple and fit well, allowing maximum and minimum ion flux values to be determined by curve fitting, but in cases where antagonists had weak functional potency, minimum ion flux was set at 0% of control. Note that because agonist concentrations used for test ligand antagonism assessments were EC<sub>80</sub>−EC<sub>90</sub> values, not all of the data, even at the lowest concentrations of test antagonist, approaches 100% of specific efflux as separately determined in sister samples exposed to fully efficacious concentrations of agonist.</div></div><div id="sec5_50_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Behavior</h3><div class="NLM_p last">Mice were tested for nicotine-induced antinociception, hypothermia, and hypomotility. The complex set of nicotinic effects makes it difficult to measure a single representative “nicotinic” acute response in animals. We opted instead in our study for a battery of tests where these different effects of the drug are measured. Factors such as agonist potency, time-course, site of action, and nicotinic receptor subtypes mediating these effects were taken into consideration. For obvious reasons, these nicotinic effects measured are centrally mediated. Although little is known about the different nicotinic receptor subtypes activated for some of these different responses, the antinociceptive effects of nicotine were among the best described. Recent report showed that neuronal α4β2 nAChRs subtypes are involved in nicotine-induced antinociception in the tail-flick and hot-plate tests. However, the primary sites of action are different for the two tests (the tail-flick assay involves a spinal reflex but in contrast, supraspinal sites are more likely to be involved in the hot-plate test). Moreover, spinal sites seems to involve both α4β2 and non-α4β2 receptors, whereas supraspinal sites are more likely to involve α4β2 neuronal subtypes as major component.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(37)</a> We therefore decided to measure nicotinic responses in both pain tests. All animal experiments were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and Institutional Animal Care and Use Committee guidelines.</div></div><div id="sec5_50_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Animals</h3><div class="NLM_p last">Male Institute of Cancer Research (ICR) mice (weighing 20−25 g) obtained from Harlan (Indianapolis, IN) were used throughout the study. Animals were housed in an Association for Assessment and Accreditation of Laboratory Animal Care-approved facility, were placed in groups of six, and had free access to food and water. Studies were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University.</div></div><div id="sec5_50_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Tail-Flick Test</h3><div class="NLM_p last">Antinociception for pain mediated at the spinal level was assessed by the tail-flick method of D’Amour and Smith.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(38)</a> In brief, mice were lightly restrained while a radiant heat source was shone onto the upper portion of the tail. To minimize tissue damage, a maximum latency of 10 s was imposed. Latency to remove the tail from the heat source was recorded for each animal. A control response (2−4 s) was determined for each mouse before treatment, and a test latency was determined after drug administration (nicotine as an analgesic 5 min after subcutaneous administration at 2.5 mg/kg; nicotine administration 15 min after exposure to saline of bupropion analogue to assess the latter drug’s ability to block nicotine-mediated antinociception). Antinociceptive response was calculated as the percentage of maximum possible effect (%MPE), where %MPE = [(test control)/(10 control)] × 100.</div></div><div id="sec5_50_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Hot-Plate Test</h3><div class="NLM_p last">Mice were placed into a 10 cm wide glass cylinder on a hot plate (Thermojust Apparatus) maintained at 55 °C for assessment of pain responses mediated at supraspinal levels. To minimize tissue damage, a maximum exposure to the hot plate 40 s was imposed. Measures of control latencies (time until the animal jumped or licked its paws; typically 8−12 s) were done twice for stimuli applied at least 10 min apart for each mouse. Antinociceptive responses after test drug administrations were determined and calculated as the %MPE, where %MPE = [(test latency in s − control latency in s)/(40 s − control latency in s) × 100]. Groups of 8−12 animals were used for each drug condition. Antagonism studies were carried in mice pretreated with either saline or bupropion metabolites 15 min before nicotine administration. The animals were then tested 5 min after administration of a subcutaneous dose of 2.5 mg/kg nicotine.</div></div><div id="sec5_50_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Locomotor Activity</h3><div class="NLM_p last">Mice were placed into individual Omnitech photocell activity cages (28 cm × 16.5 cm; Omnitech Electronics, Columbus, OH) 5 min after subcutaneous administration of either 0.9% saline or nicotine (1.5 mg/kg). Interruptions of the photocell beams (two banks of eight cells each) were then recorded for the next 10 min. Data were expressed as the number of photocell interruptions. Antagonism studies were carried out by pretreating the mice with either saline or bupropion metabolites 15 min before nicotine administration.</div></div><div id="sec5_50_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Body Temperature</h3><div class="NLM_p last">Rectal temperature was measured by a thermistor probe (inserted 24 mm) and digital thermometer (YSI Inc., Yellow Springs, OH). Readings were taken just before and 30 min after subcutaneous injection of either saline or 2.5 mg/kg nicotine. The difference in rectal temperature before and after treatment was calculated for each mouse. The ambient temperature of the laboratory varied from 21 to 24 °C from day to day. Antagonism studies were carried out by pretreating the mice with either saline or bupropion metabolites 15 min before nicotine administration. The animals were then tested 30 min after administration of a subcutaneous dose of 2.5 mg/kg nicotine.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/jm1003232">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35854" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35854" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1003232/suppl_file/jm1003232_si_001.pdf">jm1003232_si_001.pdf (27.21 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm1003232" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41508" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41508" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Ivy Carroll</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, P.O. Box 12194, Research Triangle Park, North Carolina 27709</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f5939c96b587819cdb9a8792"><span class="__cf_email__" data-cfemail="1b7d72785b696f723574697c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald J. Lukas</span> - <span class="hlFld-Affiliation affiliation">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Z. Muresan</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, P.O. Box 12194, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">M. Imad Damaj</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce E. Blough</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, P.O. Box 12194, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaodong Huang</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, P.O. Box 12194, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hernán A. Navarro</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, P.O. Box 12194, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">S. Wayne Mascarella</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, P.O. Box 12194, Research Triangle Park, North Carolina 27709</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Brek Eaton</span> - <span class="hlFld-Affiliation affiliation">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Syndia K. Marxer-Miller</span> - <span class="hlFld-Affiliation affiliation">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by National Institutes of Health National Cooperative Drug Discovery Group grant U19 DA019377. Other effort was supported by grants (to R.J.L.) from the National Institutes of Health (DA015389) and the Barrow Neurological Foundation.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Centers for Disease Control and Prevention</span><span class="NLM_x">. </span>Smoking and Tobacco Use—Fact Sheet: Health Effects of Cigarette Smoking, (updated January<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">) </span>,<a href="http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/" class="extLink">http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Centers+for+Disease+Control+and+Prevention&title=Smoking+and+Tobacco+Use%E2%80%94Fact+Sheet%3A+Health+Effects+of+Cigarette+Smoking"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DSmoking%2520and%2520Tobacco%2520Use%25E2%2580%2594Fact%2520Sheet%253A%2520Health%2520Effects%2520of%2520Cigarette%2520Smoking%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">US Department of Health and Human Services</span><span class="NLM_x">. </span> <span class="citation_source-book">The Health Consequences of Smoking: What It Means to You</span>; <span class="NLM_publisher-name">NIH</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=US+Department+of+Health+and+Human+Services&title=The+Health+Consequences+of+Smoking%3A+What+It+Means+to+You"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DThe%2520Health%2520Consequences%2520of%2520Smoking%253A%2520What%2520It%2520Means%2520to%2520You%26pub%3DNIH%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">SAMHSA (Substance Abuse and Mental Health Services Administration)</span><span class="NLM_x">. </span> <span class="citation_source-book">Results from the 2008 National Survey on Drug Use and Health</span>; <span class="NLM_publisher-name">Department of Health and Human Services</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=SAMHSA+%28Substance+Abuse+and+Mental+Health+Services+Administration%29&title=Results+from+the+2008+National+Survey+on+Drug+Use+and+Health"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DResults%2520from%2520the%25202008%2520National%2520Survey%2520on%2520Drug%2520Use%2520and%2520Health%26pub%3DDepartment%2520of%2520Health%2520and%2520Human%2520Services%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeSage, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benowitz, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigall, W. A.</span><span> </span><span class="NLM_article-title">Translational research in medication development for nicotine dependence</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=746-762&author=C.+Lermanauthor=M.+G.+LeSageauthor=K.+A.+Perkinsauthor=S.+S.+O%E2%80%99Malleyauthor=S.+J.+Siegelauthor=N.+L.+Benowitzauthor=W.+A.+Corrigall&title=Translational+research+in+medication+development+for+nicotine+dependence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerman%26aufirst%3DC.%26aulast%3DLeSage%26aufirst%3DM.%2BG.%26aulast%3DPerkins%26aufirst%3DK.%2BA.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%2BS.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26aulast%3DBenowitz%26aufirst%3DN.%2BL.%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26atitle%3DTranslational%2520research%2520in%2520medication%2520development%2520for%2520nicotine%2520dependence%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D746%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corringer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences</span> <span class="citation_source-journal">J. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1002%2Fneu.10153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=12436412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1KlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=447-456&author=N.+Le+Novereauthor=P.+J.+Corringerauthor=J.+P.+Changeux&title=The+diversity+of+subunit+composition+in+nAChRs%3A+evolutionary+origins%2C+physiologic+and+pharmacologic+consequences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences</span></div><div class="casAuthors">Le Novere, Nicolas; Corringer, Pierre-Jean; Changeux, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-456</span>CODEN:
                <span class="NLM_cas:coden">JNEUBZ</span>;
        ISSN:<span class="NLM_cas:issn">0022-3034</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Nicotinic acetylcholine receptors are made up of homologous subunits, which are encoded by a large multigene family.  The wide no. of receptor oligomers generated display variable pharmacol. properties.  One of the main questions underlying research in mol. pharmacol. resides in the actual role of this diversity.  It is generally assumed that the obsd. differences between the pharmacol. of homologous receptors, for instance, the EC50 for the endogenous agonist, or the kinetics of desensitization, bear some kind of physiol. relevance in vivo.  Here we develop the quite challenging point of view that, at least within a given subfamily of nicotinic receptor subunits, the pharmacol. variability obsd. in vitro would not be directly relevant to the function of receptor proteins in vivo.  In vivo responses are not expected to be sensitive to mild differences in affinities, and several examples of functional replacement of 1 subunit by another have been unraveled by knockout animals.  The diversity of subunits might have been conserved through evolution primarily to account for the topol. diversity of subunit distribution patterns, at the cellular and subcellular levels.  A quant. variation of pharmacol. properties would be tolerated within a physiol. envelope, as a consequence of a near-neutral genetic drift.  Such a gratuitous pharmacol. diversity is nevertheless of practical interest for the design of drugs, which would specifically tackle particular receptor oligomers with a defined subunit compn. among the multiple nicotinic receptors present in the organism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqAH4UkSOhFLVg90H21EOLACvtfcHk0lgOBT-4OlQWmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1KlsLg%253D&md5=e1b495f93280d9fd3109e67b22e90c4c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fneu.10153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fneu.10153%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DCorringer%26aufirst%3DP.%2BJ.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520diversity%2520of%2520subunit%2520composition%2520in%2520nAChRs%253A%2520evolutionary%2520origins%252C%2520physiologic%2520and%2520pharmacologic%2520consequences%26jtitle%3DJ.%2520Neurobiol.%26date%3D2002%26volume%3D53%26spage%3D447%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Heterogeneity and complexity of native brain nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1102-1111&author=C.+Gottiauthor=M.+Morettiauthor=A.+Gaimarriauthor=A.+Zanardiauthor=F.+Clementiauthor=M.+Zoli&title=Heterogeneity+and+complexity+of+native+brain+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DZanardi%26aufirst%3DA.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DHeterogeneity%2520and%2520complexity%2520of%2520native%2520brain%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1102%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, A. C.</span><span> </span><span class="NLM_article-title">Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzilate</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1982&pages=554-564&author=M.+J.+Marksauthor=A.+C.+Collins&title=Characterization+of+nicotine+binding+in+mouse+brain+and+comparison+with+the+binding+of+%CE%B1-bungarotoxin+and+quinuclidinyl+benzilate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26atitle%3DCharacterization%2520of%2520nicotine%2520binding%2520in%2520mouse%2520brain%2520and%2520comparison%2520with%2520the%2520binding%2520of%2520%25CE%25B1-bungarotoxin%2520and%2520quinuclidinyl%2520benzilate%26jtitle%3DMol.%2520Pharmacol.%26date%3D1982%26volume%3D22%26spage%3D554%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Hernandez, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction</span> <span class="citation_source-journal">CNS Neurol. Disord. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.2174%2F187152708786927831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=19128201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFansQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=422-441&author=S.+Rahmanauthor=G.+Y.+Lopez-Hernandezauthor=W.+A.+Corrigallauthor=R.+L.+Papke&title=Neuronal+nicotinic+receptors+as+brain+targets+for+pharmacotherapy+of+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction</span></div><div class="casAuthors">Rahman, Shafiqur; Lopez-Hernandez, Gretchen Y.; Corrigall, William A.; Papke, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-441</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotine addiction and other forms of drug addiction continue to be significant public health problems in the United States and the rest of the world.  Accumulated evidence indicates that brain nicotinic acetylcholine receptors (nAChRs) are a heterogenous family of ion channels expressed in the various parts of the brain.  A growing body of preclin. studies suggests that brain nAChRs are crit. targets for the development of pharmacotherapies for nicotine and other drug addictions.  In this review, we will discuss the nAChR subtypes, their function in response to endogenous brain transmitters, and how their functions are regulated in the presence of nicotine.  Furthermore, we will discuss the role of nAChRs in mediating nicotine-induced addictive behavior in animal models.  Addnl., we will provide an overview of the effects of nicotine and nicotinic compds. on the mesolimbic dopamine system, part of the reinforcement/reward circuitry of the brain, as an example of the neurochem. basis of nicotine addiction and other drug addictions.  An appreciation of the complexity of nicotinic receptors and their regulation will be necessary for the development of nicotinic receptor modulators as potential pharmacotherapy for drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuQExQTuj1E7Vg90H21EOLACvtfcHk0lhxEpzYYyQ2BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFansQ%253D%253D&md5=1e358be78d8fd3b9da199e25dbb950a5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F187152708786927831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708786927831%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DLopez-Hernandez%26aufirst%3DG.%2BY.%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26atitle%3DNeuronal%2520nicotinic%2520receptors%2520as%2520brain%2520targets%2520for%2520pharmacotherapy%2520of%2520drug%2520addiction%26jtitle%3DCNS%2520Neurol.%2520Disord.%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D422%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Adams, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutter, T. J.</span><span> </span><span class="NLM_article-title">Calcium permeability and modulation of nicotinic acetylcholine receptor-channels in rat parasympathetic neurons</span> <span class="citation_source-journal">J. Physiol. (Paris)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1992&pages=67-76&author=D.+J.+Adamsauthor=T.+J.+Nutter&title=Calcium+permeability+and+modulation+of+nicotinic+acetylcholine+receptor-channels+in+rat+parasympathetic+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DNutter%26aufirst%3DT.%2BJ.%26atitle%3DCalcium%2520permeability%2520and%2520modulation%2520of%2520nicotinic%2520acetylcholine%2520receptor-channels%2520in%2520rat%2520parasympathetic%2520neurons%26jtitle%3DJ.%2520Physiol.%2520%2528Paris%2529%26date%3D1992%26volume%3D86%26spage%3D67%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2428</span><span class="NLM_x">–</span> <span class="NLM_lpage">2439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1111%2Fj.1460-9568.1996.tb01206.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=8950106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A280%3ADyaK2s7gslemuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=2428-2439&author=N.+Le+Novereauthor=M.+Zoliauthor=J.+P.+Changeux&title=Neuronal+nicotinic+receptor+alpha+6+subunit+mRNA+is+selectively+concentrated+in+catecholaminergic+nuclei+of+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain</span></div><div class="casAuthors">Le Novere N; Zoli M; Changeux J P</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2428-39</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Although the neuronal nicotinic receptor alpha 6 subunit was cloned several years ago, its functional significance remains to be investigated.  Here we describe an in situ hybridization study of the mRNA for this subunit in the adult rat central nervous system using oligonucleotide probes.  Specific alpha 6 mRNA labelling was restricted to a few nuclei throughout the brain; it was particularly high in several catecholaminergic nuclei [the locus coeruleus (A6), the ventral tegmental area (A10) and the substantia nigra (A9)] at levels significantly higher than those found for any other known nicotinic receptor subunit mRNA.  Labelling for alpha 6 mRNA was also detected at lower levels in the reticular thalamic nucleus, the supramammillary nucleus and the mesencephalic V nucleus.  Some cells of the medial habenula (medioventral part) and of the interpeduncular nucleus (central and lateral parts) were also labelled.  The distribution of alpha 6 mRNA was compared with the distribution of the other known nicotinic acetylcholine receptor subunit mRNAs.  In several nuclei, the expression of alpha 6 was complementary to those of other alpha subunits.  Moreover, some of the cell groups (such as the substantia nigra, the ventral tegmental area and the locus coeruleus) previously thought to contain mainly alpha 3 mRNA in fact were found to contain high levels of alpha 6 mRNA.  Finally, we found extensive colocalization of alpha 6 and beta 3, indicating the possible existence of nicotinic receptor hetero-oligomers containing both subunits.  The present results show that alpha 6 is the major nicotinic acetylcholine receptor alpha subunit expressed in dopaminergic cell groups of the mesencephalon and noradrenergic cells of the locus coeruleus.  This suggests the involvement of the alpha 6 subunit in some of the major functions of central nicotinic circuits, including the modulation of locomotor behaviour and reward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGTspW95ieGmK_SFaaT9INfW6udTcc2ebEijZXxH1j47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7gslemuw%253D%253D&md5=1703784567106fda7afda74e1ca6e554</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1996.tb01206.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1996.tb01206.x%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520alpha%25206%2520subunit%2520mRNA%2520is%2520selectively%2520concentrated%2520in%2520catecholaminergic%2520nuclei%2520of%2520the%2520rat%2520brain%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1996%26volume%3D8%26spage%3D2428%26epage%3D2439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Goldner, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineley, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, J. W.</span><span> </span><span class="NLM_article-title">Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha6 to dopaminergic neurons in the substantia nigra and ventral tegmental area</span> <span class="citation_source-journal">Neuroreport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2739</span><span class="NLM_x">–</span> <span class="NLM_lpage">2742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=2739-2742&author=F.+M.+Goldnerauthor=K.+T.+Dineleyauthor=J.+W.+Patrick&title=Immunohistochemical+localization+of+the+nicotinic+acetylcholine+receptor+subunit+alpha6+to+dopaminergic+neurons+in+the+substantia+nigra+and+ventral+tegmental+area"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldner%26aufirst%3DF.%2BM.%26aulast%3DDineley%26aufirst%3DK.%2BT.%26aulast%3DPatrick%26aufirst%3DJ.%2BW.%26atitle%3DImmunohistochemical%2520localization%2520of%2520the%2520nicotinic%2520acetylcholine%2520receptor%2520subunit%2520alpha6%2520to%2520dopaminergic%2520neurons%2520in%2520the%2520substantia%2520nigra%2520and%2520ventral%2520tegmental%2520area%26jtitle%3DNeuroreport%26date%3D1997%26volume%3D8%26spage%3D2739%26epage%3D2742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Exley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, S. J.</span><span> </span><span class="NLM_article-title">Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2158</span><span class="NLM_x">–</span> <span class="NLM_lpage">2166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2158-2166&author=R.+Exleyauthor=M.+A.+Clementsauthor=H.+Hartungauthor=J.+M.+McIntoshauthor=S.+J.+Cragg&title=Alpha6-containing+nicotinic+acetylcholine+receptors+dominate+the+nicotine+control+of+dopamine+neurotransmission+in+nucleus+accumbens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DExley%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%2BA.%26aulast%3DHartung%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DCragg%26aufirst%3DS.%2BJ.%26atitle%3DAlpha6-containing%2520nicotinic%2520acetylcholine%2520receptors%2520dominate%2520the%2520nicotine%2520control%2520of%2520dopamine%2520neurotransmission%2520in%2520nucleus%2520accumbens%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D2158%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Taly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corringer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guedin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=733-750&author=A.+Talyauthor=P.+J.+Corringerauthor=D.+Guedinauthor=P.+Lestageauthor=J.+P.+Changeux&title=Nicotinic+receptors%3A+allosteric+transitions+and+therapeutic+targets+in+the+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaly%26aufirst%3DA.%26aulast%3DCorringer%26aufirst%3DP.%2BJ.%26aulast%3DGuedin%26aufirst%3DD.%26aulast%3DLestage%26aufirst%3DP.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DNicotinic%2520receptors%253A%2520allosteric%2520transitions%2520and%2520therapeutic%2520targets%2520in%2520the%2520nervous%2520system%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D733%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Corrigall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. B.</span><span> </span><span class="NLM_article-title">The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1992&pages=285-289&author=W.+A.+Corrigallauthor=K.+B.+Franklinauthor=K.+M.+Coenauthor=P.+B.+Clarke&title=The+mesolimbic+dopaminergic+system+is+implicated+in+the+reinforcing+effects+of+nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26aulast%3DFranklin%26aufirst%3DK.%2BB.%26aulast%3DCoen%26aufirst%3DK.%2BM.%26aulast%3DClarke%26aufirst%3DP.%2BB.%26atitle%3DThe%2520mesolimbic%2520dopaminergic%2520system%2520is%2520implicated%2520in%2520the%2520reinforcing%2520effects%2520of%2520nicotine%26jtitle%3DPsychopharmacology%26date%3D1992%26volume%3D107%26spage%3D285%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Brody, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olmstead, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farahi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkern, M. A.</span><span> </span><span class="NLM_article-title">Smoking-induced ventral striatum dopamine release</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1176%2Fappi.ajp.161.7.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=15229053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A280%3ADC%252BD2czis1yqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=1211-1218&author=A.+L.+Brodyauthor=R.+E.+Olmsteadauthor=E.+D.+Londonauthor=J.+Farahiauthor=J.+H.+Meyerauthor=P.+Grossmanauthor=G.+S.+Leeauthor=J.+Huangauthor=E.+L.+Hahnauthor=M.+A.+Mandelkern&title=Smoking-induced+ventral+striatum+dopamine+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Smoking-induced ventral striatum dopamine release</span></div><div class="casAuthors">Brody Arthur L; Olmstead Richard E; London Edythe D; Farahi Judah; Meyer Jeffrey H; Grossman Paul; Lee Grace S; Huang Joe; Hahn Emily L; Mandelkern Mark A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1211-8</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Substantial evidence from animal models demonstrates that dopamine release in the ventral striatum underlies the reinforcing properties of nicotine.  The authors used [(11)C]raclopride bolus-plus-continuous-infusion positron emission tomography (PET) to determine smoking-induced ventral striatum dopamine release in humans.  METHOD:  Twenty nicotine-dependent smokers (who smoked > or =15 cigarettes/day) underwent a [(11)C]raclopride bolus-plus-continuous-infusion PET session.  During the session, subjects had a 10-minute break outside the PET apparatus during which 10 subjects smoked a cigarette and 10 did not smoke (as a control condition).  RESULTS:  The group that smoked had greater reductions in [(11)C]raclopride binding potential in ventral striatum regions of interest than the group that did not smoke, particularly in the left ventral caudate/nucleus accumbens and left ventral putamen (range for smoking group=-25.9% to -36.6% reduction).  Significant correlations were found between change from before to after the smoking break in craving ratings and change from before to after the break in binding potential for these two regions.  CONCLUSIONS:  Nicotine-dependent subjects who smoked during a break in PET scanning had greater reductions in [(11)C]raclopride binding potential (an indirect measure of dopamine release) than nicotine-dependent subjects who did not smoke.  The magnitude of binding potential changes was comparable to that found in studies that used similar methods to examine the effects of other addictive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRk4_DvvsbbrpggzHGM8X5CfW6udTcc2eaDTNBSPkcb_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czis1yqtg%253D%253D&md5=745fbf6bd4538acec7ac76bbca229ce9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.7.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.7.1211%26sid%3Dliteratum%253Aachs%26aulast%3DBrody%26aufirst%3DA.%2BL.%26aulast%3DOlmstead%26aufirst%3DR.%2BE.%26aulast%3DLondon%26aufirst%3DE.%2BD.%26aulast%3DFarahi%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DGrossman%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DG.%2BS.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DE.%2BL.%26aulast%3DMandelkern%26aufirst%3DM.%2BA.%26atitle%3DSmoking-induced%2520ventral%2520striatum%2520dopamine%2520release%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D1211%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Johnston, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadbetter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmith, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durcan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, B.</span><span> </span><span class="NLM_article-title">Pharmacokinetic optimization of sustained-release bupropion for smoking cessation</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=11-24&issue=Suppl+2&author=A.+J.+Johnstonauthor=J.+Ascherauthor=R.+Leadbetterauthor=V.+D.+Schmithauthor=D.+K.+Patelauthor=M.+Durcanauthor=B.+Bentley&title=Pharmacokinetic+optimization+of+sustained-release+bupropion+for+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DA.%2BJ.%26aulast%3DAscher%26aufirst%3DJ.%26aulast%3DLeadbetter%26aufirst%3DR.%26aulast%3DSchmith%26aufirst%3DV.%2BD.%26aulast%3DPatel%26aufirst%3DD.%2BK.%26aulast%3DDurcan%26aufirst%3DM.%26aulast%3DBentley%26aufirst%3DB.%26atitle%3DPharmacokinetic%2520optimization%2520of%2520sustained-release%2520bupropion%2520for%2520smoking%2520cessation%26jtitle%3DDrugs%26date%3D2002%26volume%3D62%26issue%3DSuppl%25202%26spage%3D11%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hesse, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatakrishnan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Moltke, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shader, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. J.</span><span> </span><span class="NLM_article-title">CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1176-1183&author=L.+M.+Hesseauthor=K.+Venkatakrishnanauthor=M.+H.+Courtauthor=L.+L.+von+Moltkeauthor=S.+X.+Duanauthor=R.+I.+Shaderauthor=D.+J.+Greenblatt&title=CYP2B6+mediates+the+in+vitro+hydroxylation+of+bupropion%3A+potential+drug+interactions+with+other+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHesse%26aufirst%3DL.%2BM.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DCourt%26aufirst%3DM.%2BH.%26aulast%3Dvon%2BMoltke%26aufirst%3DL.%2BL.%26aulast%3DDuan%26aufirst%3DS.%2BX.%26aulast%3DShader%26aufirst%3DR.%2BI.%26aulast%3DGreenblatt%26aufirst%3DD.%2BJ.%26atitle%3DCYP2B6%2520mediates%2520the%2520in%2520vitro%2520hydroxylation%2520of%2520bupropion%253A%2520potential%2520drug%2520interactions%2520with%2520other%2520antidepressants%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2000%26volume%3D28%26spage%3D1176%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Faucette, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecluyse, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shord, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laethem, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindley, C. M.</span><span> </span><span class="NLM_article-title">Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1222-1230&author=S.+R.+Faucetteauthor=R.+L.+Hawkeauthor=E.+L.+Lecluyseauthor=S.+S.+Shordauthor=B.+Yanauthor=R.+M.+Laethemauthor=C.+M.+Lindley&title=Validation+of+bupropion+hydroxylation+as+a+selective+marker+of+human+cytochrome+P450+2B6+catalytic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaucette%26aufirst%3DS.%2BR.%26aulast%3DHawke%26aufirst%3DR.%2BL.%26aulast%3DLecluyse%26aufirst%3DE.%2BL.%26aulast%3DShord%26aufirst%3DS.%2BS.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DLaethem%26aufirst%3DR.%2BM.%26aulast%3DLindley%26aufirst%3DC.%2BM.%26atitle%3DValidation%2520of%2520bupropion%2520hydroxylation%2520as%2520a%2520selective%2520marker%2520of%2520human%2520cytochrome%2520P450%25202B6%2520catalytic%2520activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2000%26volume%3D28%26spage%3D1222%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Faucette, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shord, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecluyse, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindley, C. M.</span><span> </span><span class="NLM_article-title">Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=1123-1129&author=S.+R.+Faucetteauthor=R.+L.+Hawkeauthor=S.+S.+Shordauthor=E.+L.+Lecluyseauthor=C.+M.+Lindley&title=Evaluation+of+the+contribution+of+cytochrome+P450+3A4+to+human+liver+microsomal+bupropion+hydroxylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaucette%26aufirst%3DS.%2BR.%26aulast%3DHawke%26aufirst%3DR.%2BL.%26aulast%3DShord%26aufirst%3DS.%2BS.%26aulast%3DLecluyse%26aufirst%3DE.%2BL.%26aulast%3DLindley%26aufirst%3DC.%2BM.%26atitle%3DEvaluation%2520of%2520the%2520contribution%2520of%2520cytochrome%2520P450%25203A4%2520to%2520human%2520liver%2520microsomal%2520bupropion%2520hydroxylation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D1123%26epage%3D1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondareva, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Behavioral and biochemical investigations of bupropion metabolites</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">474</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1016%2FS0014-2999%2803%2902010-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=12909199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFyms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2003&pages=85-93&author=M.+L.+Bondarevauthor=T.+S.+Bondarevaauthor=R.+Youngauthor=R.+A.+Glennon&title=Behavioral+and+biochemical+investigations+of+bupropion+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and biochemical investigations of bupropion metabolites</span></div><div class="casAuthors">Bondarev, Mikhail L.; Bondareva, Tatiana S.; Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The stimulus effects of bupropion metabolites were examd. in a drug discrimination procedure using (-)nicotine- and (+)amphetamine-trained rats.  (+)- And (-)threohydrobupropion partially substituted in each group.  R,R-hydroxybupropion produced vehicle-appropriate responding in (-)nicotine animals but, when given in combination with the training dose of (-)nicotine, resulted in an attenuated effect.  S,S-Hydroxybupropion partially (66%) substituted for (-)nicotine.  In (+)amphetamine-trained animals, S,S-hydroxybupropion (ED50=4.4 mg/kg) generalized completely and was similar in potency to bupropion (ED50=5.4 mg/kg).  Bupropion and its metabolites lacked affinity for nicotinic acetylcholinergic receptors, but all antagonized (-)nicotine-induced 86Rb+ efflux in cells expressing α3β4 nicotinic cholinergic receptors.  S,S-Hydroxybupropion possessed affinity at the dopamine transporter comparable to bupropion, and was also found to bind at the norepinephrine transporter.  Although it is unlikely that any metabolite isomer is chiefly responsible for the stimulus actions of bupropion, some probably play a role in the complex actions of this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgimuwMhfmhrVg90H21EOLACvtfcHk0ljFuT3YaBWfvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFyms7s%253D&md5=cd1a5d83d88f14454e99ff8315b952c5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2902010-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252902010-7%26sid%3Dliteratum%253Aachs%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DBondareva%26aufirst%3DT.%2BS.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBehavioral%2520and%2520biochemical%2520investigations%2520of%2520bupropion%2520metabolites%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D474%26spage%3D85%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirza, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=675-682&author=M.+I.+Damajauthor=F.+I.+Carrollauthor=J.+B.+Eatonauthor=H.+A.+Navarroauthor=B.+E.+Bloughauthor=S.+Mirzaauthor=R.+J.+Lukasauthor=B.+R.+Martin&title=Enantioselective+effects+of+hydroxy+metabolites+of+bupropion+on+behavior+and+on+function+of+monoamine+transporters+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DMirza%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DEnantioselective%2520effects%2520of%2520hydroxy%2520metabolites%2520of%2520bupropion%2520on%2520behavior%2520and%2520on%2520function%2520of%2520monoamine%2520transporters%2520and%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D675%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Jefferson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradko, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, K. T.</span><span> </span><span class="NLM_article-title">Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1016%2Fj.clinthera.2005.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=16368442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlWntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1685-1695&author=J.+W.+Jeffersonauthor=J.+F.+Pradkoauthor=K.+T.+Muir&title=Bupropion+for+major+depressive+disorder%3A+Pharmacokinetic+and+formulation+considerations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Bupropion for major depressive disorder: pharmacokinetic and formulation considerations</span></div><div class="casAuthors">Jefferson, James W.; Pradko, James F.; Muir, Keith T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1685-1695</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Major depressive disorder (MDD) is a common psychiatric condition, with 6.6% of the adult population in the United States experiencing a major depressive episode during any given year.  Depressed patients must receive adequate treatment to maximize the likelihood of clin. success.  Bupropion hydrochloride, a noradrenergic/dopaminergic antidepressant, is available in 3 oral formulations: immediate release (IR) (given TID), sustained release (SR) (given BID), and extended release (XL) (given QD).  Understanding the pharmacokinetic (PK) properties and formulations of bupropion can help optimize clin. use.  Objectives: The aims of this article were to provide a review of the PK properties of bupropion and identify its various formulations and clin. applications to help optimize treatment of MDD.  Methods: In this review, data concerning PK trials/reports were collected from articles identified using a PubMed search.  The search was conducted without date limitations and using the search terms bupropion, bupropion SR, bupropion XL, bupropion pharmacokinetics, bupropion metab., and bupropion drug interactions.  Addnl. reports were selected from refs. that appeared in articles identified in the original search.  In addn., data from studies summarized in product information and labeling were obtained.  All available information, concg. on studies in humans, pertinent to bupropion PK properties and/or formulations was included.  Results: Bupropion is extensively metabolized by the liver (t1/2, ∼21 h).  Hydroxybupropion, the primary active metabolite (t1/2, ∼20 h), is formed by cytochrome P 450 (CYP) 2B6.  At steady state, Cmax of hydroxybupropion is 4- to 7-fold higher, and the AUC is ∼10-fold greater, compared with those of the parent drug.  Threohydrobupropion and erythrohydrobupropion (mean [SD] t1/2 values, ∼37 [13] and ∼33 [10] hours, resp.), the other active metabolites of bupropion, are formed via nonmicrosomal pathways.  Relative to bupropion, the Cmax values are ∼5-fold greater for threohydrobupropion and similar for erythrohydrobupropion.  Based on a mouse antitetrabenazine model, hydroxybupropion is ∼50% as active as bupropion, and threohydrobupropion and erythrohydrobupropion are ∼20% as active as bupropion.  Bupropion lowers the seizure threshold and, therefore, concurrent administration with other agents that lower the seizure threshold should be undertaken cautiously.  Potential interactions with other agents that are metabolized by CYP2B6 should be considered.  In addn., bupropion inhibits CYP2D6 and may reduce clearance of agents metabolized by this enzyme.  Absorption of the XL formulation is prolonged compared with the IR and SR formulations (Tmax, ∼5 h vs ∼1.5 and ∼3 h, resp.).  Bupropion is dosed without regard to food.  Conclusions: Understanding the PK profile and formulations of bupropion can help optimize clin. use.  Bupropion is metabolized extensively, resulting in 3 active metabolites.  This metabolic profile, various patient factors (eg, age, medical illnesses), and potential drug interactions should be considered when prescribing bupropion.  The 3 formulations-bupropion, bupropion SR, and bupropion XL-are bioequivalent and offer options to optimize treatment for patients with MDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT3CDzRR147rVg90H21EOLACvtfcHk0liakRM_Zxh9tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlWntQ%253D%253D&md5=a97383a3d5b93a852add3e2d986d1aa2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DJefferson%26aufirst%3DJ.%2BW.%26aulast%3DPradko%26aufirst%3DJ.%2BF.%26aulast%3DMuir%26aufirst%3DK.%2BT.%26atitle%3DBupropion%2520for%2520major%2520depressive%2520disorder%253A%2520Pharmacokinetic%2520and%2520formulation%2520considerations%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1685%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kharasch, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coles, R.</span><span> </span><span class="NLM_article-title">Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1177%2F0091270008314254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=18287571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=464-474&author=E.+D.+Kharaschauthor=D.+Mitchellauthor=R.+Coles&title=Stereoselective+bupropion+hydroxylation+as+an+in+vivo+phenotypic+probe+for+cytochrome+P4502B6+%28CYP2B6%29+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity</span></div><div class="casAuthors">Kharasch, Evan D.; Mitchell, Darain; Coles, Rebecka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">464-474</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The clearance of racemic bupropion, metabolized selectively by CYP2B6 in vitro, has been used clin. to phenotype CYP2B6 activity, polymorphisms, and drug interactions but has known limitations.  Bupropion hydroxylation by CYP2B6 is stereoselective.  This investigation assessed the stereoselectivity of bupropion pharmacokinetics and the influence of CYP2B6 induction.  Ten healthy volunteers received immediate-release bupropion before and after 7 days of rifampin.  Plasma and urine bupropion and hydroxybupropion were analyzed using a stereoselective assay.  Plasma area under the curve (AUC0-∞) and max. concns. were 3-fold greater for R- than S-bupropion.  Bupropion apparent oral clearance was 3- and 2-fold greater for S- than R- and R,S-bupropion, resp.  Hydroxybupropion plasma AUC0-∞ and elimination half-life were significantly less for (S,S)- than (R,R)- and the racemate.  (S,S)-hydroxybupropion was formation rate limited, whereas (R,R)-hydroxybupropion and the race-mate were elimination rate limited.  Rifampin doubled both R- and S-bupropion clearance and caused 4-fold increases in both (R,R)- and (S,S)-hydroxybupropion formation clearances.  Increases in the plasma hydroxybupropion/bupropion AUC0-∞ ratio were greater for (S,S)- than (R,R)-hydroxybupropion.  Simplified plasma and urine metrics of stereoselective bupropion metab. and clearance were identified.  Because metabolite formation clearance is the best in vivo metric of enzyme activity and due, therefore, to faster S-bupropion elimination and formation rate-limited (S,S)-hydroxybupropion kinetics, stereoselective S-bupropion hydroxylation and (S,S)-hydroxybupropion formation clearance may be a useful and improved phenotypic probe for CYP2B6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKWGq-Fnd6xbVg90H21EOLACvtfcHk0liakRM_Zxh9tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslKntLg%253D&md5=220bf3a8f9c4d2e334870473344db952</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1177%2F0091270008314254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270008314254%26sid%3Dliteratum%253Aachs%26aulast%3DKharasch%26aufirst%3DE.%2BD.%26aulast%3DMitchell%26aufirst%3DD.%26aulast%3DColes%26aufirst%3DR.%26atitle%3DStereoselective%2520bupropion%2520hydroxylation%2520as%2520an%2520in%2520vivo%2520phenotypic%2520probe%2520for%2520cytochrome%2520P4502B6%2520%2528CYP2B6%2529%2520activity%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D48%26spage%3D464%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fang, Q. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senanayake, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wald, S. A.</span><span> </span><span class="NLM_article-title">Rapid access to enantiopure bupropion and its major metabolite by stereospecific nucleophilic substitution on an α-ketotriflate</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3659</span><span class="NLM_x">–</span> <span class="NLM_lpage">3663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=3659-3663&author=Q.+K.+Fangauthor=Z.+Hanauthor=P.+Groverauthor=D.+Kesslerauthor=C.+H.+Senanayakeauthor=S.+A.+Wald&title=Rapid+access+to+enantiopure+bupropion+and+its+major+metabolite+by+stereospecific+nucleophilic+substitution+on+an+%CE%B1-ketotriflate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DQ.%2BK.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DGrover%26aufirst%3DP.%26aulast%3DKessler%26aufirst%3DD.%26aulast%3DSenanayake%26aufirst%3DC.%2BH.%26aulast%3DWald%26aufirst%3DS.%2BA.%26atitle%3DRapid%2520access%2520to%2520enantiopure%2520bupropion%2520and%2520its%2520major%2520metabolite%2520by%2520stereospecific%2520nucleophilic%2520substitution%2520on%2520an%2520%25CE%25B1-ketotriflate%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2000%26volume%3D11%26spage%3D3659%26epage%3D3663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kelley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musso, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boswell, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroko, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. R.</span><span> </span><span class="NLM_article-title">(2<i>S</i>,3<i>S</i>,5<i>R</i>)-2-(3,5-Difluorophenyl)-3,5-dimethyl-2-morpholinol: a novel antidepressant agent and selective inhibitor of norepinephrine uptake</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950630p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=347-349&author=J.+L.+Kelleyauthor=D.+L.+Mussoauthor=G.+E.+Boswellauthor=F.+E.+Sorokoauthor=B.+R.+Cooper&title=%282S%2C3S%2C5R%29-2-%283%2C5-Difluorophenyl%29-3%2C5-dimethyl-2-morpholinol%3A+a+novel+antidepressant+agent+and+selective+inhibitor+of+norepinephrine+uptake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm950630p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950630p%26sid%3Dliteratum%253Aachs%26aulast%3DKelley%26aufirst%3DJ.%2BL.%26aulast%3DMusso%26aufirst%3DD.%2BL.%26aulast%3DBoswell%26aufirst%3DG.%2BE.%26aulast%3DSoroko%26aufirst%3DF.%2BE.%26aulast%3DCooper%26aufirst%3DB.%2BR.%26atitle%3D%25282S%252C3S%252C5R%2529-2-%25283%252C5-Difluorophenyl%2529-3%252C5-dimethyl-2-morpholinol%253A%2520a%2520novel%2520antidepressant%2520agent%2520and%2520selective%2520inhibitor%2520of%2520norepinephrine%2520uptake%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D347%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumbay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martens, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span> </span><span class="NLM_article-title">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=10215666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=877-885&author=A.+J.+Eshlemanauthor=M.+Carmolliauthor=M.+Cumbayauthor=C.+R.+Martensauthor=K.+A.+Neveauthor=A.+Janowsky&title=Characteristics+of+drug+interactions+with+recombinant+biogenic+amine+transporters+expressed+in+the+same+cell+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span></div><div class="casAuthors">Eshleman, Amy J.; Carmolli, Marya; Cumbay, Medhane; Martens, Carey R.; Neve, Kim A.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of drugs on the uptake of [3H]neurotransmitter by and the binding of [125I]3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester ([125I]RTI-55) to the recombinant human dopamine (hDAT), serotonin (hSERT), or norepinephrine (hNET) transporters stably expressed in human embryonic kidney 293 cells were studied.  RTI-55 had similar affinity for the hDAT and hSERT and lower affinity for hNET (Kd = 1.83, 0.98, and 12.1 nM, resp.).  Kinetic anal. of [125I]RTI-55 binding indicated that the dissocn. rate (k-1) was significantly lower for hSERT and the assocn. rate (k+1) was significantly lower for hNET compared with the hDAT.  The potency of drugs at blocking [3H]neurotransmitter uptake was highly correlated with potency at blocking radioligand binding for hDAT and hSERT.  Substrates were more potent at the inhibition of [3H]neurotransmitter uptake than radioligand binding.  The potency of drugs was highly correlated between displacement of [3H]nisoxetine (Kd = 6.0 nM) and [125I]RTI-55 from the hNET, suggesting that these radioligands recognize similar sites on the transporter protein.  The correlation obsd. between inhibitory potency for uptake and binding of either ligand at the hNET was lower than correlations between uptake and binding for hDAT and hSERT.  The present results indicate that the cocaine analog [125I]RTI-55 has unique binding properties at each of the transporters and that the use of recombinant transporters expressed by a single cell type can provide a powerful screening tool for drugs interacting with biogenic amine transporters, such as possible cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn_1UJqie3bVg90H21EOLACvtfcHk0ljw9x4gMOc0kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D&md5=c808b4d81da86e57460406d2163c5e65</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DCarmolli%26aufirst%3DM.%26aulast%3DCumbay%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DC.%2BR.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DCharacteristics%2520of%2520drug%2520interactions%2520with%2520recombinant%2520biogenic%2520amine%2520transporters%2520expressed%2520in%2520the%2520same%2520cell%2520type%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei-Yin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassco, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Antinociceptive responses to nicotinic acertylcholine receptors ligands after systemic amd inthathecal administration in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=9495867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADyaK1cXhs1ygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1998&pages=1058-1065&author=M.+I.+Damajauthor=M.+Fei-Yinauthor=M.+Dukatauthor=W.+Glasscoauthor=R.+A.+Glennonauthor=B.+R.+Martin&title=Antinociceptive+responses+to+nicotinic+acertylcholine+receptors+ligands+after+systemic+amd+inthathecal+administration+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice</span></div><div class="casAuthors">Damaj, M. I.; Fei-Yin, M.; Dukat, M.; Glassco, W.; Glennon, R. A.; Martin, B. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1058-1065</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The objective of this study was to det. which nicotinic receptor subtypes are involved in antinociception and their site of action.  For that, the antinociceptive effects of several nicotinic receptor ligands were evaluated in the tail-flick test both after s.c. and intrathecal (i.t.) administration.  Nicotine and other nicotine agonists increased tail-flick latencies in a dose-dependent manner after both routes of administration.  Epibatidine enantiomers were the most potent agonists examd.  Cytisine, a potent nicotinic ligand, failed to elicit antinociception when injected either i.t. or s.c.  Despite some similarities in the effects of nicotinic agonists after i.t. and s.c. injections, their rank-order potency was different.  In contrast to the s.c. results, the stereoselectivity of nicotine's effect after i.t. administration was minimal.  When various nicotinic antagonists were compared after i.t. and s.c. administration, the results showed that mecamylamine and dihydro-β-erythroidine differ in potency and their degree of antagonism of some of the nicotinic agonists given i.t.  These data suggest that different subtypes of nicotinic receptors may exist in the spinal cord.  A good correlation was found between binding affinity to [3H]-nicotine binding sites and analgesic potency after i.t. (r = 0.82), suggesting the involvement of α4β2 receptor subunits.  In contrast, studies with MLA and α-BGTX suggested a minimal role for α-BGTX-sensitive receptors in the antinociceptive effect of nicotinic agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6OOvP1aoamLVg90H21EOLACvtfcHk0ljw9x4gMOc0kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs1ygs74%253D&md5=41c0c91b2db51d949ab33215e07536d9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DFei-Yin%26aufirst%3DM.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DGlassco%26aufirst%3DW.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DAntinociceptive%2520responses%2520to%2520nicotinic%2520acertylcholine%2520receptors%2520ligands%2520after%2520systemic%2520amd%2520inthathecal%2520administration%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D284%26spage%3D1058%26epage%3D1065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarella, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2204</span><span class="NLM_x">–</span> <span class="NLM_lpage">2214</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9017465" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2204-2214&author=F.+I.+Carrollauthor=B.+E.+Bloughauthor=S.+W.+Mascarellaauthor=H.+A.+Navarroauthor=J.+B.+Eatonauthor=R.+J.+Lukasauthor=M.+I.+Damaj&title=Synthesis+and+Biological+Evaluation+of+Bupropion+Analogues+as+Potential+Pharmacotherapies+for+Smoking+Cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm9017465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9017465%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Bupropion%2520Analogues%2520as%2520Potential%2520Pharmacotherapies%2520for%2520Smoking%2520Cessation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2204%26epage%3D2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Silverstone, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogarty, S.</span><span> </span><span class="NLM_article-title">Effect of increasing intraperitoneal infusion rates on bupropion hydrochloride-induced seizures in mice</span> <span class="citation_source-journal">Ann. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1186%2F1744-859X-7-27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=19105845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FmsF2lug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=27&author=P.+H.+Silverstoneauthor=R.+Williamsauthor=L.+McMahonauthor=R.+Flemingauthor=S.+Fogarty&title=Effect+of+increasing+intraperitoneal+infusion+rates+on+bupropion+hydrochloride-induced+seizures+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of increasing intraperitoneal infusion rates on bupropion hydrochloride-induced seizures in mice</span></div><div class="casAuthors">Silverstone Peter H; Williams Robert; McMahon Louis; Fleming Rosanna; Fogarty Siobhan</div><div class="citationInfo"><span class="NLM_cas:title">Annals of general psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  It is not known if there is a relationship between input rate and incidence of bupropion-induced seizures.  This is important, since different controlled release formulations of bupropion release the active drug at different rates.  METHODS:  We investigated the effect of varying the intraperitoneal infusion rates of bupropion HCl 120 mg/kg, a known convulsive dose 50 (CD50), on the incidence and severity of bupropion-induced convulsions in the Swiss albino mice.  A total of 69 mice, approximately 7 weeks of age, and weighing 21.0 to 29.1 g were randomly assigned to bupropion HCl 120 mg/kg treatment by intraperitoneal (IP) administration in 7 groups (9 to 10 animals per group).  Bupropion HCl was infused through a surgically implanted IP dosing catheter with infusions in each group of 0 min, 15 min, 30 min, 60 min, 90 min, 120 min, and 240 min.  The number, time of onset, duration and the intensity of the convulsions or absence of convulsions were recorded.  RESULTS:  The results showed that IP administration of bupropion HCl 120 mg/kg by bolus injection induced convulsions in 6 out of 10 mice (60% of convulsing mice) in group 1.  Logistic regression analysis revealed that infusion time was significant (p = 0.0004; odds ratio = 0.974) and increasing the IP infusion time of bupropion HCl 120 mg/kg was associated with a 91% reduced odds of convulsions at infusion times of 15 to 90 min compared to bolus injection.  Further increase in infusion time resulted in further reduction in the odds of convulsions to 99.8% reduction at 240 min.  CONCLUSION:  In conclusion, the demonstration of an inverse relationship between infusion time of a fixed and convulsive dose of bupropion and the risk of convulsions in a prospective study is novel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTt1IXJ690iurxanA7vODO6fW6udTcc2eacnHPWrfEaQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FmsF2lug%253D%253D&md5=38de7887416746ea81d01a509cd44b27</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2F1744-859X-7-27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-859X-7-27%26sid%3Dliteratum%253Aachs%26aulast%3DSilverstone%26aufirst%3DP.%2BH.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcMahon%26aufirst%3DL.%26aulast%3DFleming%26aufirst%3DR.%26aulast%3DFogarty%26aufirst%3DS.%26atitle%3DEffect%2520of%2520increasing%2520intraperitoneal%2520infusion%2520rates%2520on%2520bupropion%2520hydrochloride-induced%2520seizures%2520in%2520mice%26jtitle%3DAnn.%2520Gen.%2520Psychiatry%26date%3D2008%26volume%3D7%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolckenhauer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landavazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatch, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M. J.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6768</span><span class="NLM_x">–</span> <span class="NLM_lpage">6781</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901189z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6768-6781&author=F.+I.+Carrollauthor=B.+Bloughauthor=P.+Abrahamauthor=A.+C.+Millsauthor=J.+A.+Hollemanauthor=S.+A.+Wolckenhauerauthor=A.+M.+Deckerauthor=A.+Landavazoauthor=K.+T.+McElroyauthor=H.+A.+Navarroauthor=M.+B.+Gatchauthor=M.+J.+Foster&title=Synthesis+and+Biological+Evaluation+of+Bupropion+Analogues+as+Potential+Pharmacotherapies+for+Cocaine+Addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</span></div><div class="casAuthors">Carroll, F. Ivy; Blough, Bruce E.; Abraham, Philip; Mills, Andrew C.; Holleman, J. Ashley; Wolckenhauer, Scott A.; Decker, Ann M.; Landavazo, Antonio; McElroy, K. Timothy; Navarro, Hernan A.; Gatch, Michael B.; Forster, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6768-6781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of bupropion (I) analogs was synthesized, and their in vitro and in vivo pharmacol. properties evaluated with the goal of developing an analog that had better properties for treating addictions.  Their in vitro pharmacol. properties were examd. by [3H]dopamine ([3H]DA), [3H]serotonin ([3H]5HT), and [3H]norepinephrine ([3H]NE) uptake inhibition studies, and by binding studies at the dopamine, serotonin, and norepinephrine transporters using [125I]RTI-55 in cloned transporters.  Several analogs showed increased [3H]DA uptake inhibition with reduced or little change in [3H]5HT and [3H]NE uptake inhibition relative to bupropion.  Thirty-five analogs were evaluated in a 1 h locomotor activity observation test and 32 in an 8 h locomotor activity observation test and compared to the locomotor activity of cocaine.  Twenty-four analogs were evaluated for generalization to cocaine drug discrimination after i.p. administration, and twelve analogs were tested in a time course cocaine discrimination study using oral administration.  2-(N-Cyclopropylamino)-3-chloropropiophenone (II) had the most favorable in vitro efficacy and in vivo pharmacol. profile for an indirect dopamine agonist pharmacotherapy for treating cocaine, methamphetamine, nicotine, and other drugs of abuse addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpISymClen03bVg90H21EOLACvtfcHk0liZFAs8e-TbZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLnL&md5=b3511748a08e7abf7510ceddb12bbedc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm901189z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901189z%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBlough%26aufirst%3DB.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DMills%26aufirst%3DA.%2BC.%26aulast%3DHolleman%26aufirst%3DJ.%2BA.%26aulast%3DWolckenhauer%26aufirst%3DS.%2BA.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DLandavazo%26aufirst%3DA.%26aulast%3DMcElroy%26aufirst%3DK.%2BT.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DGatch%26aufirst%3DM.%2BB.%26aulast%3DFoster%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Bupropion%2520Analogues%2520as%2520Potential%2520Pharmacotherapies%2520for%2520Cocaine%2520Addiction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6768%26epage%3D6781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Anderson, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. N.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of furan, thiophene, and azole bis[(carbamoyloxy)methyl] derivatives as potential antineoplastic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1559</span><span class="NLM_x">–</span> <span class="NLM_lpage">1565</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00378a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=1559-1565&author=W.+K.+Andersonauthor=A.+N.+Jones&title=Synthesis+and+evaluation+of+furan%2C+thiophene%2C+and+azole+bis%5B%28carbamoyloxy%29methyl%5D+derivatives+as+potential+antineoplastic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00378a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00378a006%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DW.%2BK.%26aulast%3DJones%26aufirst%3DA.%2BN.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520furan%252C%2520thiophene%252C%2520and%2520azole%2520bis%255B%2528carbamoyloxy%2529methyl%255D%2520derivatives%2520as%2520potential%2520antineoplastic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D1559%26epage%3D1565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hoffman, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, J.</span><span> </span><span class="NLM_article-title">A simple, stereoselective synthesis of ketomethylene dipeptide isosteres</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7119</span><span class="NLM_x">–</span> <span class="NLM_lpage">7125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=7119-7125&author=R.+V.+Hoffmanauthor=J.+Tao&title=A+simple%2C+stereoselective+synthesis+of+ketomethylene+dipeptide+isosteres"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DR.%2BV.%26aulast%3DTao%26aufirst%3DJ.%26atitle%3DA%2520simple%252C%2520stereoselective%2520synthesis%2520of%2520ketomethylene%2520dipeptide%2520isosteres%26jtitle%3DTetrahedron%26date%3D1997%26volume%3D53%26spage%3D7119%26epage%3D7125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Koch, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNiro, J.</span><span> </span><span class="NLM_article-title">Unusually weak carbon−carbon single bond</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">7285</span><span class="NLM_x">–</span> <span class="NLM_lpage">7288</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00858a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1975&pages=7285-7288&author=T.+H.+Kochauthor=J.+A.+Olesenauthor=J.+DeNiro&title=Unusually+weak+carbon%E2%88%92carbon+single+bond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja00858a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00858a014%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DT.%2BH.%26aulast%3DOlesen%26aufirst%3DJ.%2BA.%26aulast%3DDeNiro%26aufirst%3DJ.%26atitle%3DUnusually%2520weak%2520carbon%25E2%2588%2592carbon%2520single%2520bond%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1975%26volume%3D97%26spage%3D7285%26epage%3D7288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lukas, R. J.; Fryer, J. D.; Eaton, J. B.; Gentry, C. L.</span><span> </span><span class="NLM_article-title">Some methods for studies of nicotinic acetylcholine receptor pharmacology</span>. In  <span class="citation_source-book">Nicotinic Receptors and the Nervous System</span>; <span class="NLM_contrib-group">Levin, E. D.</span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">3</span>− <span class="NLM_lpage">27</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=3-27&author=R.+J.+Lukas&author=J.+D.+Fryer&author=J.+B.+Eaton&author=C.+L.+Gentryauthor=E.+D.+Levin&title=Nicotinic+Receptors+and+the+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DSome%2520methods%2520for%2520studies%2520of%2520nicotinic%2520acetylcholine%2520receptor%2520pharmacology%26btitle%3DNicotinic%2520Receptors%2520and%2520the%2520Nervous%2520System%26aulast%3DLevin%26aufirst%3DE.%2BD.%26pub%3DCRC%2520Press%26date%3D2002%26spage%3D3%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhlman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinlein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1283-1294&author=J.+B.+Eatonauthor=J.+H.+Pengauthor=K.+M.+Schroederauthor=A.+A.+Georgeauthor=J.+D.+Fryerauthor=C.+Krishnanauthor=L.+Buhlmanauthor=Y.+P.+Kuoauthor=O.+Steinleinauthor=R.+J.+Lukas&title=Characterization+of+human+alpha+4+beta+2-nicotinic+acetylcholine+receptors+stably+and+heterologously+expressed+in+native+nicotinic+receptor-null+SH-EP1+human+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DPeng%26aufirst%3DJ.%2BH.%26aulast%3DSchroeder%26aufirst%3DK.%2BM.%26aulast%3DGeorge%26aufirst%3DA.%2BA.%26aulast%3DFryer%26aufirst%3DJ.%2BD.%26aulast%3DKrishnan%26aufirst%3DC.%26aulast%3DBuhlman%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DY.%2BP.%26aulast%3DSteinlein%26aufirst%3DO.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DCharacterization%2520of%2520human%2520alpha%25204%2520beta%25202-nicotinic%2520acetylcholine%2520receptors%2520stably%2520and%2520heterologously%2520expressed%2520in%2520native%2520nicotinic%2520receptor-null%2520SH-EP1%2520human%2520epithelial%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D1283%26epage%3D1294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Gentry, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=11714893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVCktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=1038-1048&author=C.+L.+Gentryauthor=R.+J.+Lukas&title=Local+anesthetics+noncompetitively+inhibit+function+of+four+distinct+nicotinic+acetylcholine+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes</span></div><div class="casAuthors">Gentry, Cynthia L.; Lukas, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1038-1048</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Local anesthetics (LAs) are considered to act primarily by inhibiting voltage-gated Na+ channels.  However, LAs also are pharmacol. active at other ion channels including nicotinic acetylcholine receptors (nAChR).  NAChR exist as a family of diverse subtypes, each of which has a unique pharmacol. profile.  The current studies established effects of LAs on function of four human nAChR subtypes: naturally expressed muscle-type (α1*-nAChR) or autonomic (α3β4*-nAChR) nAChR, or heterologously expressed nAChR contg. α4 with either β2- or β4-subunits (α4β2- or α4β4-nAChR).  Of the LAs tested, those with structures contg. two sepd. arom. rings (e.g., proadifen and adiphenine) had the greatest inhibition potency (IC50 values between 0.34 and 6.3 μM) but lowest selectivity (∼4-fold) across the four nAChR subtypes examd.  From the fused, two-ring (isoquinoline backbone) class of LAs, dimethisoquin had comparatively moderate inhibition potency (IC50 values between 2.4 and 61 μM) and ∼30-fold selectivity across nAChR subtypes.  Lidocaine, a commonly used LA from the single ring category of LAs, blocked nAChR function with IC50 values of between 52 and 250 μM and had only ∼5-fold selectivity across nAChR subtypes.  Its quaternary tri-Et ammonium analog, QX-314, had greater inhibition potency, but the tri-Me ammonium deriv., QX-222, was the least potent LA at all but the α4β2-nAChR subtype.  With only a few exceptions, LA effects were consistent with noncompetitive inhibition of nAChR function and occurred at therapeutic doses.  These studies suggest structural determinants for LA action at diverse nAChR subtypes and that nAChR likely are clin. relevant targets of LAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgwUhNlMnNWrVg90H21EOLACvtfcHk0ljESdE8nah5vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVCktL0%253D&md5=93812a342040356130830e57ac370bb8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGentry%26aufirst%3DC.%2BL.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DLocal%2520anesthetics%2520noncompetitively%2520inhibit%2520function%2520of%2520four%2520distinct%2520nicotinic%2520acetylcholine%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D1038%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Marubio, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Mar Arroyo-Jimenez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordero-Erausquin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kerchove d’Exaerde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huchet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Reduced antinociception in mice lacking neuronal nicotinic receptor subunits</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=805-810&author=L.+M.+Marubioauthor=M.+del+Mar+Arroyo-Jimenezauthor=M.+Cordero-Erausquinauthor=C.+Lenaauthor=N.+Le+Novereauthor=A.+de+Kerchove+d%E2%80%99Exaerdeauthor=M.+Huchetauthor=M.+I.+Damajauthor=J.+P.+Changeux&title=Reduced+antinociception+in+mice+lacking+neuronal+nicotinic+receptor+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarubio%26aufirst%3DL.%2BM.%26aulast%3Ddel%2BMar%2BArroyo-Jimenez%26aufirst%3DM.%26aulast%3DCordero-Erausquin%26aufirst%3DM.%26aulast%3DLena%26aufirst%3DC.%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3Dde%2BKerchove%2Bd%25E2%2580%2599Exaerde%26aufirst%3DA.%26aulast%3DHuchet%26aufirst%3DM.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DReduced%2520antinociception%2520in%2520mice%2520lacking%2520neuronal%2520nicotinic%2520receptor%2520subunits%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D805%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">D’Amour, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span> </span><span class="NLM_article-title">A method for determining loss of pain sensation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1941</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1941&pages=74-79&author=F.+E.+D%E2%80%99Amourauthor=D.+L.+Smith&title=A+method+for+determining+loss+of+pain+sensation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Amour%26aufirst%3DF.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26atitle%3DA%2520method%2520for%2520determining%2520loss%2520of%2520pain%2520sensation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1941%26volume%3D72%26spage%3D74%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Katsuhiko Moriyama, Masako Kuramochi, Seiji Tsuzuki, Kozo Fujii, <span class="NLM_string-name hlFld-ContribAuthor">Takeshi Morita</span>. </span><span class="cited-content_cbyCitation_article-title">Nitroxyl Catalysts for Six-Membered Ring Bromolactonization and Intermolecular Bromoesterification of Alkenes with Carboxylic Acids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (2)
                                     , 268-273. <a href="https://doi.org/10.1021/acs.orglett.0c03546" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03546%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNitroxyl%252BCatalysts%252Bfor%252BSix-Membered%252BRing%252BBromolactonization%252Band%252BIntermolecular%252BBromoesterification%252Bof%252BAlkenes%252Bwith%252BCarboxylic%252BAcids%26aulast%3DMoriyama%26aufirst%3DKatsuhiko%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D24102020%26date%3D10122020%26volume%3D23%26issue%3D2%26spage%3D268%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">Antonio  Landavazo</span>, <span class="hlFld-ContribAuthor ">John S.  Partilla</span>, <span class="hlFld-ContribAuthor ">Michael H.  Baumann</span>, <span class="hlFld-ContribAuthor ">Ann M.  Decker</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Page</span>, and <span class="hlFld-ContribAuthor ">Richard B.  Rothman</span>  . </span><span class="cited-content_cbyCitation_article-title">Hybrid Dopamine Uptake Blocker–Serotonin Releaser Ligands: A New Twist on Transporter-Focused Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (6)
                                     , 623-627. <a href="https://doi.org/10.1021/ml500113s" title="DOI URL">https://doi.org/10.1021/ml500113s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500113s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500113s%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHybrid%252BDopamine%252BUptake%252BBlocker%2525E2%252580%252593Serotonin%252BReleaser%252BLigands%25253A%252BA%252BNew%252BTwist%252Bon%252BTransporter-Focused%252BTherapeutics%26aulast%3DBlough%26aufirst%3DBruce%2BE.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D05092013%26date%3D15042014%26date%3D25042014%26date%3D12062014%26date%3D15042014%26volume%3D5%26issue%3D6%26spage%3D623%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A Bakarr  Kanu</span>, <span class="hlFld-ContribAuthor ">Simon D.  Brandt</span>, <span class="hlFld-ContribAuthor ">Mike D.  Williams</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, and <span class="hlFld-ContribAuthor ">Herbert H.  Hill</span>  . </span><span class="cited-content_cbyCitation_article-title">Analysis of Psychoactive Cathinones and Tryptamines by Electrospray Ionization Atmospheric Pressure Ion Mobility Time-of-Flight Mass Spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2013,</strong> <em>85 </em>
                                    (18)
                                     , 8535-8542. <a href="https://doi.org/10.1021/ac401951a" title="DOI URL">https://doi.org/10.1021/ac401951a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ac401951a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fac401951a%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DAnalysis%252Bof%252BPsychoactive%252BCathinones%252Band%252BTryptamines%252Bby%252BElectrospray%252BIonization%252BAtmospheric%252BPressure%252BIon%252BMobility%252BTime-of-Flight%252BMass%252BSpectrometry%26aulast%3DKanu%26aufirst%3DA%2BBakarr%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D16112012%26date%3D22072013%26date%3D20082013%26date%3D17092013%26date%3D22072013%26volume%3D85%26issue%3D18%26spage%3D8535%26epage%3D8542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Ivy  Carroll</span>, <span class="hlFld-ContribAuthor ">Ana Z.  Muresan</span>, <span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">Hernán A.  Navarro</span>, <span class="hlFld-ContribAuthor ">S. Wayne  Mascarella</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Huang</span>, <span class="hlFld-ContribAuthor ">M. Imad  Damaj</span>, and <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-(Substituted Phenyl)-3,5,5-trimethylmorpholine Analogues and Their Effects on Monoamine Uptake, Nicotinic Acetylcholine Receptor Function, and Behavioral Effects of Nicotine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (5)
                                     , 1441-1448. <a href="https://doi.org/10.1021/jm1014555" title="DOI URL">https://doi.org/10.1021/jm1014555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1014555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1014555%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-%252528Substituted%252BPhenyl%252529-3%25252C5%25252C5-trimethylmorpholine%252BAnalogues%252Band%252BTheir%252BEffects%252Bon%252BMonoamine%252BUptake%25252C%252BNicotinic%252BAcetylcholine%252BReceptor%252BFunction%25252C%252Band%252BBehavioral%252BEffects%252Bof%252BNicotine%26aulast%3DCarroll%26aufirst%3DF.%2BIvy%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D11112010%26date%3D14022011%26date%3D10032011%26volume%3D54%26issue%3D5%26spage%3D1441%26epage%3D1448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Ivy  Carroll</span>, <span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">S. Wayne  Mascarella</span>, <span class="hlFld-ContribAuthor ">Hernán A.  Navarro</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Ronald, J.  Lukas</span>, and <span class="hlFld-ContribAuthor ">M. Imad  Damaj</span>  . </span><span class="cited-content_cbyCitation_article-title">Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2β-substituted Tropanes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (23)
                                     , 8345-8353. <a href="https://doi.org/10.1021/jm100994w" title="DOI URL">https://doi.org/10.1021/jm100994w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100994w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100994w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNicotinic%252BAcetylcholine%252BReceptor%252BEfficacy%252Band%252BPharmacological%252BProperties%252Bof%252B3-%252528Substituted%252Bphenyl%252529-2%2525CE%2525B2-substituted%252BTropanes%26aulast%3DCarroll%26aufirst%3DF.%2BIvy%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D02082010%26date%3D08112010%26date%3D09122010%26volume%3D53%26issue%3D23%26spage%3D8345%26epage%3D8353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evan D.  Kharasch</span>, <span class="hlFld-ContribAuthor ">Alicia  Neiner</span>, <span class="hlFld-ContribAuthor ">Kristin  Kraus</span>, <span class="hlFld-ContribAuthor ">Jane  Blood</span>, <span class="hlFld-ContribAuthor ">Angela  Stevens</span>, <span class="hlFld-ContribAuthor ">J. Philip  Miller</span>, <span class="hlFld-ContribAuthor ">Eric J.  Lenze</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Steady‐State Disposition and Bioequivalence of Brand and Generic Bupropion in Adults. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>108 </em>
                                    (5)
                                     , 1036-1048. <a href="https://doi.org/10.1002/cpt.1888" title="DOI URL">https://doi.org/10.1002/cpt.1888</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpt.1888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpt.1888%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DStereoselective%252BSteady%2525E2%252580%252590State%252BDisposition%252Band%252BBioequivalence%252Bof%252BBrand%252Band%252BGeneric%252BBupropion%252Bin%252BAdults%26aulast%3DKharasch%26aufirst%3DEvan%2BD.%26date%3D2020%26date%3D2020%26volume%3D108%26issue%3D5%26spage%3D1036%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Murtaza A.  Patharia</span>, <span class="hlFld-ContribAuthor ">Santosh V.  Raut</span>, <span class="hlFld-ContribAuthor ">Bharat K.  Dhotre</span>, <span class="hlFld-ContribAuthor ">Mohammad Arif  Pathan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis of Some New
              N
              -(2-fluoro-4-morpholin-4-yl-phenyl)-Substituted-Benzamide Derivatives and Screening of Their Microbial Activities. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2020,</strong> <em>14 </em>, 1-11. <a href="https://doi.org/10.1080/10406638.2020.1833047" title="DOI URL">https://doi.org/10.1080/10406638.2020.1833047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2020.1833047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2020.1833047%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DDesign%25252C%252BSynthesis%252Bof%252BSome%252BNew%252BN%252B-%2525282-fluoro-4-morpholin-4-yl-phenyl%252529-Substituted-Benzamide%252BDerivatives%252Band%252BScreening%252Bof%252BTheir%252BMicrobial%252BActivities%26aulast%3DPatharia%26aufirst%3DMurtaza%2BA.%26date%3D2020%26date%3D2020%26volume%3D14%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gian Marco  Elisi</span>, <span class="hlFld-ContribAuthor ">Annalida  Bedini</span>, <span class="hlFld-ContribAuthor ">Laura  Scalvini</span>, <span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Silvia  Bartolucci</span>, <span class="hlFld-ContribAuthor ">Valeria  Lucini</span>, <span class="hlFld-ContribAuthor ">Francesco  Scaglione</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Gilberto  Spadoni</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4057. <a href="https://doi.org/10.3390/molecules25184057" title="DOI URL">https://doi.org/10.3390/molecules25184057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184057%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DChiral%252BRecognition%252Bof%252BFlexible%252BMelatonin%252BReceptor%252BLigands%252BInduced%252Bby%252BConformational%252BEquilibria%26aulast%3DElisi%26aufirst%3DGian%2BMarco%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Archana  Kumari</span>, <span class="hlFld-ContribAuthor ">Rajesh K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>96 </em>, 103578. <a href="https://doi.org/10.1016/j.bioorg.2020.103578" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103578%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DMorpholine%252Bas%252Bubiquitous%252Bpharmacophore%252Bin%252Bmedicinal%252Bchemistry%25253A%252BDeep%252Binsight%252Binto%252Bthe%252Bstructure-activity%252Brelationship%252B%252528SAR%252529%26aulast%3DKumari%26aufirst%3DArchana%26date%3D2020%26volume%3D96%26spage%3D103578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Blair K.A.  Willette</span>, <span class="hlFld-ContribAuthor ">Anica  Nangia</span>, <span class="hlFld-ContribAuthor ">Sarah  Howard</span>, <span class="hlFld-ContribAuthor ">Devon  DiPalma</span>, <span class="hlFld-ContribAuthor ">Collin  McMillan</span>, <span class="hlFld-ContribAuthor ">Sonum  Tharwani</span>, <span class="hlFld-ContribAuthor ">Janequia  Evans</span>, <span class="hlFld-ContribAuthor ">Corinne  Wells</span>, <span class="hlFld-ContribAuthor ">Susan  Slade</span>, <span class="hlFld-ContribAuthor ">Brandon J.  Hall</span>, <span class="hlFld-ContribAuthor ">Amir H.  Rezvani</span>, <span class="hlFld-ContribAuthor ">Edward D.  Levin</span>. </span><span class="cited-content_cbyCitation_article-title">Acute and chronic interactive treatments of serotonin 5HT2C and dopamine D1 receptor systems for decreasing nicotine self-administration in female rats. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2019,</strong> <em>186 </em>, 172766. <a href="https://doi.org/10.1016/j.pbb.2019.172766" title="DOI URL">https://doi.org/10.1016/j.pbb.2019.172766</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2019.172766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2019.172766%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DAcute%252Band%252Bchronic%252Binteractive%252Btreatments%252Bof%252Bserotonin%252B5HT2C%252Band%252Bdopamine%252BD1%252Breceptor%252Bsystems%252Bfor%252Bdecreasing%252Bnicotine%252Bself-administration%252Bin%252Bfemale%252Brats%26aulast%3DWillette%26aufirst%3DBlair%2BK.A.%26date%3D2019%26volume%3D186%26spage%3D172766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafaela  Costa</span>, <span class="hlFld-ContribAuthor ">Nuno G.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Ricardo Jorge  Dinis-Oliveira</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2019,</strong> <em>51 </em>
                                    (3)
                                     , 293-313. <a href="https://doi.org/10.1080/03602532.2019.1620763" title="DOI URL">https://doi.org/10.1080/03602532.2019.1620763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03602532.2019.1620763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03602532.2019.1620763%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DPharmacokinetic%252Band%252Bpharmacodynamic%252Bof%252Bbupropion%25253A%252Bintegrative%252Boverview%252Bof%252Brelevant%252Bclinical%252Band%252Bforensic%252Baspects%26aulast%3DCosta%26aufirst%3DRafaela%26date%3D2019%26date%3D2019%26volume%3D51%26issue%3D3%26spage%3D293%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Martin  Berger</span>, <span class="hlFld-ContribAuthor ">Wojciech  Zawodny</span>, <span class="hlFld-ContribAuthor ">Marwan  Simaan</span>, <span class="hlFld-ContribAuthor ">Nuno  Maulide</span>. </span><span class="cited-content_cbyCitation_article-title">A Chemoselective α-Oxytriflation Enables the Direct Asymmetric Arylation of Amides. </span><span class="cited-content_cbyCitation_journal-name">Chem</span><span> <strong>2019,</strong> <em>5 </em>
                                    (7)
                                     , 1883-1891. <a href="https://doi.org/10.1016/j.chempr.2019.05.006" title="DOI URL">https://doi.org/10.1016/j.chempr.2019.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chempr.2019.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chempr.2019.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DChem%26atitle%3DA%252BChemoselective%252B%2525CE%2525B1-Oxytriflation%252BEnables%252Bthe%252BDirect%252BAsymmetric%252BArylation%252Bof%252BAmides%26aulast%3DLi%26aufirst%3DJing%26date%3D2019%26volume%3D5%26issue%3D7%26spage%3D1883%26epage%3D1891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evan D.  Kharasch</span>, <span class="hlFld-ContribAuthor ">Alicia  Neiner</span>, <span class="hlFld-ContribAuthor ">Kristin  Kraus</span>, <span class="hlFld-ContribAuthor ">Jane  Blood</span>, <span class="hlFld-ContribAuthor ">Angela  Stevens</span>, <span class="hlFld-ContribAuthor ">Julia  Schweiger</span>, <span class="hlFld-ContribAuthor ">J. Philip  Miller</span>, <span class="hlFld-ContribAuthor ">Eric J.  Lenze</span>. </span><span class="cited-content_cbyCitation_article-title">Bioequivalence and Therapeutic Equivalence of Generic and Brand Bupropion in Adults With Major Depression: A Randomized Clinical Trial. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>105 </em>
                                    (5)
                                     , 1164-1174. <a href="https://doi.org/10.1002/cpt.1309" title="DOI URL">https://doi.org/10.1002/cpt.1309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpt.1309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpt.1309%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DBioequivalence%252Band%252BTherapeutic%252BEquivalence%252Bof%252BGeneric%252Band%252BBrand%252BBupropion%252Bin%252BAdults%252BWith%252BMajor%252BDepression%25253A%252BA%252BRandomized%252BClinical%252BTrial%26aulast%3DKharasch%26aufirst%3DEvan%2BD.%26date%3D2019%26date%3D2019%26volume%3D105%26issue%3D5%26spage%3D1164%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Sarojinidevi</span>, <span class="hlFld-ContribAuthor ">P.  Subramani</span>, <span class="hlFld-ContribAuthor ">Mani  Jeeva</span>, <span class="hlFld-ContribAuthor ">N.  Sundaraganesan</span>, <span class="hlFld-ContribAuthor ">Maria  SusaiBoobalan</span>, <span class="hlFld-ContribAuthor ">G.  VenkatesaPrabhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, molecular structure, quantum chemical analysis, spectroscopic and molecular docking studies of N-(Morpholinomethyl) succinimide using DFT method. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1175 </em>, 609-623. <a href="https://doi.org/10.1016/j.molstruc.2018.07.101" title="DOI URL">https://doi.org/10.1016/j.molstruc.2018.07.101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2018.07.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2018.07.101%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bmolecular%252Bstructure%25252C%252Bquantum%252Bchemical%252Banalysis%25252C%252Bspectroscopic%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252BN-%252528Morpholinomethyl%252529%252Bsuccinimide%252Busing%252BDFT%252Bmethod%26aulast%3DSarojinidevi%26aufirst%3DK.%26date%3D2019%26volume%3D1175%26spage%3D609%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mashooq  Bhat</span>, <span class="hlFld-ContribAuthor ">Mohamed  Al-Omar</span>, <span class="hlFld-ContribAuthor ">Hazem  Ghabbour</span>, <span class="hlFld-ContribAuthor ">Ahmed  Naglah</span>. </span><span class="cited-content_cbyCitation_article-title">A One-Pot Biginelli Synthesis and Characterization of Novel Dihydropyrimidinone Derivatives Containing Piperazine/Morpholine Moiety. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1559. <a href="https://doi.org/10.3390/molecules23071559" title="DOI URL">https://doi.org/10.3390/molecules23071559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071559%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DA%252BOne-Pot%252BBiginelli%252BSynthesis%252Band%252BCharacterization%252Bof%252BNovel%252BDihydropyrimidinone%252BDerivatives%252BContaining%252BPiperazine%25252FMorpholine%252BMoiety%26aulast%3DBhat%26aufirst%3DMashooq%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. Krishna  Murthy</span>, <span class="hlFld-ContribAuthor ">Y.  Sheena Mary</span>, <span class="hlFld-ContribAuthor ">Y.  Shyma Mary</span>, <span class="hlFld-ContribAuthor ">C. Yohannan  Panicker</span>, <span class="hlFld-ContribAuthor ">V.  Suneetha</span>, <span class="hlFld-ContribAuthor ">Stevan  Armaković</span>, <span class="hlFld-ContribAuthor ">Sanja J.  Armaković</span>, <span class="hlFld-ContribAuthor ">C.  Van Alsenoy</span>, <span class="hlFld-ContribAuthor ">P.A.  Suchetan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, crystal structure analysis, spectral investigations, DFT computations and molecular dynamics and docking study of 4-benzyl-5-oxomorpholine-3-carbamide, a potential bioactive agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1134 </em>, 25-39. <a href="https://doi.org/10.1016/j.molstruc.2016.12.037" title="DOI URL">https://doi.org/10.1016/j.molstruc.2016.12.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2016.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2016.12.037%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bcrystal%252Bstructure%252Banalysis%25252C%252Bspectral%252Binvestigations%25252C%252BDFT%2525C2%2525A0computations%252Band%252Bmolecular%252Bdynamics%252Band%252Bdocking%252Bstudy%252Bof%252B4-benzyl-5-oxomorpholine-3-carbamide%25252C%252Ba%252Bpotential%252Bbioactive%252Bagent%26aulast%3DMurthy%26aufirst%3DP.%2BKrishna%26date%3D2017%26volume%3D1134%26spage%3D25%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chrislean Jun  Botanas</span>, <span class="hlFld-ContribAuthor ">Seong Shoon  Yoon</span>, <span class="hlFld-ContribAuthor ">June Bryan  de la Peña</span>, <span class="hlFld-ContribAuthor ">Irene Joy  dela Peña</span>, <span class="hlFld-ContribAuthor ">Mikyung  Kim</span>, <span class="hlFld-ContribAuthor ">Taeseon  Woo</span>, <span class="hlFld-ContribAuthor ">Joung-Wook  Seo</span>, <span class="hlFld-ContribAuthor ">Choon-Gon  Jang</span>, <span class="hlFld-ContribAuthor ">Kyung-Tae  Park</span>, <span class="hlFld-ContribAuthor ">Young Hun  Lee</span>, <span class="hlFld-ContribAuthor ">Yong Sup  Lee</span>, <span class="hlFld-ContribAuthor ">Hee Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Jae Hoon  Cheong</span>. </span><span class="cited-content_cbyCitation_article-title">A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Brain Research</span><span> <strong>2017,</strong> <em>317 </em>, 494-501. <a href="https://doi.org/10.1016/j.bbr.2016.10.016" title="DOI URL">https://doi.org/10.1016/j.bbr.2016.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbr.2016.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbr.2016.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Brain%2520Research%26atitle%3DA%252Bnovel%252Bsynthetic%252Bcathinone%25252C%252B2-%252528methylamino%252529-1-%252528naphthalen-2-yl%252529%252Bpropan-1-one%252B%252528BMAPN%252529%25252C%252Bproduced%252Brewarding%252Beffects%252Band%252Baltered%252Bstriatal%252Bdopamine-related%252Bgene%252Bexpression%252Bin%252Bmice%26aulast%3DBotanas%26aufirst%3DChrislean%2BJun%26date%3D2017%26volume%3D317%26spage%3D494%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Zdrazil</span>, <span class="hlFld-ContribAuthor ">Eva  Hellsberg</span>, <span class="hlFld-ContribAuthor ">Michael  Viereck</span>, <span class="hlFld-ContribAuthor ">Gerhard F.  Ecker</span>. </span><span class="cited-content_cbyCitation_article-title">From linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporter. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (9)
                                     , 1819-1831. <a href="https://doi.org/10.1039/C6MD00207B" title="DOI URL">https://doi.org/10.1039/C6MD00207B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00207B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00207B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DFrom%252Blinked%252Bopen%252Bdata%252Bto%252Bmolecular%252Binteraction%25253A%252Bstudying%252Bselectivity%252Btrends%252Bfor%252Bligands%252Bof%252Bthe%252Bhuman%252Bserotonin%252Band%252Bdopamine%252Btransporter%26aulast%3DZdrazil%26aufirst%3DBarbara%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D9%26spage%3D1819%26epage%3D1831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Guy  Boiteau</span>, <span class="hlFld-ContribAuthor ">Claire  Bouix-Peter</span>, <span class="hlFld-ContribAuthor ">Sandrine  Chambon</span>, <span class="hlFld-ContribAuthor ">Laurence  Clary</span>, <span class="hlFld-ContribAuthor ">Sebastien  Daver</span>, <span class="hlFld-ContribAuthor ">Laurence  Dumais</span>, <span class="hlFld-ContribAuthor ">Jean-François  Fournier</span>, <span class="hlFld-ContribAuthor ">Craig S.  Harris</span>, <span class="hlFld-ContribAuthor ">Kenny  Mebrouk</span>, <span class="hlFld-ContribAuthor ">Corinne  Millois</span>, <span class="hlFld-ContribAuthor ">Romain  Pierre</span>, <span class="hlFld-ContribAuthor ">Nicolas  Rodeville</span>, <span class="hlFld-ContribAuthor ">Sandrine  Talano</span>, <span class="hlFld-ContribAuthor ">Loïc  Tomas</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient multi-component synthesis of N-1-alkylated 5-nitrouracils from α-amino acids. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (22)
                                     , 2367-2371. <a href="https://doi.org/10.1016/j.tetlet.2016.04.039" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.04.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.04.039%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Bmulti-component%252Bsynthesis%252Bof%252BN-1-alkylated%252B5-nitrouracils%252Bfrom%252B%2525CE%2525B1-amino%252Bacids%26aulast%3DBoiteau%26aufirst%3DJean-Guy%26date%3D2016%26volume%3D57%26issue%3D22%26spage%3D2367%26epage%3D2371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T. I. F. H.  Cremers</span>, <span class="hlFld-ContribAuthor ">G.  Flik</span>, <span class="hlFld-ContribAuthor ">J. H. A.  Folgering</span>, <span class="hlFld-ContribAuthor ">H.  Rollema</span>, <span class="hlFld-ContribAuthor ">R. E.  Stratford</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Rat Plasma and Brain Extracellular Fluid Pharmacokinetic Model for Bupropion and Hydroxybupropion Based on Microdialysis Sampling, and Application to Predict Human Brain Concentrations. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2016,</strong> <em>44 </em>
                                    (5)
                                     , 624-633. <a href="https://doi.org/10.1124/dmd.115.068932" title="DOI URL">https://doi.org/10.1124/dmd.115.068932</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.115.068932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.115.068932%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DDevelopment%252Bof%252Ba%252BRat%252BPlasma%252Band%252BBrain%252BExtracellular%252BFluid%252BPharmacokinetic%252BModel%252Bfor%252BBupropion%252Band%252BHydroxybupropion%252BBased%252Bon%252BMicrodialysis%252BSampling%25252C%252Band%252BApplication%252Bto%252BPredict%252BHuman%252BBrain%252BConcentrations%26aulast%3DCremers%26aufirst%3DT.%2BI.%2BF.%2BH.%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D5%26spage%3D624%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  Malcolm</span>, <span class="hlFld-ContribAuthor ">F. I.  Carroll</span>, <span class="hlFld-ContribAuthor ">B.  Blough</span>, <span class="hlFld-ContribAuthor ">M. I.  Damaj</span>, <span class="hlFld-ContribAuthor ">M.  Shoaib</span>. </span><span class="cited-content_cbyCitation_article-title">Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2015,</strong> <em>232 </em>
                                    (15)
                                     , 2763-2771. <a href="https://doi.org/10.1007/s00213-015-3908-z" title="DOI URL">https://doi.org/10.1007/s00213-015-3908-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-015-3908-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-015-3908-z%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DExamination%252Bof%252Bthe%252Bmetabolite%252Bhydroxybupropion%252Bin%252Bthe%252Breinforcing%252Band%252Baversive%252Bstimulus%252Beffects%252Bof%252Bnicotine%252Bin%252Brats%26aulast%3DMalcolm%26aufirst%3DE.%26date%3D2015%26date%3D2015%26volume%3D232%26issue%3D15%26spage%3D2763%26epage%3D2771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brandon J.  Hall</span>, <span class="hlFld-ContribAuthor ">Susan  Slade</span>, <span class="hlFld-ContribAuthor ">Corinne  Wells</span>, <span class="hlFld-ContribAuthor ">Jed E.  Rose</span>, <span class="hlFld-ContribAuthor ">Edward D.  Levin</span>. </span><span class="cited-content_cbyCitation_article-title">Bupropion–varenicline interactions and nicotine self-administration behavior in rats. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2015,</strong> <em>130 </em>, 84-89. <a href="https://doi.org/10.1016/j.pbb.2015.01.009" title="DOI URL">https://doi.org/10.1016/j.pbb.2015.01.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2015.01.009%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DBupropion%2525E2%252580%252593varenicline%252Binteractions%252Band%252Bnicotine%252Bself-administration%252Bbehavior%252Bin%252Brats%26aulast%3DHall%26aufirst%3DBrandon%2BJ.%26date%3D2015%26volume%3D130%26spage%3D84%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">References. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 290-333. <a href="https://doi.org/10.1002/9781118943670.refs" title="DOI URL">https://doi.org/10.1002/9781118943670.refs</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118943670.refs&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118943670.refs%26sid%3Dliteratum%253Aachs%26atitle%3DReferences%26date%3D2014%26date%3D2014%26spage%3D290%26epage%3D333%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDiscovery%252Bfor%252Bthe%252BTreatment%252Bof%252BAddiction%26aulast%3DFulton%26aufirst%3DBrian%2BS.%26date%3D2014%26volume%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander S.  Belov</span>, <span class="hlFld-ContribAuthor ">Anna V.  Vologzhanina</span>, <span class="hlFld-ContribAuthor ">Valentin V.  Novikov</span>, <span class="hlFld-ContribAuthor ">Valentina V.  Negrutska</span>, <span class="hlFld-ContribAuthor ">Igor Y.  Dubey</span>, <span class="hlFld-ContribAuthor ">Zoya A.  Mikhailova</span>, <span class="hlFld-ContribAuthor ">Ekaterina G.  Lebed</span>, <span class="hlFld-ContribAuthor ">Yan Z.  Voloshin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of the first morpholine-containing iron(II) clathrochelates: A new class of efficient functionalized transcription inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Inorganica Chimica Acta</span><span> <strong>2014,</strong> <em>421 </em>, 300-306. <a href="https://doi.org/10.1016/j.ica.2014.06.016" title="DOI URL">https://doi.org/10.1016/j.ica.2014.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ica.2014.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ica.2014.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganica%2520Chimica%2520Acta%26atitle%3DSynthesis%252Bof%252Bthe%252Bfirst%252Bmorpholine-containing%252Biron%252528II%252529%252Bclathrochelates%25253A%252BA%252Bnew%252Bclass%252Bof%252Befficient%252Bfunctionalized%252Btranscription%252Binhibitors%26aulast%3DBelov%26aufirst%3DAlexander%2BS.%26date%3D2014%26volume%3D421%26spage%3D300%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brandon J.  Hall</span>, <span class="hlFld-ContribAuthor ">Corinne  Wells</span>, <span class="hlFld-ContribAuthor ">Cheyenne  Allenby</span>, <span class="hlFld-ContribAuthor ">Mung Yan  Lin</span>, <span class="hlFld-ContribAuthor ">Ian  Hao</span>, <span class="hlFld-ContribAuthor ">Lindsey  Marshall</span>, <span class="hlFld-ContribAuthor ">Jed E.  Rose</span>, <span class="hlFld-ContribAuthor ">Edward D.  Levin</span>. </span><span class="cited-content_cbyCitation_article-title">Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2014,</strong> <em>120 </em>, 103-108. <a href="https://doi.org/10.1016/j.pbb.2014.02.011" title="DOI URL">https://doi.org/10.1016/j.pbb.2014.02.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2014.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2014.02.011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DDifferential%252Beffects%252Bof%252Bnon-nicotine%252Btobacco%252Bconstituent%252Bcompounds%252Bon%252Bnicotine%252Bself-administration%252Bin%252Brats%26aulast%3DHall%26aufirst%3DBrandon%2BJ.%26date%3D2014%26volume%3D120%26spage%3D103%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Ivy  Carroll</span>, <span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">S. Wayne  Mascarella</span>, <span class="hlFld-ContribAuthor ">Hernán A.  Navarro</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, <span class="hlFld-ContribAuthor ">M. Imad  Damaj</span>. </span><span class="cited-content_cbyCitation_article-title">Bupropion and Bupropion Analogs as Treatments for CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 177-216. <a href="https://doi.org/10.1016/B978-0-12-420118-7.00005-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-420118-7.00005-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-420118-7.00005-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-420118-7.00005-6%26sid%3Dliteratum%253Aachs%26atitle%3DBupropion%252Band%252BBupropion%252BAnalogs%252Bas%252BTreatments%252Bfor%252BCNS%252BDisorders%26aulast%3DCarroll%26aufirst%3DF.%2BIvy%26date%3D2014%26spage%3D177%26epage%3D216%26pub%3DElsevier%26atitle%3DEmerging%252BTargets%252B%252526%252BTherapeutics%252Bin%252Bthe%252BTreatment%252Bof%252BPsychostimulant%252BAbuse%26date%3D2014%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger L.  Papke</span>, <span class="hlFld-ContribAuthor ">Clare  Stokes</span>, <span class="hlFld-ContribAuthor ">Pretal  Muldoon</span>, <span class="hlFld-ContribAuthor ">M.  Imad Damaj</span>. </span><span class="cited-content_cbyCitation_article-title">Similar activity of mecamylamine stereoisomers in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2013,</strong> <em>720 </em>
                                    (1-3)
                                     , 264-275. <a href="https://doi.org/10.1016/j.ejphar.2013.10.018" title="DOI URL">https://doi.org/10.1016/j.ejphar.2013.10.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2013.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2013.10.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DSimilar%252Bactivity%252Bof%252Bmecamylamine%252Bstereoisomers%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DPapke%26aufirst%3DRoger%2BL.%26date%3D2013%26volume%3D720%26issue%3D1-3%26spage%3D264%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. A.  Pal’chikov</span>. </span><span class="cited-content_cbyCitation_article-title">Morpholines. Synthesis and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>49 </em>
                                    (6)
                                     , 787-814. <a href="https://doi.org/10.1134/S1070428013060018" title="DOI URL">https://doi.org/10.1134/S1070428013060018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428013060018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428013060018%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMorpholines.%252BSynthesis%252Band%252Bbiological%252Bactivity%26aulast%3DPal%25E2%2580%2599chikov%26aufirst%3DV.%2BA.%26date%3D2013%26date%3D2013%26volume%3D49%26issue%3D6%26spage%3D787%26epage%3D814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas V.  Cozzi</span>, <span class="hlFld-ContribAuthor ">Simon D.  Brandt</span>, <span class="hlFld-ContribAuthor ">Paul F.  Daley</span>, <span class="hlFld-ContribAuthor ">John S.  Partilla</span>, <span class="hlFld-ContribAuthor ">Richard B.  Rothman</span>, <span class="hlFld-ContribAuthor ">Andreas  Tulzer</span>, <span class="hlFld-ContribAuthor ">Harald H.  Sitte</span>, <span class="hlFld-ContribAuthor ">Michael H.  Baumann</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2013,</strong> <em>699 </em>
                                    (1-3)
                                     , 180-187. <a href="https://doi.org/10.1016/j.ejphar.2012.11.008" title="DOI URL">https://doi.org/10.1016/j.ejphar.2012.11.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2012.11.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DPharmacological%252Bexamination%252Bof%252Btrifluoromethyl%252Bring-substituted%252Bmethcathinone%252Banalogs%26aulast%3DCozzi%26aufirst%3DNicholas%2BV.%26date%3D2013%26volume%3D699%26issue%3D1-3%26spage%3D180%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hugo R.  Arias</span>, <span class="hlFld-ContribAuthor ">Dominik  Feuerbach</span>, <span class="hlFld-ContribAuthor ">Katarzyna M.  Targowska-Duda</span>, <span class="hlFld-ContribAuthor ">Shaili  Aggarwal</span>, <span class="hlFld-ContribAuthor ">David J.  Lapinsky</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Jozwiak</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and functional interaction of (±)-2-(N-tert-butylamino)-3′-iodo-4′-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Neurochemistry International</span><span> <strong>2012,</strong> <em>61 </em>
                                    (8)
                                     , 1433-1441. <a href="https://doi.org/10.1016/j.neuint.2012.10.011" title="DOI URL">https://doi.org/10.1016/j.neuint.2012.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuint.2012.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuint.2012.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemistry%2520International%26atitle%3DStructural%252Band%252Bfunctional%252Binteraction%252Bof%252B%252528%2525C2%2525B1%252529-2-%252528N-tert-butylamino%252529-3%2525E2%252580%2525B2-iodo-4%2525E2%252580%2525B2-azidopropiophenone%25252C%252Ba%252Bphotoreactive%252Bbupropion%252Bderivative%25252C%252Bwith%252Bnicotinic%252Bacetylcholine%252Breceptors%26aulast%3DArias%26aufirst%3DHugo%2BR.%26date%3D2012%26volume%3D61%26issue%3D8%26spage%3D1433%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A Z X  Zhu</span>, <span class="hlFld-ContribAuthor ">L S  Cox</span>, <span class="hlFld-ContribAuthor ">N  Nollen</span>, <span class="hlFld-ContribAuthor ">B  Faseru</span>, <span class="hlFld-ContribAuthor ">K S  Okuyemi</span>, <span class="hlFld-ContribAuthor ">J S  Ahluwalia</span>, <span class="hlFld-ContribAuthor ">N L  Benowitz</span>, <span class="hlFld-ContribAuthor ">R F  Tyndale</span>. </span><span class="cited-content_cbyCitation_article-title">CYP2B6 and Bupropion’s Smoking-Cessation Pharmacology: The Role of Hydroxybupropion. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2012,</strong> <em>92 </em>
                                    (6)
                                     , 771-777. <a href="https://doi.org/10.1038/clpt.2012.186" title="DOI URL">https://doi.org/10.1038/clpt.2012.186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/clpt.2012.186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fclpt.2012.186%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DCYP2B6%252Band%252BBupropion%2525E2%252580%252599s%252BSmoking-Cessation%252BPharmacology%25253A%252BThe%252BRole%252Bof%252BHydroxybupropion%26aulast%3DZhu%26aufirst%3DA%2BZ%2BX%26date%3D2012%26date%3D2012%26volume%3D92%26issue%3D6%26spage%3D771%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Othman A.  Hamed</span>, <span class="hlFld-ContribAuthor ">Arab  El-Qisairi</span>, <span class="hlFld-ContribAuthor ">Hanan  Qaseer</span>, <span class="hlFld-ContribAuthor ">Emad M.  Hamed</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Henry</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Becker</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric α-hydroxy ketone synthesis by direct ketone oxidation using a bimetallic palladium(II) complex. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (22)
                                     , 2699-2701. <a href="https://doi.org/10.1016/j.tetlet.2012.03.066" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.03.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.03.066%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAsymmetric%252B%2525CE%2525B1-hydroxy%252Bketone%252Bsynthesis%252Bby%252Bdirect%252Bketone%252Boxidation%252Busing%252Ba%252Bbimetallic%252Bpalladium%252528II%252529%252Bcomplex%26aulast%3DHamed%26aufirst%3DOthman%2BA.%26date%3D2012%26volume%3D53%26issue%3D22%26spage%3D2699%26epage%3D2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Lapinsky</span>, <span class="hlFld-ContribAuthor ">Shaili  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Tammy L.  Nolan</span>, <span class="hlFld-ContribAuthor ">Christopher K.  Surratt</span>, <span class="hlFld-ContribAuthor ">John R.  Lever</span>, <span class="hlFld-ContribAuthor ">Rejwi  Acharya</span>, <span class="hlFld-ContribAuthor ">Roxanne A.  Vaughan</span>, <span class="hlFld-ContribAuthor ">Akash  Pandhare</span>, <span class="hlFld-ContribAuthor ">Michael P.  Blanton</span>. </span><span class="cited-content_cbyCitation_article-title">(±)-2-(N-tert-Butylamino)-3′-[125I]-iodo-4′-azidopropiophenone: A dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 523-526. <a href="https://doi.org/10.1016/j.bmcl.2011.10.086" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.10.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.10.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.10.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%252528%2525C2%2525B1%252529-2-%252528N-tert-Butylamino%252529-3%2525E2%252580%2525B2-%25255B125I%25255D-iodo-4%2525E2%252580%2525B2-azidopropiophenone%25253A%252BA%252Bdopamine%252Btransporter%252Band%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bphotoaffinity%252Bligand%252Bbased%252Bon%252Bbupropion%252B%252528Wellbutrin%25252C%252BZyban%252529%26aulast%3DLapinsky%26aufirst%3DDavid%2BJ.%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D523%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon D.  Brandt</span>, <span class="hlFld-ContribAuthor ">Sally  Freeman</span>, <span class="hlFld-ContribAuthor ">Harry R.  Sumnall</span>, <span class="hlFld-ContribAuthor ">Fiona  Measham</span>, <span class="hlFld-ContribAuthor ">Jon  Cole</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones. </span><span class="cited-content_cbyCitation_journal-name">Drug Testing and Analysis</span><span> <strong>2011,</strong> <em>3 </em>
                                    (9)
                                     , 569-575. <a href="https://doi.org/10.1002/dta.204" title="DOI URL">https://doi.org/10.1002/dta.204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/dta.204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fdta.204%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Testing%2520and%2520Analysis%26atitle%3DAnalysis%252Bof%252BNRG%252B%2525E2%252580%252598legal%252Bhighs%2525E2%252580%252599%252Bin%252Bthe%252BUK%25253A%252Bidentification%252Band%252Bformation%252Bof%252Bnovel%252Bcathinones%26aulast%3DBrandt%26aufirst%3DSimon%2BD.%26date%3D2011%26date%3D2010%26volume%3D3%26issue%3D9%26spage%3D569%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John P.  Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">Cathinone derivatives: A review of their chemistry, pharmacology and toxicology. </span><span class="cited-content_cbyCitation_journal-name">Drug Testing and Analysis</span><span> <strong>2011,</strong> <em>3 </em>
                                    (7-8)
                                     , 439-453. <a href="https://doi.org/10.1002/dta.313" title="DOI URL">https://doi.org/10.1002/dta.313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/dta.313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fdta.313%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Testing%2520and%2520Analysis%26atitle%3DCathinone%252Bderivatives%25253A%252BA%252Breview%252Bof%252Btheir%252Bchemistry%25252C%252Bpharmacology%252Band%252Btoxicology%26aulast%3DKelly%26aufirst%3DJohn%2BP.%26date%3D2011%26date%3D2011%26volume%3D3%26issue%3D7-8%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) RCH<sub>2</sub>MgBr; (b) TBSOTf, CH<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N; (c) AD-mix-β, <i>t</i>-BuOH/H<sub>2</sub>O; (d) Tf<sub>2</sub>O, proton sponge, 2-amino-2-methyl-1-propanol, CH<sub>3</sub>CN.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) EtMgBr; (b) nBuLi, CH<sub>3</sub>CH<sub>2</sub>CN; (c) Br<sub>2</sub>; (d) 2-amino-2-methyl-1-propanol, CH<sub>3</sub>CN.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Tf<sub>2</sub>O, 2,6-lutidine; (b) 2-amino-2-methyl-1-propanol, CH<sub>2</sub>Cl<sub>2</sub>, −40 °C to RT; (c) arylmagnesium bromide.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>.</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Specific <sup>86</sup>Rb<sup>+</sup> efflux (ordinate; percentage of control) was determined for functional, human muscle-type α1β1γδ-nAChR (●), ganglionic α3β4*-nAChR (○), α4β2-nAChR (▲), or α4β4-nAChR (▽) naturally or heterologously expressed in human cell lines in the presence of a receptor subtype-specific, EC<sub>80</sub>−EC<sub>90</sub> concentration of the full agonist, carbamylcholine, either alone or in the presence of the indicated concentrations (abscissa, log molar) of (2<i>S</i>,3<i>S)</i>-hydroxybupropion [(2<i>S</i>,3<i>S</i>)-<b>4a</b>] or its analogues (compounds <b>4d</b>, <b>4c</b>, and <b>4g</b>) as indicated. Mean micromolar IC<sub>50</sub> values and SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> value are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/medium/jm-2010-003232_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Specific <sup>86</sup>Rb<sup>+</sup> efflux (ordinate; percentage of control) was determined for functional, human muscle-type α1β1γδ-nAChR (●), ganglionic α3β4*-nAChR (○), α4β2-nAChR (▲), or α4β4-nAChR (▽) naturally or heterologously expressed in human cell lines in the presence of a receptor subtype-specific, EC<sub>80</sub>−EC<sub>90</sub> concentration of the full agonist, carbamylcholine, either alone or in the presence of the indicated concentrations (abscissa, log molar) of (2<i>R</i>,3<i>R</i>)-hydroxybupropion [(2<i>R</i>,3<i>R</i>)-<b>4a</b>] or analogues (compounds <b>4s</b>, <b>4w</b>, and <b>4t</b>) as indicated. Mean micromolar IC<sub>50</sub> values and SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> value are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-12/jm1003232/production/images/large/jm-2010-003232_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1003232&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Centers for Disease Control and Prevention</span><span class="NLM_x">. </span>Smoking and Tobacco Use—Fact Sheet: Health Effects of Cigarette Smoking, (updated January<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">) </span>,<a href="http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/" class="extLink">http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Centers+for+Disease+Control+and+Prevention&title=Smoking+and+Tobacco+Use%E2%80%94Fact+Sheet%3A+Health+Effects+of+Cigarette+Smoking"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DSmoking%2520and%2520Tobacco%2520Use%25E2%2580%2594Fact%2520Sheet%253A%2520Health%2520Effects%2520of%2520Cigarette%2520Smoking%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">US Department of Health and Human Services</span><span class="NLM_x">. </span> <span class="citation_source-book">The Health Consequences of Smoking: What It Means to You</span>; <span class="NLM_publisher-name">NIH</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=US+Department+of+Health+and+Human+Services&title=The+Health+Consequences+of+Smoking%3A+What+It+Means+to+You"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DThe%2520Health%2520Consequences%2520of%2520Smoking%253A%2520What%2520It%2520Means%2520to%2520You%26pub%3DNIH%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">SAMHSA (Substance Abuse and Mental Health Services Administration)</span><span class="NLM_x">. </span> <span class="citation_source-book">Results from the 2008 National Survey on Drug Use and Health</span>; <span class="NLM_publisher-name">Department of Health and Human Services</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=SAMHSA+%28Substance+Abuse+and+Mental+Health+Services+Administration%29&title=Results+from+the+2008+National+Survey+on+Drug+Use+and+Health"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DResults%2520from%2520the%25202008%2520National%2520Survey%2520on%2520Drug%2520Use%2520and%2520Health%26pub%3DDepartment%2520of%2520Health%2520and%2520Human%2520Services%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeSage, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benowitz, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigall, W. A.</span><span> </span><span class="NLM_article-title">Translational research in medication development for nicotine dependence</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=746-762&author=C.+Lermanauthor=M.+G.+LeSageauthor=K.+A.+Perkinsauthor=S.+S.+O%E2%80%99Malleyauthor=S.+J.+Siegelauthor=N.+L.+Benowitzauthor=W.+A.+Corrigall&title=Translational+research+in+medication+development+for+nicotine+dependence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerman%26aufirst%3DC.%26aulast%3DLeSage%26aufirst%3DM.%2BG.%26aulast%3DPerkins%26aufirst%3DK.%2BA.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%2BS.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26aulast%3DBenowitz%26aufirst%3DN.%2BL.%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26atitle%3DTranslational%2520research%2520in%2520medication%2520development%2520for%2520nicotine%2520dependence%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D746%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corringer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences</span> <span class="citation_source-journal">J. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1002%2Fneu.10153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=12436412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1KlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=447-456&author=N.+Le+Novereauthor=P.+J.+Corringerauthor=J.+P.+Changeux&title=The+diversity+of+subunit+composition+in+nAChRs%3A+evolutionary+origins%2C+physiologic+and+pharmacologic+consequences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences</span></div><div class="casAuthors">Le Novere, Nicolas; Corringer, Pierre-Jean; Changeux, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-456</span>CODEN:
                <span class="NLM_cas:coden">JNEUBZ</span>;
        ISSN:<span class="NLM_cas:issn">0022-3034</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Nicotinic acetylcholine receptors are made up of homologous subunits, which are encoded by a large multigene family.  The wide no. of receptor oligomers generated display variable pharmacol. properties.  One of the main questions underlying research in mol. pharmacol. resides in the actual role of this diversity.  It is generally assumed that the obsd. differences between the pharmacol. of homologous receptors, for instance, the EC50 for the endogenous agonist, or the kinetics of desensitization, bear some kind of physiol. relevance in vivo.  Here we develop the quite challenging point of view that, at least within a given subfamily of nicotinic receptor subunits, the pharmacol. variability obsd. in vitro would not be directly relevant to the function of receptor proteins in vivo.  In vivo responses are not expected to be sensitive to mild differences in affinities, and several examples of functional replacement of 1 subunit by another have been unraveled by knockout animals.  The diversity of subunits might have been conserved through evolution primarily to account for the topol. diversity of subunit distribution patterns, at the cellular and subcellular levels.  A quant. variation of pharmacol. properties would be tolerated within a physiol. envelope, as a consequence of a near-neutral genetic drift.  Such a gratuitous pharmacol. diversity is nevertheless of practical interest for the design of drugs, which would specifically tackle particular receptor oligomers with a defined subunit compn. among the multiple nicotinic receptors present in the organism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqAH4UkSOhFLVg90H21EOLACvtfcHk0ljxoH7LaN1G_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1KlsLg%253D&md5=e1b495f93280d9fd3109e67b22e90c4c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fneu.10153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fneu.10153%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DCorringer%26aufirst%3DP.%2BJ.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520diversity%2520of%2520subunit%2520composition%2520in%2520nAChRs%253A%2520evolutionary%2520origins%252C%2520physiologic%2520and%2520pharmacologic%2520consequences%26jtitle%3DJ.%2520Neurobiol.%26date%3D2002%26volume%3D53%26spage%3D447%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Heterogeneity and complexity of native brain nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1102-1111&author=C.+Gottiauthor=M.+Morettiauthor=A.+Gaimarriauthor=A.+Zanardiauthor=F.+Clementiauthor=M.+Zoli&title=Heterogeneity+and+complexity+of+native+brain+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DZanardi%26aufirst%3DA.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DHeterogeneity%2520and%2520complexity%2520of%2520native%2520brain%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1102%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, A. C.</span><span> </span><span class="NLM_article-title">Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzilate</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1982&pages=554-564&author=M.+J.+Marksauthor=A.+C.+Collins&title=Characterization+of+nicotine+binding+in+mouse+brain+and+comparison+with+the+binding+of+%CE%B1-bungarotoxin+and+quinuclidinyl+benzilate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26atitle%3DCharacterization%2520of%2520nicotine%2520binding%2520in%2520mouse%2520brain%2520and%2520comparison%2520with%2520the%2520binding%2520of%2520%25CE%25B1-bungarotoxin%2520and%2520quinuclidinyl%2520benzilate%26jtitle%3DMol.%2520Pharmacol.%26date%3D1982%26volume%3D22%26spage%3D554%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Hernandez, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction</span> <span class="citation_source-journal">CNS Neurol. Disord. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.2174%2F187152708786927831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=19128201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFansQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=422-441&author=S.+Rahmanauthor=G.+Y.+Lopez-Hernandezauthor=W.+A.+Corrigallauthor=R.+L.+Papke&title=Neuronal+nicotinic+receptors+as+brain+targets+for+pharmacotherapy+of+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction</span></div><div class="casAuthors">Rahman, Shafiqur; Lopez-Hernandez, Gretchen Y.; Corrigall, William A.; Papke, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-441</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotine addiction and other forms of drug addiction continue to be significant public health problems in the United States and the rest of the world.  Accumulated evidence indicates that brain nicotinic acetylcholine receptors (nAChRs) are a heterogenous family of ion channels expressed in the various parts of the brain.  A growing body of preclin. studies suggests that brain nAChRs are crit. targets for the development of pharmacotherapies for nicotine and other drug addictions.  In this review, we will discuss the nAChR subtypes, their function in response to endogenous brain transmitters, and how their functions are regulated in the presence of nicotine.  Furthermore, we will discuss the role of nAChRs in mediating nicotine-induced addictive behavior in animal models.  Addnl., we will provide an overview of the effects of nicotine and nicotinic compds. on the mesolimbic dopamine system, part of the reinforcement/reward circuitry of the brain, as an example of the neurochem. basis of nicotine addiction and other drug addictions.  An appreciation of the complexity of nicotinic receptors and their regulation will be necessary for the development of nicotinic receptor modulators as potential pharmacotherapy for drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuQExQTuj1E7Vg90H21EOLACvtfcHk0liOiXMlL3Wq9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFansQ%253D%253D&md5=1e358be78d8fd3b9da199e25dbb950a5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F187152708786927831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708786927831%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DLopez-Hernandez%26aufirst%3DG.%2BY.%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26atitle%3DNeuronal%2520nicotinic%2520receptors%2520as%2520brain%2520targets%2520for%2520pharmacotherapy%2520of%2520drug%2520addiction%26jtitle%3DCNS%2520Neurol.%2520Disord.%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D422%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Adams, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutter, T. J.</span><span> </span><span class="NLM_article-title">Calcium permeability and modulation of nicotinic acetylcholine receptor-channels in rat parasympathetic neurons</span> <span class="citation_source-journal">J. Physiol. (Paris)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1992&pages=67-76&author=D.+J.+Adamsauthor=T.+J.+Nutter&title=Calcium+permeability+and+modulation+of+nicotinic+acetylcholine+receptor-channels+in+rat+parasympathetic+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DNutter%26aufirst%3DT.%2BJ.%26atitle%3DCalcium%2520permeability%2520and%2520modulation%2520of%2520nicotinic%2520acetylcholine%2520receptor-channels%2520in%2520rat%2520parasympathetic%2520neurons%26jtitle%3DJ.%2520Physiol.%2520%2528Paris%2529%26date%3D1992%26volume%3D86%26spage%3D67%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2428</span><span class="NLM_x">–</span> <span class="NLM_lpage">2439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1111%2Fj.1460-9568.1996.tb01206.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=8950106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A280%3ADyaK2s7gslemuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=2428-2439&author=N.+Le+Novereauthor=M.+Zoliauthor=J.+P.+Changeux&title=Neuronal+nicotinic+receptor+alpha+6+subunit+mRNA+is+selectively+concentrated+in+catecholaminergic+nuclei+of+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain</span></div><div class="casAuthors">Le Novere N; Zoli M; Changeux J P</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2428-39</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Although the neuronal nicotinic receptor alpha 6 subunit was cloned several years ago, its functional significance remains to be investigated.  Here we describe an in situ hybridization study of the mRNA for this subunit in the adult rat central nervous system using oligonucleotide probes.  Specific alpha 6 mRNA labelling was restricted to a few nuclei throughout the brain; it was particularly high in several catecholaminergic nuclei [the locus coeruleus (A6), the ventral tegmental area (A10) and the substantia nigra (A9)] at levels significantly higher than those found for any other known nicotinic receptor subunit mRNA.  Labelling for alpha 6 mRNA was also detected at lower levels in the reticular thalamic nucleus, the supramammillary nucleus and the mesencephalic V nucleus.  Some cells of the medial habenula (medioventral part) and of the interpeduncular nucleus (central and lateral parts) were also labelled.  The distribution of alpha 6 mRNA was compared with the distribution of the other known nicotinic acetylcholine receptor subunit mRNAs.  In several nuclei, the expression of alpha 6 was complementary to those of other alpha subunits.  Moreover, some of the cell groups (such as the substantia nigra, the ventral tegmental area and the locus coeruleus) previously thought to contain mainly alpha 3 mRNA in fact were found to contain high levels of alpha 6 mRNA.  Finally, we found extensive colocalization of alpha 6 and beta 3, indicating the possible existence of nicotinic receptor hetero-oligomers containing both subunits.  The present results show that alpha 6 is the major nicotinic acetylcholine receptor alpha subunit expressed in dopaminergic cell groups of the mesencephalon and noradrenergic cells of the locus coeruleus.  This suggests the involvement of the alpha 6 subunit in some of the major functions of central nicotinic circuits, including the modulation of locomotor behaviour and reward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGTspW95ieGmK_SFaaT9INfW6udTcc2ebqumnhXhVu57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7gslemuw%253D%253D&md5=1703784567106fda7afda74e1ca6e554</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1996.tb01206.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1996.tb01206.x%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520alpha%25206%2520subunit%2520mRNA%2520is%2520selectively%2520concentrated%2520in%2520catecholaminergic%2520nuclei%2520of%2520the%2520rat%2520brain%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1996%26volume%3D8%26spage%3D2428%26epage%3D2439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Goldner, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineley, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, J. W.</span><span> </span><span class="NLM_article-title">Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha6 to dopaminergic neurons in the substantia nigra and ventral tegmental area</span> <span class="citation_source-journal">Neuroreport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2739</span><span class="NLM_x">–</span> <span class="NLM_lpage">2742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=2739-2742&author=F.+M.+Goldnerauthor=K.+T.+Dineleyauthor=J.+W.+Patrick&title=Immunohistochemical+localization+of+the+nicotinic+acetylcholine+receptor+subunit+alpha6+to+dopaminergic+neurons+in+the+substantia+nigra+and+ventral+tegmental+area"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldner%26aufirst%3DF.%2BM.%26aulast%3DDineley%26aufirst%3DK.%2BT.%26aulast%3DPatrick%26aufirst%3DJ.%2BW.%26atitle%3DImmunohistochemical%2520localization%2520of%2520the%2520nicotinic%2520acetylcholine%2520receptor%2520subunit%2520alpha6%2520to%2520dopaminergic%2520neurons%2520in%2520the%2520substantia%2520nigra%2520and%2520ventral%2520tegmental%2520area%26jtitle%3DNeuroreport%26date%3D1997%26volume%3D8%26spage%3D2739%26epage%3D2742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Exley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, S. J.</span><span> </span><span class="NLM_article-title">Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2158</span><span class="NLM_x">–</span> <span class="NLM_lpage">2166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2158-2166&author=R.+Exleyauthor=M.+A.+Clementsauthor=H.+Hartungauthor=J.+M.+McIntoshauthor=S.+J.+Cragg&title=Alpha6-containing+nicotinic+acetylcholine+receptors+dominate+the+nicotine+control+of+dopamine+neurotransmission+in+nucleus+accumbens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DExley%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%2BA.%26aulast%3DHartung%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DCragg%26aufirst%3DS.%2BJ.%26atitle%3DAlpha6-containing%2520nicotinic%2520acetylcholine%2520receptors%2520dominate%2520the%2520nicotine%2520control%2520of%2520dopamine%2520neurotransmission%2520in%2520nucleus%2520accumbens%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D2158%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Taly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corringer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guedin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=733-750&author=A.+Talyauthor=P.+J.+Corringerauthor=D.+Guedinauthor=P.+Lestageauthor=J.+P.+Changeux&title=Nicotinic+receptors%3A+allosteric+transitions+and+therapeutic+targets+in+the+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaly%26aufirst%3DA.%26aulast%3DCorringer%26aufirst%3DP.%2BJ.%26aulast%3DGuedin%26aufirst%3DD.%26aulast%3DLestage%26aufirst%3DP.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DNicotinic%2520receptors%253A%2520allosteric%2520transitions%2520and%2520therapeutic%2520targets%2520in%2520the%2520nervous%2520system%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D733%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Corrigall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. B.</span><span> </span><span class="NLM_article-title">The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1992&pages=285-289&author=W.+A.+Corrigallauthor=K.+B.+Franklinauthor=K.+M.+Coenauthor=P.+B.+Clarke&title=The+mesolimbic+dopaminergic+system+is+implicated+in+the+reinforcing+effects+of+nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26aulast%3DFranklin%26aufirst%3DK.%2BB.%26aulast%3DCoen%26aufirst%3DK.%2BM.%26aulast%3DClarke%26aufirst%3DP.%2BB.%26atitle%3DThe%2520mesolimbic%2520dopaminergic%2520system%2520is%2520implicated%2520in%2520the%2520reinforcing%2520effects%2520of%2520nicotine%26jtitle%3DPsychopharmacology%26date%3D1992%26volume%3D107%26spage%3D285%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Brody, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olmstead, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farahi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkern, M. A.</span><span> </span><span class="NLM_article-title">Smoking-induced ventral striatum dopamine release</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1176%2Fappi.ajp.161.7.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=15229053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A280%3ADC%252BD2czis1yqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=1211-1218&author=A.+L.+Brodyauthor=R.+E.+Olmsteadauthor=E.+D.+Londonauthor=J.+Farahiauthor=J.+H.+Meyerauthor=P.+Grossmanauthor=G.+S.+Leeauthor=J.+Huangauthor=E.+L.+Hahnauthor=M.+A.+Mandelkern&title=Smoking-induced+ventral+striatum+dopamine+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Smoking-induced ventral striatum dopamine release</span></div><div class="casAuthors">Brody Arthur L; Olmstead Richard E; London Edythe D; Farahi Judah; Meyer Jeffrey H; Grossman Paul; Lee Grace S; Huang Joe; Hahn Emily L; Mandelkern Mark A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1211-8</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Substantial evidence from animal models demonstrates that dopamine release in the ventral striatum underlies the reinforcing properties of nicotine.  The authors used [(11)C]raclopride bolus-plus-continuous-infusion positron emission tomography (PET) to determine smoking-induced ventral striatum dopamine release in humans.  METHOD:  Twenty nicotine-dependent smokers (who smoked > or =15 cigarettes/day) underwent a [(11)C]raclopride bolus-plus-continuous-infusion PET session.  During the session, subjects had a 10-minute break outside the PET apparatus during which 10 subjects smoked a cigarette and 10 did not smoke (as a control condition).  RESULTS:  The group that smoked had greater reductions in [(11)C]raclopride binding potential in ventral striatum regions of interest than the group that did not smoke, particularly in the left ventral caudate/nucleus accumbens and left ventral putamen (range for smoking group=-25.9% to -36.6% reduction).  Significant correlations were found between change from before to after the smoking break in craving ratings and change from before to after the break in binding potential for these two regions.  CONCLUSIONS:  Nicotine-dependent subjects who smoked during a break in PET scanning had greater reductions in [(11)C]raclopride binding potential (an indirect measure of dopamine release) than nicotine-dependent subjects who did not smoke.  The magnitude of binding potential changes was comparable to that found in studies that used similar methods to examine the effects of other addictive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRk4_DvvsbbrpggzHGM8X5CfW6udTcc2ebm9JZF-SPigbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czis1yqtg%253D%253D&md5=745fbf6bd4538acec7ac76bbca229ce9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.7.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.7.1211%26sid%3Dliteratum%253Aachs%26aulast%3DBrody%26aufirst%3DA.%2BL.%26aulast%3DOlmstead%26aufirst%3DR.%2BE.%26aulast%3DLondon%26aufirst%3DE.%2BD.%26aulast%3DFarahi%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DGrossman%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DG.%2BS.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DE.%2BL.%26aulast%3DMandelkern%26aufirst%3DM.%2BA.%26atitle%3DSmoking-induced%2520ventral%2520striatum%2520dopamine%2520release%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D1211%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Johnston, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadbetter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmith, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durcan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, B.</span><span> </span><span class="NLM_article-title">Pharmacokinetic optimization of sustained-release bupropion for smoking cessation</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=11-24&issue=Suppl+2&author=A.+J.+Johnstonauthor=J.+Ascherauthor=R.+Leadbetterauthor=V.+D.+Schmithauthor=D.+K.+Patelauthor=M.+Durcanauthor=B.+Bentley&title=Pharmacokinetic+optimization+of+sustained-release+bupropion+for+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DA.%2BJ.%26aulast%3DAscher%26aufirst%3DJ.%26aulast%3DLeadbetter%26aufirst%3DR.%26aulast%3DSchmith%26aufirst%3DV.%2BD.%26aulast%3DPatel%26aufirst%3DD.%2BK.%26aulast%3DDurcan%26aufirst%3DM.%26aulast%3DBentley%26aufirst%3DB.%26atitle%3DPharmacokinetic%2520optimization%2520of%2520sustained-release%2520bupropion%2520for%2520smoking%2520cessation%26jtitle%3DDrugs%26date%3D2002%26volume%3D62%26issue%3DSuppl%25202%26spage%3D11%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hesse, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatakrishnan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Moltke, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shader, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. J.</span><span> </span><span class="NLM_article-title">CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1176-1183&author=L.+M.+Hesseauthor=K.+Venkatakrishnanauthor=M.+H.+Courtauthor=L.+L.+von+Moltkeauthor=S.+X.+Duanauthor=R.+I.+Shaderauthor=D.+J.+Greenblatt&title=CYP2B6+mediates+the+in+vitro+hydroxylation+of+bupropion%3A+potential+drug+interactions+with+other+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHesse%26aufirst%3DL.%2BM.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DCourt%26aufirst%3DM.%2BH.%26aulast%3Dvon%2BMoltke%26aufirst%3DL.%2BL.%26aulast%3DDuan%26aufirst%3DS.%2BX.%26aulast%3DShader%26aufirst%3DR.%2BI.%26aulast%3DGreenblatt%26aufirst%3DD.%2BJ.%26atitle%3DCYP2B6%2520mediates%2520the%2520in%2520vitro%2520hydroxylation%2520of%2520bupropion%253A%2520potential%2520drug%2520interactions%2520with%2520other%2520antidepressants%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2000%26volume%3D28%26spage%3D1176%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Faucette, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecluyse, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shord, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laethem, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindley, C. M.</span><span> </span><span class="NLM_article-title">Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=1222-1230&author=S.+R.+Faucetteauthor=R.+L.+Hawkeauthor=E.+L.+Lecluyseauthor=S.+S.+Shordauthor=B.+Yanauthor=R.+M.+Laethemauthor=C.+M.+Lindley&title=Validation+of+bupropion+hydroxylation+as+a+selective+marker+of+human+cytochrome+P450+2B6+catalytic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaucette%26aufirst%3DS.%2BR.%26aulast%3DHawke%26aufirst%3DR.%2BL.%26aulast%3DLecluyse%26aufirst%3DE.%2BL.%26aulast%3DShord%26aufirst%3DS.%2BS.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DLaethem%26aufirst%3DR.%2BM.%26aulast%3DLindley%26aufirst%3DC.%2BM.%26atitle%3DValidation%2520of%2520bupropion%2520hydroxylation%2520as%2520a%2520selective%2520marker%2520of%2520human%2520cytochrome%2520P450%25202B6%2520catalytic%2520activity%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2000%26volume%3D28%26spage%3D1222%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Faucette, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shord, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecluyse, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindley, C. M.</span><span> </span><span class="NLM_article-title">Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1129</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=1123-1129&author=S.+R.+Faucetteauthor=R.+L.+Hawkeauthor=S.+S.+Shordauthor=E.+L.+Lecluyseauthor=C.+M.+Lindley&title=Evaluation+of+the+contribution+of+cytochrome+P450+3A4+to+human+liver+microsomal+bupropion+hydroxylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaucette%26aufirst%3DS.%2BR.%26aulast%3DHawke%26aufirst%3DR.%2BL.%26aulast%3DShord%26aufirst%3DS.%2BS.%26aulast%3DLecluyse%26aufirst%3DE.%2BL.%26aulast%3DLindley%26aufirst%3DC.%2BM.%26atitle%3DEvaluation%2520of%2520the%2520contribution%2520of%2520cytochrome%2520P450%25203A4%2520to%2520human%2520liver%2520microsomal%2520bupropion%2520hydroxylation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D1123%26epage%3D1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondareva, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Behavioral and biochemical investigations of bupropion metabolites</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">474</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1016%2FS0014-2999%2803%2902010-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=12909199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFyms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2003&pages=85-93&author=M.+L.+Bondarevauthor=T.+S.+Bondarevaauthor=R.+Youngauthor=R.+A.+Glennon&title=Behavioral+and+biochemical+investigations+of+bupropion+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and biochemical investigations of bupropion metabolites</span></div><div class="casAuthors">Bondarev, Mikhail L.; Bondareva, Tatiana S.; Young, Richard; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The stimulus effects of bupropion metabolites were examd. in a drug discrimination procedure using (-)nicotine- and (+)amphetamine-trained rats.  (+)- And (-)threohydrobupropion partially substituted in each group.  R,R-hydroxybupropion produced vehicle-appropriate responding in (-)nicotine animals but, when given in combination with the training dose of (-)nicotine, resulted in an attenuated effect.  S,S-Hydroxybupropion partially (66%) substituted for (-)nicotine.  In (+)amphetamine-trained animals, S,S-hydroxybupropion (ED50=4.4 mg/kg) generalized completely and was similar in potency to bupropion (ED50=5.4 mg/kg).  Bupropion and its metabolites lacked affinity for nicotinic acetylcholinergic receptors, but all antagonized (-)nicotine-induced 86Rb+ efflux in cells expressing α3β4 nicotinic cholinergic receptors.  S,S-Hydroxybupropion possessed affinity at the dopamine transporter comparable to bupropion, and was also found to bind at the norepinephrine transporter.  Although it is unlikely that any metabolite isomer is chiefly responsible for the stimulus actions of bupropion, some probably play a role in the complex actions of this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgimuwMhfmhrVg90H21EOLACvtfcHk0ljX7L2t3FBEPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFyms7s%253D&md5=cd1a5d83d88f14454e99ff8315b952c5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2902010-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252902010-7%26sid%3Dliteratum%253Aachs%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DBondareva%26aufirst%3DT.%2BS.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBehavioral%2520and%2520biochemical%2520investigations%2520of%2520bupropion%2520metabolites%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D474%26spage%3D85%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirza, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=675-682&author=M.+I.+Damajauthor=F.+I.+Carrollauthor=J.+B.+Eatonauthor=H.+A.+Navarroauthor=B.+E.+Bloughauthor=S.+Mirzaauthor=R.+J.+Lukasauthor=B.+R.+Martin&title=Enantioselective+effects+of+hydroxy+metabolites+of+bupropion+on+behavior+and+on+function+of+monoamine+transporters+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DMirza%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DEnantioselective%2520effects%2520of%2520hydroxy%2520metabolites%2520of%2520bupropion%2520on%2520behavior%2520and%2520on%2520function%2520of%2520monoamine%2520transporters%2520and%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D675%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Jefferson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradko, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, K. T.</span><span> </span><span class="NLM_article-title">Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1016%2Fj.clinthera.2005.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=16368442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlWntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1685-1695&author=J.+W.+Jeffersonauthor=J.+F.+Pradkoauthor=K.+T.+Muir&title=Bupropion+for+major+depressive+disorder%3A+Pharmacokinetic+and+formulation+considerations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Bupropion for major depressive disorder: pharmacokinetic and formulation considerations</span></div><div class="casAuthors">Jefferson, James W.; Pradko, James F.; Muir, Keith T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1685-1695</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: Major depressive disorder (MDD) is a common psychiatric condition, with 6.6% of the adult population in the United States experiencing a major depressive episode during any given year.  Depressed patients must receive adequate treatment to maximize the likelihood of clin. success.  Bupropion hydrochloride, a noradrenergic/dopaminergic antidepressant, is available in 3 oral formulations: immediate release (IR) (given TID), sustained release (SR) (given BID), and extended release (XL) (given QD).  Understanding the pharmacokinetic (PK) properties and formulations of bupropion can help optimize clin. use.  Objectives: The aims of this article were to provide a review of the PK properties of bupropion and identify its various formulations and clin. applications to help optimize treatment of MDD.  Methods: In this review, data concerning PK trials/reports were collected from articles identified using a PubMed search.  The search was conducted without date limitations and using the search terms bupropion, bupropion SR, bupropion XL, bupropion pharmacokinetics, bupropion metab., and bupropion drug interactions.  Addnl. reports were selected from refs. that appeared in articles identified in the original search.  In addn., data from studies summarized in product information and labeling were obtained.  All available information, concg. on studies in humans, pertinent to bupropion PK properties and/or formulations was included.  Results: Bupropion is extensively metabolized by the liver (t1/2, ∼21 h).  Hydroxybupropion, the primary active metabolite (t1/2, ∼20 h), is formed by cytochrome P 450 (CYP) 2B6.  At steady state, Cmax of hydroxybupropion is 4- to 7-fold higher, and the AUC is ∼10-fold greater, compared with those of the parent drug.  Threohydrobupropion and erythrohydrobupropion (mean [SD] t1/2 values, ∼37 [13] and ∼33 [10] hours, resp.), the other active metabolites of bupropion, are formed via nonmicrosomal pathways.  Relative to bupropion, the Cmax values are ∼5-fold greater for threohydrobupropion and similar for erythrohydrobupropion.  Based on a mouse antitetrabenazine model, hydroxybupropion is ∼50% as active as bupropion, and threohydrobupropion and erythrohydrobupropion are ∼20% as active as bupropion.  Bupropion lowers the seizure threshold and, therefore, concurrent administration with other agents that lower the seizure threshold should be undertaken cautiously.  Potential interactions with other agents that are metabolized by CYP2B6 should be considered.  In addn., bupropion inhibits CYP2D6 and may reduce clearance of agents metabolized by this enzyme.  Absorption of the XL formulation is prolonged compared with the IR and SR formulations (Tmax, ∼5 h vs ∼1.5 and ∼3 h, resp.).  Bupropion is dosed without regard to food.  Conclusions: Understanding the PK profile and formulations of bupropion can help optimize clin. use.  Bupropion is metabolized extensively, resulting in 3 active metabolites.  This metabolic profile, various patient factors (eg, age, medical illnesses), and potential drug interactions should be considered when prescribing bupropion.  The 3 formulations-bupropion, bupropion SR, and bupropion XL-are bioequivalent and offer options to optimize treatment for patients with MDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT3CDzRR147rVg90H21EOLACvtfcHk0liku6wiFENGkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlWntQ%253D%253D&md5=a97383a3d5b93a852add3e2d986d1aa2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DJefferson%26aufirst%3DJ.%2BW.%26aulast%3DPradko%26aufirst%3DJ.%2BF.%26aulast%3DMuir%26aufirst%3DK.%2BT.%26atitle%3DBupropion%2520for%2520major%2520depressive%2520disorder%253A%2520Pharmacokinetic%2520and%2520formulation%2520considerations%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1685%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kharasch, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coles, R.</span><span> </span><span class="NLM_article-title">Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1177%2F0091270008314254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=18287571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=464-474&author=E.+D.+Kharaschauthor=D.+Mitchellauthor=R.+Coles&title=Stereoselective+bupropion+hydroxylation+as+an+in+vivo+phenotypic+probe+for+cytochrome+P4502B6+%28CYP2B6%29+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity</span></div><div class="casAuthors">Kharasch, Evan D.; Mitchell, Darain; Coles, Rebecka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">464-474</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The clearance of racemic bupropion, metabolized selectively by CYP2B6 in vitro, has been used clin. to phenotype CYP2B6 activity, polymorphisms, and drug interactions but has known limitations.  Bupropion hydroxylation by CYP2B6 is stereoselective.  This investigation assessed the stereoselectivity of bupropion pharmacokinetics and the influence of CYP2B6 induction.  Ten healthy volunteers received immediate-release bupropion before and after 7 days of rifampin.  Plasma and urine bupropion and hydroxybupropion were analyzed using a stereoselective assay.  Plasma area under the curve (AUC0-∞) and max. concns. were 3-fold greater for R- than S-bupropion.  Bupropion apparent oral clearance was 3- and 2-fold greater for S- than R- and R,S-bupropion, resp.  Hydroxybupropion plasma AUC0-∞ and elimination half-life were significantly less for (S,S)- than (R,R)- and the racemate.  (S,S)-hydroxybupropion was formation rate limited, whereas (R,R)-hydroxybupropion and the race-mate were elimination rate limited.  Rifampin doubled both R- and S-bupropion clearance and caused 4-fold increases in both (R,R)- and (S,S)-hydroxybupropion formation clearances.  Increases in the plasma hydroxybupropion/bupropion AUC0-∞ ratio were greater for (S,S)- than (R,R)-hydroxybupropion.  Simplified plasma and urine metrics of stereoselective bupropion metab. and clearance were identified.  Because metabolite formation clearance is the best in vivo metric of enzyme activity and due, therefore, to faster S-bupropion elimination and formation rate-limited (S,S)-hydroxybupropion kinetics, stereoselective S-bupropion hydroxylation and (S,S)-hydroxybupropion formation clearance may be a useful and improved phenotypic probe for CYP2B6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKWGq-Fnd6xbVg90H21EOLACvtfcHk0liku6wiFENGkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslKntLg%253D&md5=220bf3a8f9c4d2e334870473344db952</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1177%2F0091270008314254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270008314254%26sid%3Dliteratum%253Aachs%26aulast%3DKharasch%26aufirst%3DE.%2BD.%26aulast%3DMitchell%26aufirst%3DD.%26aulast%3DColes%26aufirst%3DR.%26atitle%3DStereoselective%2520bupropion%2520hydroxylation%2520as%2520an%2520in%2520vivo%2520phenotypic%2520probe%2520for%2520cytochrome%2520P4502B6%2520%2528CYP2B6%2529%2520activity%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D48%26spage%3D464%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fang, Q. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senanayake, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wald, S. A.</span><span> </span><span class="NLM_article-title">Rapid access to enantiopure bupropion and its major metabolite by stereospecific nucleophilic substitution on an α-ketotriflate</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3659</span><span class="NLM_x">–</span> <span class="NLM_lpage">3663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=3659-3663&author=Q.+K.+Fangauthor=Z.+Hanauthor=P.+Groverauthor=D.+Kesslerauthor=C.+H.+Senanayakeauthor=S.+A.+Wald&title=Rapid+access+to+enantiopure+bupropion+and+its+major+metabolite+by+stereospecific+nucleophilic+substitution+on+an+%CE%B1-ketotriflate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DQ.%2BK.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DGrover%26aufirst%3DP.%26aulast%3DKessler%26aufirst%3DD.%26aulast%3DSenanayake%26aufirst%3DC.%2BH.%26aulast%3DWald%26aufirst%3DS.%2BA.%26atitle%3DRapid%2520access%2520to%2520enantiopure%2520bupropion%2520and%2520its%2520major%2520metabolite%2520by%2520stereospecific%2520nucleophilic%2520substitution%2520on%2520an%2520%25CE%25B1-ketotriflate%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2000%26volume%3D11%26spage%3D3659%26epage%3D3663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kelley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musso, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boswell, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroko, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. R.</span><span> </span><span class="NLM_article-title">(2<i>S</i>,3<i>S</i>,5<i>R</i>)-2-(3,5-Difluorophenyl)-3,5-dimethyl-2-morpholinol: a novel antidepressant agent and selective inhibitor of norepinephrine uptake</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950630p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=347-349&author=J.+L.+Kelleyauthor=D.+L.+Mussoauthor=G.+E.+Boswellauthor=F.+E.+Sorokoauthor=B.+R.+Cooper&title=%282S%2C3S%2C5R%29-2-%283%2C5-Difluorophenyl%29-3%2C5-dimethyl-2-morpholinol%3A+a+novel+antidepressant+agent+and+selective+inhibitor+of+norepinephrine+uptake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm950630p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950630p%26sid%3Dliteratum%253Aachs%26aulast%3DKelley%26aufirst%3DJ.%2BL.%26aulast%3DMusso%26aufirst%3DD.%2BL.%26aulast%3DBoswell%26aufirst%3DG.%2BE.%26aulast%3DSoroko%26aufirst%3DF.%2BE.%26aulast%3DCooper%26aufirst%3DB.%2BR.%26atitle%3D%25282S%252C3S%252C5R%2529-2-%25283%252C5-Difluorophenyl%2529-3%252C5-dimethyl-2-morpholinol%253A%2520a%2520novel%2520antidepressant%2520agent%2520and%2520selective%2520inhibitor%2520of%2520norepinephrine%2520uptake%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D347%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumbay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martens, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span> </span><span class="NLM_article-title">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=10215666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=877-885&author=A.+J.+Eshlemanauthor=M.+Carmolliauthor=M.+Cumbayauthor=C.+R.+Martensauthor=K.+A.+Neveauthor=A.+Janowsky&title=Characteristics+of+drug+interactions+with+recombinant+biogenic+amine+transporters+expressed+in+the+same+cell+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span></div><div class="casAuthors">Eshleman, Amy J.; Carmolli, Marya; Cumbay, Medhane; Martens, Carey R.; Neve, Kim A.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of drugs on the uptake of [3H]neurotransmitter by and the binding of [125I]3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester ([125I]RTI-55) to the recombinant human dopamine (hDAT), serotonin (hSERT), or norepinephrine (hNET) transporters stably expressed in human embryonic kidney 293 cells were studied.  RTI-55 had similar affinity for the hDAT and hSERT and lower affinity for hNET (Kd = 1.83, 0.98, and 12.1 nM, resp.).  Kinetic anal. of [125I]RTI-55 binding indicated that the dissocn. rate (k-1) was significantly lower for hSERT and the assocn. rate (k+1) was significantly lower for hNET compared with the hDAT.  The potency of drugs at blocking [3H]neurotransmitter uptake was highly correlated with potency at blocking radioligand binding for hDAT and hSERT.  Substrates were more potent at the inhibition of [3H]neurotransmitter uptake than radioligand binding.  The potency of drugs was highly correlated between displacement of [3H]nisoxetine (Kd = 6.0 nM) and [125I]RTI-55 from the hNET, suggesting that these radioligands recognize similar sites on the transporter protein.  The correlation obsd. between inhibitory potency for uptake and binding of either ligand at the hNET was lower than correlations between uptake and binding for hDAT and hSERT.  The present results indicate that the cocaine analog [125I]RTI-55 has unique binding properties at each of the transporters and that the use of recombinant transporters expressed by a single cell type can provide a powerful screening tool for drugs interacting with biogenic amine transporters, such as possible cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn_1UJqie3bVg90H21EOLACvtfcHk0liku6wiFENGkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D&md5=c808b4d81da86e57460406d2163c5e65</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DCarmolli%26aufirst%3DM.%26aulast%3DCumbay%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DC.%2BR.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DCharacteristics%2520of%2520drug%2520interactions%2520with%2520recombinant%2520biogenic%2520amine%2520transporters%2520expressed%2520in%2520the%2520same%2520cell%2520type%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei-Yin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassco, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Antinociceptive responses to nicotinic acertylcholine receptors ligands after systemic amd inthathecal administration in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=9495867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADyaK1cXhs1ygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1998&pages=1058-1065&author=M.+I.+Damajauthor=M.+Fei-Yinauthor=M.+Dukatauthor=W.+Glasscoauthor=R.+A.+Glennonauthor=B.+R.+Martin&title=Antinociceptive+responses+to+nicotinic+acertylcholine+receptors+ligands+after+systemic+amd+inthathecal+administration+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice</span></div><div class="casAuthors">Damaj, M. I.; Fei-Yin, M.; Dukat, M.; Glassco, W.; Glennon, R. A.; Martin, B. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1058-1065</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The objective of this study was to det. which nicotinic receptor subtypes are involved in antinociception and their site of action.  For that, the antinociceptive effects of several nicotinic receptor ligands were evaluated in the tail-flick test both after s.c. and intrathecal (i.t.) administration.  Nicotine and other nicotine agonists increased tail-flick latencies in a dose-dependent manner after both routes of administration.  Epibatidine enantiomers were the most potent agonists examd.  Cytisine, a potent nicotinic ligand, failed to elicit antinociception when injected either i.t. or s.c.  Despite some similarities in the effects of nicotinic agonists after i.t. and s.c. injections, their rank-order potency was different.  In contrast to the s.c. results, the stereoselectivity of nicotine's effect after i.t. administration was minimal.  When various nicotinic antagonists were compared after i.t. and s.c. administration, the results showed that mecamylamine and dihydro-β-erythroidine differ in potency and their degree of antagonism of some of the nicotinic agonists given i.t.  These data suggest that different subtypes of nicotinic receptors may exist in the spinal cord.  A good correlation was found between binding affinity to [3H]-nicotine binding sites and analgesic potency after i.t. (r = 0.82), suggesting the involvement of α4β2 receptor subunits.  In contrast, studies with MLA and α-BGTX suggested a minimal role for α-BGTX-sensitive receptors in the antinociceptive effect of nicotinic agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6OOvP1aoamLVg90H21EOLACvtfcHk0lhCncN9ecadnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs1ygs74%253D&md5=41c0c91b2db51d949ab33215e07536d9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DFei-Yin%26aufirst%3DM.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DGlassco%26aufirst%3DW.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DAntinociceptive%2520responses%2520to%2520nicotinic%2520acertylcholine%2520receptors%2520ligands%2520after%2520systemic%2520amd%2520inthathecal%2520administration%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D284%26spage%3D1058%26epage%3D1065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarella, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2204</span><span class="NLM_x">–</span> <span class="NLM_lpage">2214</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9017465" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2204-2214&author=F.+I.+Carrollauthor=B.+E.+Bloughauthor=S.+W.+Mascarellaauthor=H.+A.+Navarroauthor=J.+B.+Eatonauthor=R.+J.+Lukasauthor=M.+I.+Damaj&title=Synthesis+and+Biological+Evaluation+of+Bupropion+Analogues+as+Potential+Pharmacotherapies+for+Smoking+Cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm9017465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9017465%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Bupropion%2520Analogues%2520as%2520Potential%2520Pharmacotherapies%2520for%2520Smoking%2520Cessation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2204%26epage%3D2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Silverstone, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogarty, S.</span><span> </span><span class="NLM_article-title">Effect of increasing intraperitoneal infusion rates on bupropion hydrochloride-induced seizures in mice</span> <span class="citation_source-journal">Ann. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm1003232&amp;key=10.1186%2F1744-859X-7-27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=19105845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FmsF2lug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=27&author=P.+H.+Silverstoneauthor=R.+Williamsauthor=L.+McMahonauthor=R.+Flemingauthor=S.+Fogarty&title=Effect+of+increasing+intraperitoneal+infusion+rates+on+bupropion+hydrochloride-induced+seizures+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of increasing intraperitoneal infusion rates on bupropion hydrochloride-induced seizures in mice</span></div><div class="casAuthors">Silverstone Peter H; Williams Robert; McMahon Louis; Fleming Rosanna; Fogarty Siobhan</div><div class="citationInfo"><span class="NLM_cas:title">Annals of general psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  It is not known if there is a relationship between input rate and incidence of bupropion-induced seizures.  This is important, since different controlled release formulations of bupropion release the active drug at different rates.  METHODS:  We investigated the effect of varying the intraperitoneal infusion rates of bupropion HCl 120 mg/kg, a known convulsive dose 50 (CD50), on the incidence and severity of bupropion-induced convulsions in the Swiss albino mice.  A total of 69 mice, approximately 7 weeks of age, and weighing 21.0 to 29.1 g were randomly assigned to bupropion HCl 120 mg/kg treatment by intraperitoneal (IP) administration in 7 groups (9 to 10 animals per group).  Bupropion HCl was infused through a surgically implanted IP dosing catheter with infusions in each group of 0 min, 15 min, 30 min, 60 min, 90 min, 120 min, and 240 min.  The number, time of onset, duration and the intensity of the convulsions or absence of convulsions were recorded.  RESULTS:  The results showed that IP administration of bupropion HCl 120 mg/kg by bolus injection induced convulsions in 6 out of 10 mice (60% of convulsing mice) in group 1.  Logistic regression analysis revealed that infusion time was significant (p = 0.0004; odds ratio = 0.974) and increasing the IP infusion time of bupropion HCl 120 mg/kg was associated with a 91% reduced odds of convulsions at infusion times of 15 to 90 min compared to bolus injection.  Further increase in infusion time resulted in further reduction in the odds of convulsions to 99.8% reduction at 240 min.  CONCLUSION:  In conclusion, the demonstration of an inverse relationship between infusion time of a fixed and convulsive dose of bupropion and the risk of convulsions in a prospective study is novel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTt1IXJ690iurxanA7vODO6fW6udTcc2eYjYrPh27rLwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FmsF2lug%253D%253D&md5=38de7887416746ea81d01a509cd44b27</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2F1744-859X-7-27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-859X-7-27%26sid%3Dliteratum%253Aachs%26aulast%3DSilverstone%26aufirst%3DP.%2BH.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcMahon%26aufirst%3DL.%26aulast%3DFleming%26aufirst%3DR.%26aulast%3DFogarty%26aufirst%3DS.%26atitle%3DEffect%2520of%2520increasing%2520intraperitoneal%2520infusion%2520rates%2520on%2520bupropion%2520hydrochloride-induced%2520seizures%2520in%2520mice%26jtitle%3DAnn.%2520Gen.%2520Psychiatry%26date%3D2008%26volume%3D7%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolckenhauer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landavazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatch, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M. J.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6768</span><span class="NLM_x">–</span> <span class="NLM_lpage">6781</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901189z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6768-6781&author=F.+I.+Carrollauthor=B.+Bloughauthor=P.+Abrahamauthor=A.+C.+Millsauthor=J.+A.+Hollemanauthor=S.+A.+Wolckenhauerauthor=A.+M.+Deckerauthor=A.+Landavazoauthor=K.+T.+McElroyauthor=H.+A.+Navarroauthor=M.+B.+Gatchauthor=M.+J.+Foster&title=Synthesis+and+Biological+Evaluation+of+Bupropion+Analogues+as+Potential+Pharmacotherapies+for+Cocaine+Addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</span></div><div class="casAuthors">Carroll, F. Ivy; Blough, Bruce E.; Abraham, Philip; Mills, Andrew C.; Holleman, J. Ashley; Wolckenhauer, Scott A.; Decker, Ann M.; Landavazo, Antonio; McElroy, K. Timothy; Navarro, Hernan A.; Gatch, Michael B.; Forster, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6768-6781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of bupropion (I) analogs was synthesized, and their in vitro and in vivo pharmacol. properties evaluated with the goal of developing an analog that had better properties for treating addictions.  Their in vitro pharmacol. properties were examd. by [3H]dopamine ([3H]DA), [3H]serotonin ([3H]5HT), and [3H]norepinephrine ([3H]NE) uptake inhibition studies, and by binding studies at the dopamine, serotonin, and norepinephrine transporters using [125I]RTI-55 in cloned transporters.  Several analogs showed increased [3H]DA uptake inhibition with reduced or little change in [3H]5HT and [3H]NE uptake inhibition relative to bupropion.  Thirty-five analogs were evaluated in a 1 h locomotor activity observation test and 32 in an 8 h locomotor activity observation test and compared to the locomotor activity of cocaine.  Twenty-four analogs were evaluated for generalization to cocaine drug discrimination after i.p. administration, and twelve analogs were tested in a time course cocaine discrimination study using oral administration.  2-(N-Cyclopropylamino)-3-chloropropiophenone (II) had the most favorable in vitro efficacy and in vivo pharmacol. profile for an indirect dopamine agonist pharmacotherapy for treating cocaine, methamphetamine, nicotine, and other drugs of abuse addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpISymClen03bVg90H21EOLACvtfcHk0ljpAl8KQH5LqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLnL&md5=b3511748a08e7abf7510ceddb12bbedc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm901189z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901189z%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBlough%26aufirst%3DB.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DMills%26aufirst%3DA.%2BC.%26aulast%3DHolleman%26aufirst%3DJ.%2BA.%26aulast%3DWolckenhauer%26aufirst%3DS.%2BA.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DLandavazo%26aufirst%3DA.%26aulast%3DMcElroy%26aufirst%3DK.%2BT.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DGatch%26aufirst%3DM.%2BB.%26aulast%3DFoster%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Bupropion%2520Analogues%2520as%2520Potential%2520Pharmacotherapies%2520for%2520Cocaine%2520Addiction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6768%26epage%3D6781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Anderson, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. N.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of furan, thiophene, and azole bis[(carbamoyloxy)methyl] derivatives as potential antineoplastic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1559</span><span class="NLM_x">–</span> <span class="NLM_lpage">1565</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00378a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=1559-1565&author=W.+K.+Andersonauthor=A.+N.+Jones&title=Synthesis+and+evaluation+of+furan%2C+thiophene%2C+and+azole+bis%5B%28carbamoyloxy%29methyl%5D+derivatives+as+potential+antineoplastic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00378a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00378a006%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DW.%2BK.%26aulast%3DJones%26aufirst%3DA.%2BN.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520furan%252C%2520thiophene%252C%2520and%2520azole%2520bis%255B%2528carbamoyloxy%2529methyl%255D%2520derivatives%2520as%2520potential%2520antineoplastic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D1559%26epage%3D1565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hoffman, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, J.</span><span> </span><span class="NLM_article-title">A simple, stereoselective synthesis of ketomethylene dipeptide isosteres</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7119</span><span class="NLM_x">–</span> <span class="NLM_lpage">7125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=7119-7125&author=R.+V.+Hoffmanauthor=J.+Tao&title=A+simple%2C+stereoselective+synthesis+of+ketomethylene+dipeptide+isosteres"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DR.%2BV.%26aulast%3DTao%26aufirst%3DJ.%26atitle%3DA%2520simple%252C%2520stereoselective%2520synthesis%2520of%2520ketomethylene%2520dipeptide%2520isosteres%26jtitle%3DTetrahedron%26date%3D1997%26volume%3D53%26spage%3D7119%26epage%3D7125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Koch, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNiro, J.</span><span> </span><span class="NLM_article-title">Unusually weak carbon−carbon single bond</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">7285</span><span class="NLM_x">–</span> <span class="NLM_lpage">7288</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00858a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1975&pages=7285-7288&author=T.+H.+Kochauthor=J.+A.+Olesenauthor=J.+DeNiro&title=Unusually+weak+carbon%E2%88%92carbon+single+bond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja00858a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00858a014%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DT.%2BH.%26aulast%3DOlesen%26aufirst%3DJ.%2BA.%26aulast%3DDeNiro%26aufirst%3DJ.%26atitle%3DUnusually%2520weak%2520carbon%25E2%2588%2592carbon%2520single%2520bond%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1975%26volume%3D97%26spage%3D7285%26epage%3D7288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lukas, R. J.; Fryer, J. D.; Eaton, J. B.; Gentry, C. L.</span><span> </span><span class="NLM_article-title">Some methods for studies of nicotinic acetylcholine receptor pharmacology</span>. In  <span class="citation_source-book">Nicotinic Receptors and the Nervous System</span>; <span class="NLM_contrib-group">Levin, E. D.</span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">3</span>− <span class="NLM_lpage">27</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=3-27&author=R.+J.+Lukas&author=J.+D.+Fryer&author=J.+B.+Eaton&author=C.+L.+Gentryauthor=E.+D.+Levin&title=Nicotinic+Receptors+and+the+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DSome%2520methods%2520for%2520studies%2520of%2520nicotinic%2520acetylcholine%2520receptor%2520pharmacology%26btitle%3DNicotinic%2520Receptors%2520and%2520the%2520Nervous%2520System%26aulast%3DLevin%26aufirst%3DE.%2BD.%26pub%3DCRC%2520Press%26date%3D2002%26spage%3D3%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhlman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinlein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1283-1294&author=J.+B.+Eatonauthor=J.+H.+Pengauthor=K.+M.+Schroederauthor=A.+A.+Georgeauthor=J.+D.+Fryerauthor=C.+Krishnanauthor=L.+Buhlmanauthor=Y.+P.+Kuoauthor=O.+Steinleinauthor=R.+J.+Lukas&title=Characterization+of+human+alpha+4+beta+2-nicotinic+acetylcholine+receptors+stably+and+heterologously+expressed+in+native+nicotinic+receptor-null+SH-EP1+human+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DPeng%26aufirst%3DJ.%2BH.%26aulast%3DSchroeder%26aufirst%3DK.%2BM.%26aulast%3DGeorge%26aufirst%3DA.%2BA.%26aulast%3DFryer%26aufirst%3DJ.%2BD.%26aulast%3DKrishnan%26aufirst%3DC.%26aulast%3DBuhlman%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DY.%2BP.%26aulast%3DSteinlein%26aufirst%3DO.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DCharacterization%2520of%2520human%2520alpha%25204%2520beta%25202-nicotinic%2520acetylcholine%2520receptors%2520stably%2520and%2520heterologously%2520expressed%2520in%2520native%2520nicotinic%2520receptor-null%2520SH-EP1%2520human%2520epithelial%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D1283%26epage%3D1294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Gentry, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm1003232&amp;key=11714893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm1003232&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVCktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=1038-1048&author=C.+L.+Gentryauthor=R.+J.+Lukas&title=Local+anesthetics+noncompetitively+inhibit+function+of+four+distinct+nicotinic+acetylcholine+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes</span></div><div class="casAuthors">Gentry, Cynthia L.; Lukas, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1038-1048</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Local anesthetics (LAs) are considered to act primarily by inhibiting voltage-gated Na+ channels.  However, LAs also are pharmacol. active at other ion channels including nicotinic acetylcholine receptors (nAChR).  NAChR exist as a family of diverse subtypes, each of which has a unique pharmacol. profile.  The current studies established effects of LAs on function of four human nAChR subtypes: naturally expressed muscle-type (α1*-nAChR) or autonomic (α3β4*-nAChR) nAChR, or heterologously expressed nAChR contg. α4 with either β2- or β4-subunits (α4β2- or α4β4-nAChR).  Of the LAs tested, those with structures contg. two sepd. arom. rings (e.g., proadifen and adiphenine) had the greatest inhibition potency (IC50 values between 0.34 and 6.3 μM) but lowest selectivity (∼4-fold) across the four nAChR subtypes examd.  From the fused, two-ring (isoquinoline backbone) class of LAs, dimethisoquin had comparatively moderate inhibition potency (IC50 values between 2.4 and 61 μM) and ∼30-fold selectivity across nAChR subtypes.  Lidocaine, a commonly used LA from the single ring category of LAs, blocked nAChR function with IC50 values of between 52 and 250 μM and had only ∼5-fold selectivity across nAChR subtypes.  Its quaternary tri-Et ammonium analog, QX-314, had greater inhibition potency, but the tri-Me ammonium deriv., QX-222, was the least potent LA at all but the α4β2-nAChR subtype.  With only a few exceptions, LA effects were consistent with noncompetitive inhibition of nAChR function and occurred at therapeutic doses.  These studies suggest structural determinants for LA action at diverse nAChR subtypes and that nAChR likely are clin. relevant targets of LAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgwUhNlMnNWrVg90H21EOLACvtfcHk0ljRtkJDDMp6Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVCktL0%253D&md5=93812a342040356130830e57ac370bb8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGentry%26aufirst%3DC.%2BL.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DLocal%2520anesthetics%2520noncompetitively%2520inhibit%2520function%2520of%2520four%2520distinct%2520nicotinic%2520acetylcholine%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D1038%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Marubio, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Mar Arroyo-Jimenez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordero-Erausquin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kerchove d’Exaerde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huchet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Reduced antinociception in mice lacking neuronal nicotinic receptor subunits</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">398</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=1999&pages=805-810&author=L.+M.+Marubioauthor=M.+del+Mar+Arroyo-Jimenezauthor=M.+Cordero-Erausquinauthor=C.+Lenaauthor=N.+Le+Novereauthor=A.+de+Kerchove+d%E2%80%99Exaerdeauthor=M.+Huchetauthor=M.+I.+Damajauthor=J.+P.+Changeux&title=Reduced+antinociception+in+mice+lacking+neuronal+nicotinic+receptor+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarubio%26aufirst%3DL.%2BM.%26aulast%3Ddel%2BMar%2BArroyo-Jimenez%26aufirst%3DM.%26aulast%3DCordero-Erausquin%26aufirst%3DM.%26aulast%3DLena%26aufirst%3DC.%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3Dde%2BKerchove%2Bd%25E2%2580%2599Exaerde%26aufirst%3DA.%26aulast%3DHuchet%26aufirst%3DM.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DReduced%2520antinociception%2520in%2520mice%2520lacking%2520neuronal%2520nicotinic%2520receptor%2520subunits%26jtitle%3DNature%26date%3D1999%26volume%3D398%26spage%3D805%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">D’Amour, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span> </span><span class="NLM_article-title">A method for determining loss of pain sensation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1941</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1941&pages=74-79&author=F.+E.+D%E2%80%99Amourauthor=D.+L.+Smith&title=A+method+for+determining+loss+of+pain+sensation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Amour%26aufirst%3DF.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26atitle%3DA%2520method%2520for%2520determining%2520loss%2520of%2520pain%2520sensation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1941%26volume%3D72%26spage%3D74%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a href="/doi/suppl/10.1021/jm1003232">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_52784"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1003232/suppl_file/jm1003232_si_001.pdf">jm1003232_si_001.pdf (27.21 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm1003232&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm1003232%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-12" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm1003232" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992f05db3f3dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
